An evaluation of supplemental methionine sources for lactating dairy cows by Ordway, Ryan S
University of New Hampshire
University of New Hampshire Scholars' Repository
Doctoral Dissertations Student Scholarship
Spring 2005
An evaluation of supplemental methionine sources
for lactating dairy cows
Ryan S. Ordway
University of New Hampshire, Durham
Follow this and additional works at: https://scholars.unh.edu/dissertation
This Dissertation is brought to you for free and open access by the Student Scholarship at University of New Hampshire Scholars' Repository. It has
been accepted for inclusion in Doctoral Dissertations by an authorized administrator of University of New Hampshire Scholars' Repository. For more
information, please contact nicole.hentz@unh.edu.
Recommended Citation
Ordway, Ryan S., "An evaluation of supplemental methionine sources for lactating dairy cows" (2005). Doctoral Dissertations. 271.
https://scholars.unh.edu/dissertation/271




B.S., The Pennsylvania State University; 1999 
M.S., The Pennsylvania State University, 2001
DISSERTATION
Submitted to the University of New Hampshire 
in Partial Fulfillment of 
the Requirements for the Degree of
Doctor of Philosophy 
in
Animal and Nutritional Sciences
May, 2005
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
UMI Number: 3169088
INFORMATION TO USERS
The quality of this reproduction is dependent upon the quality of the copy 
submitted. Broken or indistinct print, colored or poor quality illustrations and 
photographs, print bleed-through, substandard margins, and improper 
alignment can adversely affect reproduction.
In the unlikely event that the author did not send a complete manuscript 
and there are missing pages, these will be noted. Also, if unauthorized 
copyright material had to be removed, a note will indicate the deletion.
®
UMI
UMI Microform 3169088 
Copyright 2005 by ProQuest Information and Learning Company. 
All rights reserved. This microform edition is protected against 
unauthorized copying under Title 17, United States Code.
ProQuest Information and Learning Company 
300 North Zeeb Road 
P.O. Box 1346 
Ann Arbor, Ml 48106-1346
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
This dissertation has been examined and approved.
Dissertation Director, Dr. Charles G. Schwab
Professor of Animal and Nutritional Sciences
0 /7
Dr. Peter S. Erickson,
Associate Professor of Animal and Nutritional Sciences
f t  l (  S
Dr. Brian K. Sloan, /
Ruminant Methionine Products Manager 
Adisseo USA, Inc., Alpharetta. GA
Dr. Samuel C. Smith
Professor of Animal and Nutritional Sciences
•iormand R. SUPierre"
Professor of Animal and Nutritional Sciences 
The Ohio State University, Columbus, OH
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
DEDICATION
To my wife, Melissa, for her support, encouragement, patience, and dedication in helping 
me pursue my Ph.D.
iii
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
ACKNOWLEDGEMENTS
I would like to thank my committee members, Dr. Peter S. Erickson, Dr. Brian K. 
Sloan, Dr. Samuel C. Smith, and Dr. Normand R. St-Pierre for their guidance, assistance, 
time, wisdom, and evaluation o f my research and dissertation.
Special thanks to Nancy Whitehouse for her laboratory and sampling assistance. 
Thanks to my fellow graduate students both in Ritzman Laboratory and in Kendall Hall 
for their assistance in the laboratory and in sample collection, and for their 
encouragement.
I would also like to thank the staff of the Fairchild Dairy Teaching and Research 
Center for their assistance in choosing cows for research, for their dedication and 
patience during sample collection, and for their assistance in feeding and maintaining the 
health and well-being o f the research cows. I would especially like to thank Tina Savage 
and Frank Saglio for their personal friendship and for their unending concern for the 
health and well-being of the research cows and for their sincere concern interest in my 
research.
A great appreciation is extended to all of the faculty and staff members of the 
Department of Animal and Nutritional Sciences for their support and help whenever I 
needed it. Their genuine concern and interest in my research and graduate career was 
greatly appreciated.
A special thanks to Clyde and Jane Kuhns for employing a green teenager who 
knew nothing about dairy farming, for their patience in answering all of my many
iv
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
questions, and for putting up with my many mistakes. Their kindness, patience, and 
support in teaching me about dairy farming is what led me into my career in agriculture.
I would like to thank Dr. Gabriella Varga for accepting me into her laboratory to 
conduct my Master o f Science degree. Her continued mentorship and guidance is greatly 
appreciated.
I would like to thank my family and friends for always being there for me when I 
needed to talk or needed encouragement. I have always been blessed with great people in 
my life and without my friends and family, I would be nothing. Special thanks go to my 
late grandparents, Llewellyn and Frances Zullinger, my grandparents, William and Grace 
Commerer, Fred Lundy, Jack and Tina Savage, Frank Saglio, Jessica Cherry, Darren 
Myer, Brandon Boyer, Brian Rosenberg, Mike and Carmen Leatherman, Rose Kraiss, 
and my great aunt, Esther Senseny.
A special thanks to my wife’s parents, Doug and Tracy and sister, Jennifer, for 
accepting me into their lives and for encouraging and supporting their daughter and I in 
everything we have done. Not many parents would have had the patience and foresight 
to encourage their daughter to travel many miles away to support her future husband 
without knowing what lay ahead. I greatly appreciate your love and support.
I would like to thank my parents, Jack and Linda, for their honesty, kindness, and 
financial assistance, but most o f all, for their never-ending love and encouragement. I am 
truly fortunate to have been blessed with such wonderful parents. I would also like to 
thank my brother, Chad, for his love, encouragement, and for being a great example of 
hard work and determination.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
I would like to thank my wife, Melissa, whom has always encouraged and 
supported me. She has always understood my goals and has done everything possible to 
help me attain them. She is my source of inspiration.
Lastly, I would like to thank Dr. Charles G. Schwab. His mentorship, friendship, 
guidance, and exemplary work ethic has helped lead me to my goals. I could have never 
achieved my degree without his wisdom and support. He has taught me that an education 
is much more than a degree and some initials after your name, but instead, is an 
opportunity to learn and help others. His patience in dealing with and helping other 
people has left an indelible mark on my personal and professional lives. I have been 
fortunate to have had the opportunity to pursue my Ph.D. under the direction and 
guidance of one o f the most well-known and highly regarded animal scientists in the 
world. The strength of my Ph.D. program is unrivaled by any other institution and I look 
forward to having the opportunity to utilize the knowledge I have obtained in my future 
career. I would also like to thank Sandy Schwab for her guidance, cooking, and support 
and for always making Melissa and I feel like we have always had a family nearby even 
though we were many miles from home.









I. REVIEW OF LITERATURE........................................................................................... 1
A. INTRODUCTION................................................................................................. 1
B. IDEAL PROTEIN.................................................................................................. 2
C. SUPPLEMENTAL METHIONINE AND LYSINE FEEDING......................6
D. RUMEN-PROTECTED METHIONINE PRODUCTS....................................8
i. Lipid-protected Methionine Products.......................................................9
ii. pH-sensitive-protected Methionine Products.........................................12
iii. Methionine Analogs................................................................................. 14
E. METHIONINE ANALOG VS. DL-METHIONINE METABOLISM............20
F. METHIONINE, CYSTEINE, AND HOMOCYSTEINE METABOLISM 22
G. METHODS OF DETERMINING MET BIOAVAILABILITY.......................23
vii
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
H. CHALLENGES AND LIMITATIONS RELATED TO USING CURRENT 
BIO AVAILABILITY METHODOLOGIES............................................................ 26
I. CONCLUSIONS......................................................................................................30
J. REFERENCES.........................................................................................................32
II. EFFECTS OF PROVIDING TWO FORMS OF SUPPLEMENTAL METHIONINE 
TO PERIPARTURIENT HOLSTEIN DAIRY COWS ON FEED INTAKE AND 
LACTATIONAL PERFORMANCE............................ ........................................................ 38
A. ABSTRACT............................................................................................................ 38
B. INTRODUCTION.................................................................. ................................ 39
C. MATERIALS AND METHODS......................................................................... 41
i. Experimental Design and Treatments.......................................................41
ii. Preparation and Feeding of Dietary Treatments.................................... 41
iii. Management of Cows...............................................................................42
iv. Feed Sampling and Analysis....................................................................43
v. Milk Sampling and Analysis.....................................................................45
vi. Blood Sampling and Analysis..................................................................45
vii. Statistical M ethods.................................................................................. 46
D. RESULTS............................................................................................................... 49
i. Ingredient and Chemical Composition o f Diets...................................... 49
ii. Prepartum Dry Matter Intake, Body Weight, and Body Condition Score 
...................................   50
iii. Prepartum Dry Matter Intake, Body Weight, and Body Condition Score 
............................................................................................................................50
v i i i
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
iv. Milk Production and Composition..........................................................51
v. Feed Efficiency and Nitrogen Conversion..............................................52




III. USE OF CHANGES IN PLASMA METHIONINE (MET) CONCENTRATIONS 
COMPARED TO CHANGES IN MILK PROTEIN CONCENTRATIONS TO 
COMPARE THE EFFECTIVENESS OF MET PRODUCTS IN THEIR ABILITY TO 
PROVIDE ABSORBABLE MET TO LACTATING DAIRY COWS FED MET-
A. DEFICIENT OR MET-ADEQUATE DIETS.....................................................80
B. ABSTRACT.................................................................................................. 80
C. INTRODUCTION...................................................................................................82
D. MATERIALS AND METHODS......................................................................... 85
i. Experimental Design and Treatments....................................................... 85
ii. Preparation and Feeding o f Dietary Treatments.................................... 87
iii. Management of Cows............................................................................... 87
iv. Feed Sampling...........................................................................................88
v. Feed Analysis.............................................................................................. 89
vi. Milk Sampling and Analysis....................................................................90
vii. Blood Sampling and Analysis.................................................................91
viii. Statistical M ethods................................................................................. 92
ix
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
E. RESULTS.................................................................................................................93
i. Chemical Composition of Diets.................................................................93
ii. Body Weight, Body Condition Score, and Days in Milk...................... 95
iii. Feed Intake and Milk Y ield..................................................................... 95
iv. Milk Composition and Yield of Milk Components..............................95
v. Plasma AA Concentrations (p M )............................................................ 97
vi. Estimates of “Bioavailability” of Met from M etaSmart...................... 98
F. DISCUSSION.......................................................................................................... 99
i. Met Status of the Basal Diets..................................................................... 103
ii. Changes in Milk Protein Production........................................................ 104
iii. MetaSmart vs. Smartamine M Metabolism........................................... 108
iv. Effects o f Methionine Analogs and Methionine on Plasma Sulfur 
Amino A cids....................................................................................................110
v. Effects on Milk Yield and Dry Matter Intake......................................... 112
vi. Bioavailability Calculations..............................  114
G. CONCLUSIONS..................................................................................................... 115
H. REFERENCES........................................................................................................ 116
IV. A COMPARISON OF THE RELATIONSHIPS BETWEEN PREDICTED 
SUPPLIES OF METABOLIZABLE PROTEIN (MP), MP-METHIONINE, AND MP- 





Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
C. MATERIALS AND METHODS......................................................................... 158
i. Source o f Data and Criteria Used in Analyses.........................................158
ii. Statistical Analysis..................................................................................... 160
D. RESULTS AND DISCUSSION.......................................................................... 161





Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
LIST OF TABLES
TABLE 2.1. Ingredient composition of prepartum diets fed to cows receiving two forms 
of M et.......................................................................................................................................... 67
TABLE 2.2. Ingredient composition of the postpartum diets fed to cows receiving two 
forms of M e t..............................................................................................................................68
TABLE 2.3. Chemical composition and NRC (2001) evaluation o f prepartum diets fed to 
cows receiving two forms of M e t.......................................................................................... 69
TABLE 2.4. Chemical composition and NRC (2001) evaluation of postpartum diets fed 
to cows receiving two forms of M et......................................................................................70
TABLE 2.5. Chemical composition of the forages fed to cows receiving two forms of 
M et..............................................................................................................................................71
TABLE 2.6. Amino acid composition of feed ingredients fed to cows receiving two 
forms of M e t....................... ......................................................................................................72
TABLE 2.7. Particle size o f TMR, orts, and forages used in prepartum and postpartum 
diets fed to cows receiving two forms of Met.......................................................................73
TABLE 2.8. Effects o f feeding two forms of Met on least squares means o f DMI, BW, 
and BCS for prepartum and postpartum cow s......................................................................74
TABLE 2.9. Effects o f feeding two forms of Met on least squares means of milk yield, 
3.5% FCM, and milk composition......................................................................................... 75
TABLE 2.10. Effects o f feeding two forms o f Met on postpartum feed efficiency and 
conversion of feed N into milk N .......................................................................................... 76
TABLE 2.11. Effects of feeding two forms o f Met on postpartum plasma AA 
concentrations............................................................ .............................................................. 77
TABLE 3.1. Summary of plasma AA and milk production results from Schwab et al. 
(2004a)........................................................................................................................................119
TABLE 3.2. Summary o f plasma AA and milk production results from Schwab et al. 
(2004b)...................................................................................................................   120
xii
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
TABLE 3.3. Summary o f plasma AA and milk production results from Olley et al. (2004) 
 121
TABLE 3.4. A description of dietary treatments of mid-lactation cows fed Met-adequate 
or Met-deficient diets supplemented with incremental amounts of Smartamine M or 
MetaSmart..................................................................................................................  122
TABLE 3.5. Ingredient composition o f the basal diets of mid-lactation cows fed Met- 
adequate or Met-deficient diets supplemented with incremental amounts of Smartamine 
M or MetaSmart.........................................................................................................................123
TABLE 3.6. Chemical composition of the dietary feed ingredients fed to mid-lactation 
cows receiving Met-adequate or Met-deficient diets supplemented with incremental 
amounts o f Smartamine M or MetaSmart.............................................................................. 124
TABLE 3.7. Amino acid composition of feeds fed to mid-lactation cows receiving Met- 
adequate or Met-deficient diets supplemented with incremental amounts of Smartamine 
M or MetaSmart................................   125
TABLE 3.8. Chemical composition and NRC (2001) evaluation of the basal diets of mid­
lactation cows fed Met-adequate or Met-deficient diets supplemented with incremental 
amounts of Smartamine M or MetaSmart.............................................................................. 126
TABLE 3.9. Dry matter intake (DMI), milk yield, and milk yield to DMI ratios of mid­
lactation cows fed Met-adequate or Met-deficient diets supplemented with incremental 
amounts o f Smartamine M or MetaSmart............................................... 127
TABLE 3.10. Milk composition and yield of milk components o f Holstein cows fed Met- 
adequate or Met-deficient diets supplemented with incremental amounts of Smartamine 
M or MetaSmart........................................................................................................................ 128
TABLE 3.11. Milk composition and yield of milk components o f Holstein cows fed Met- 
adequate or Met-deficient diets supplemented with incremental amounts of Smartamine 
M or MetaSmart........................................................................................................................ 129
TABLE 3.12. Plasma essential A A (EAA) concentrations (pM) o f Holstein cows fed 
Met-adequate or Met-deficient diets supplemented with incremental amounts of 
Smartamine M or MetaSmart.................................................................................................. 130
TABLE 3.13. Plasma nonessential A A (NEAA) concentrations (pM) of Holstein cows 
fed Met-adequate or Met-deficient diets supplemented with incremental amounts of 
Smartamine M or MetaSmart.................................................................................................. 133
TABLE 3.14. Plasma essential AA (EAA) (% total AA) o f Holstein cows fed Met- 
adequate or Met-deficient diets supplemented with incremental amounts of Smartamine 
M or MetaSmart........................................................................................................................ 137
xiii
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
TABLE 3.15. Plasma nonessential AA (NEAA) (% total AA) of Holstein cows fed Met- 
adequate or Met-deficient diets supplemented with incremental amounts of Smartamine 
M or M etaSmart......................................................................................................................... 140
TABLE 3.16. Met “bioavailability” of Met-adequate and Met-deficient MetaSmart 
relative to that o f Met-adequate and Met-deficient Smartamine M, respectively, using 
changes in milk protein concentration (Figures 1-4), plasma Met concentration (pM) 
(Figures 5-8), plasma Met (% total AA) (Figures 9-12), plasma Met+Cys concentration 
(pM) (Figures 13-16), plasma Met+Cys (% total AA) (Figures 17-20), plasma total sulfur 
A A concentration (pM) (Figures 21-24), and plasma total sulfur AA (% total A A) 
(Figures 25-28) as the response criteria..................................................................................144
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
xiv
LIST OF FIGURES
FIGURE 1.1. Methionine, Cys, Hcys, metabolic pathways................................................ 37
FIGURE 2.1. Effects o f feeding two forms of Met on postpartum DMI for primiparous, 
multiparous, and all cows by w eek.........................................................................................78
FIGURE 2.2. Effects o f feeding two forms of Met on postpartum energy balance for 
primiparous, multiparous, and all cows by week..................................................................79
FIGURE 3.1. Effects o f feeding incremental amounts o f MetaSmart or Smartamine M to 
cows receiving Met-adequate or Met-deficient diets on milk protein concentrations. The 
equation for the regression line o f each plot is provided below the respective p lo t 146
FIGURE 3.2. Effect o f feeding incremental amounts of MetaSmart or Smartamine M to 
cows receiving Met-adequate or Met-deficient diets on plasma Met concentrations (pM). 
The equation for the regression line o f each plot is provided below the respective plot. 
...................................................................................................................................................... 147
FIGURE 3.3. Effect o f feeding incremental amounts of MetaSmart or Smartamine M to 
cows receiving Met-adequate or Met-deficient diets on plasma Met concentrations (% 
total AA). The equation for the regression line of each plot is provided below the 
respective p lo t............................................................................................................................ 148
FIGURE 3.4. Effect o f feeding incremental amounts of MetaSmart or Smartamine M to 
cows receiving Met-adequate or Met-deficient diets on plasma Met+Cys concentrations 
(pM). The equation for the regression line o f each plot is provided below the respective 
p lo t.............................................................................................................................................. 149
FIGURE 3.5. Effect o f feeding incremental amounts of MetaSmart or Smartamine M to 
cows receiving Met-adequate or Met-deficient diets on plasma Met+Cys concentrations 
(% of total AA). The equation for the regression line of each plot is provided below the 
respective p lo t............................................................................................................................ 150
FIGURE 3.6. Effect o f feeding incremental amounts of MetaSmart or Smartamine M to 
cows receiving Met-adequate or Met-deficient diets on plasma total sulfur AA 
concentrations (pM). The equation for the regression line o f each plot is provided below 
the respective p lo t......................................................................................................................151
xv
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
FIGURE 3.7. Effect o f feeding incremental amounts of MetaSmart or Smartamine M to 
cows receiving Met-adequate or Met-deficient diets on plasma total sulfur AA 
concentrations (% total AA). The equation for the regression line o f each plot is provided
below the respective p lo t .........................................................................................................152
FIGURE 3.8. Plot o f plasma Lys concentrations (pM) regressed on incremental levels of 
infused LysHCl (adapted from McLaughlin et al.; 2002)....................................................153
FIGURE 4.1. Plots o f measured milk yields and milk protein yields vs. NRC (2001) 
predicted flows of metabolizable protein (MP) (g/d)............................................................169
FIGURE 4.2. Plots o f measured milk yields and milk protein yields vs. NRC (2001) 
predicted flows of metabolizable Met (g/d)...........................................................................170
FIGURE 4.3. Plots of measured milk yields and milk protein yields vs. NRC (2001) 
predicted flows of metabolizable Lys (g/d)............................................................................171
FIGURE 4.4. Plots o f measured milk and milk protein yields vs. NRC (2001) predicted 
flows o f metabolizable protein (MP) and MP-Lys and M P-M et.......................................172
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
xvi
ABSTRACT
AN EVALUATION OF SUPPLEMENTAL METHIONINE SOURCES FOR
LACTATING DAIRY COWS
by
Ryan S. Ordway 
University of New Hampshire, May, 2005
The most effective method for increasing supplies o f MP-Met to dairy cows to 
increase milk protein production is to feed rumen-protected Met (RP-Met) products; 
however, not all RP-Met products are absorbed by the dairy cow in the same manner. 
Universally acceptable methods must be developed to determine the efficacy of different 
RP-Met products.
The first study was designed to compare the feeding o f two sources of 
supplementary Met beginning 21 d prepartum and continuing for 140 d postpartum. The 
results indicated that feeding both sources of RPMet to periparturient dairy cows is 
effective in increasing milk protein production; however, clarification of their relative 
contributions to metabolizable Met is still needed.
The second study was designed to compare the effects o f providing supplemental 
RP-Met in the form of Met analogs (MetaSmart) or DL-Met (Smartamine M) to lactating 
dairy cows fed Met-deficient or Met-adequate diets on plasma sulfur AA and milk 
protein concentrations. Results demonstrated that using changes in milk protein 
determine the amount o f absorbable Met provided by MetaSmart relative to that of 
Smartamine M is not as precise as using changes in plasma sulfur AA concentrations.
xvii
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This study also demonstrated that Met analogs are metabolized differently than DL-Met 
sources and that more research is needed to determine the best response criteria for 
determining the efficacy of Met analogs.
The third study was designed to determine the benefit o f increasing MP-Met and 
MP-Lys concentrations on increasing milk and milk protein yields. Published studies in 
the Journal o f  Dairy Science were entered into the NRC (2001) model to generate 
predicted flows of MP, MP-Met, and MP-Lys (g/d). Plots were developed by regressing 
measured milk and milk protein yields on predicted supplies of MP, MP-Met, and MP- 
Lys (g/d). Results indicated that prediction equations based on NRC (2001) predicted 
flows o f the first or co-limiting AA may be more accurate at predicting milk and milk 
protein yield than MP flows and predicting milk protein yield from flows o f MP, Met and 
Lys is more accurate than predicting milk yield.
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CHAPTER I
REVIEW OF LITERATURE 
INTRODUCTION
Methionine (Met) and lysine (Lys) have been shown to be the two most often 
limiting amino acids (AA) for milk protein production in lactating dairy cows (Schwab et 
al., 1976; Rulquin et al., 1987; Schwab et al., 1992; NRC, 2001). The limitation in Lys 
and Met is the result o f their low concentration in feed protein compared to the 
concentration found in milk protein and ruminally synthesized microbial protein (NRC, 
2001).
Synthetic forms of supplemental Met, which have the capability of bypassing the 
rumen and being digested post-ruminally, have been developed. Dietary Lys 
concentrations can be increased through the addition of high Lys containing feeds such as 
blood meal, fish meal, soybean meal and protected soybean meal. However, these feeds, 
especially blood meal and fish meal which contain the highest concentrations o f rumen 
bypass Lys, are limited in their usage resulting from problems related to availability, 
quality and consistency, cost, ethical and consumer perception, and palatability (Schwab 
et al., 1995). In the case of fish meal, an additional negative characteristic is a potentially 
adverse impact on flavoring characteristics of the milk if it is included in the diet in too 
high o f a concentration. However, there are currently no synthetic forms of supplemental
1
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rumen protected Lys available; therefore, nutritionists and dairy producers must rely on 
using blood meal, fish meal, or a soybean meal product to increase Lys concentrations to 
levels which are not limiting for milk protein synthesis.
IDEAL PROTEIN
In mammals, the plasma concentrations of AA are influenced by the nutritional or 
physiological conditions surrounding an animal (Bruhat et al., 1999). An alteration in the 
AA profile can occur if  there is a deficiency o f any one or more o f the essential AA, a 
dietary AA imbalance, or an insufficient intake of essential AA (EAA) (Bruhat et al., 
1999).
Ideal protein is a concept which has been utilized by the swine (NRC, 1998) and 
poultry (NRC, 1994) industries for many years, but has not been fully utilized and 
applied in the dairy industry. Ideal protein can be defined as the optimal pattern of 
dietary AA which corresponds to the needs of the animal (NRC, 1998). These needs, as 
defined by the Swine NRC (1998), are for maintenance, protein accretion, and milk 
protein synthesis.
Developing an ideal protein profile for swine is based on Lys which is used as a 
reference AA. The reasoning behind using Lys in swine nutrition is that it is 
predominantly used for protein synthesis and it is almost always the first-limiting AA. 
The Lys requirement has been the most extensively researched in swine. Lysine analysis 
in feeds is accurate and easy to conduct and no other limiting AA for growth is thought to 
be needed in greater concentration than Lys (Chung and Baker, 1992). Using Lys as the 
reference AA, ideal ratios o f AA to Lys for maintenance, protein accretion, body tissue,
2
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and milk protein synthesis have been developed (NRC, 1998). Lysine is given a value of 
100 percent and the other EAA are given values higher or lower than Lys to indicate how 
much of a particular EAA is required. For example, milk protein synthesis has a Met 
requirement which is 26 percent o f the Lys requirement.
I f  an ideal protein profile were to be developed for dairy cattle, Lys would also be 
the logical choice because, as in swine, Lys is one o f the most limiting AA and no other 
limiting AA is thought to be needed in greater concentrations than Lys (NRC, 2001). 
This method of basing the requirement of EAA on the requirement for Lys has been 
adopted by the Dairy Cattle NRC (2001) but has only been extended to Met. The NRC 
(2001) suggests that the optimum Met requirement is approximately 33 percent of the 
Lys requirement or in other words, Met is required in approximately a 1:3 ratio with Lys.
Protein synthesis is an intricate process in which genetic information encoded in 
nucleic acids is translated into the 20-AA alphabet o f polypeptides (McKee and McKee, 
1999). Remarkably, this process occurs continuously with the same protein structure 
occurring each time. For example, the synthesis o f milk protein results in the same AA 
sequence every time a protein is synthesized. As a result, the structure o f milk protein 
cannot be altered by changing the AA profile of the diet because the same AA are 
required each time a protein molecule is synthesized. However, the extent to which 
protein is synthesized can be affected by the supply of the necessary AA required for 
synthesizing milk protein. The amount o f AA available for milk protein synthesis is 
finite, therefore, an ideal balance or profile of EAA is necessary for maximizing milk 
protein synthesis. As soon as the availability of a specific EAA is limiting, milk protein 
synthesis is limited.
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Without the necessary AA available, new protein cannot be synthesized and the 
excess AA which are not limiting in availability will be catabolized and the nitrogen (N) 
may be excreted into the environment. This excretion is not only energetically wasteful, 
but also environmentally damaging as N pollution is a growing concern in the United 
States (Powers, 2003).
When EAA are absorbed in the body in the profile which most closely matches 
the AA profile required by the animal for milk protein synthesis (i.e., the ideal profile of 
EAA), the efficiency o f overall AA use is improved and the total amount of AA that 
needs to be absorbed can be minimized. As a result, the overall amount of rumen 
undegradable dietary crude protein (RUP) fed to lactating dairy cattle can be reduced. A 
reduction in RUP feeding will not only equate to a lower cost ration, but also to a less 
severe negative impact o f milk production on the environment.
When the ideal profile of EAA is not provided to the animal, the efficiency of use 
of AA for milk protein synthesis is reduced resulting in lower milk protein production as 
well as wasting o f N which ultimately increases the amount excreted into the 
environment. However, providing a less than ideal profile o f EAA may also have another 
negative impact. In vitro research using human cell lines has demonstrated that when 
EAA are limiting, as occurs when an imbalanced profile o f EAA is provided in the diet, 
changes in gene expression can occur. For example, depletion o f arginine, cystine, and 
all EAA has been demonstrated in a dose-dependent manner to induce insulin-like growth 
factor-binding protein-1 mRNA and protein expression (Bruhat et al., 1999). Bruhat et 
al. (1999) has demonstrated that a leucine limitation induced CCAAT/enhancer-binding 
protein homologous protein (CHOP) mRNA and protein. The elevated mRNA levels
4
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occur as a result of both an increased rate o f CHOP transcription and an increase in 
mRNA stability. Overall, an AA limitation in conjunction with hormones, can play an 
important role in regulating gene expression. The extent to which this regulation affects 
normal metabolic functions is still unknown; however, the possibility exists that the 
effects may be profound.
For lactating dairy cow diets, it is imperative that the ideal concentrations of Lys 
and Met in metabolizable protein (MP) be determined so that diets can be formulated to 
meet these ideal concentrations to maximize protein synthesis through more efficient use 
of MP while minimizing the amount of protein in the diet. Noftsger and St-Pierre (2003) 
recently demonstrated that milk protein production can be maintained while reducing the 
amount of RUP fed. Their research indicated that feeding a more intestinally digestible 
form of dietary RUP, such as a high quality blood meal product, along with supplemental 
Met products and rumen-available Met (DL-2-hydroxy-4-methylthio butanoic acid 
(HMB)) maximized milk and milk protein yield as well as N efficiency in lactating cows. 
Of particular interest, was their finding that the low CP diet containing supplemental Met 
resulted in numerically greater milk yields and significantly greater milk protein 
concentrations compared to the high CP, high digestible RUP diet. The latter diet should 
have provided excess amounts of Lys and Met due to their greater supply in MP. These 
researchers concluded that lowering the amount o f CP in the diet and properly balancing 
AA in the diet can reduce the amount of N excreted into the environment while 
maximizing production of milk and milk protein.
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SUPPLEMENTAL METHIONINE AND LYSINE FEEDING
The seminal work o f Schwab et al. (1976) indicated that Lys and Met are the first 
two limiting AA for milk protein synthesis in lactating dairy cows. In this study, 
researchers infused either single or mixtures o f AA into the abomasum of lactating dairy 
cows and measured the response in milk yield, protein production, and fat production. 
Results indicated that Lys accounted for 16% of the total response in milk protein 
production and Lys plus Met accounted for 43% of the total response in milk protein 
production, but Lys plus Met accounted for only 7% of the total response in milk yield. 
The results indicated that Met was most likely co-limiting with Lys for milk protein 
synthesis in lactating dairy cows. Amino acid infusions did not have an effect on milk fat 
production, dry matter intake, or milk urea nitrogen. The effects on milk protein yield 
were accomplished via an increase in milk protein content, not through an increase in 
milk yield.
More than a decade later, Schwab et al. (1992) conducted another study which 
also indicated that Lys was the limiting or co-limiting AA along with Met for milk 
protein synthesis in lactating dairy cows. Similar to the study o f Schwab et al. (1976), 
Schwab et al. (1992) infused either Met, Lys, Met+Lys, or casein into the duodenum of 
peak, early, mid, and late lactation dairy cows and observed the subsequent response in 
milk protein production. Their goal was to determine the sequence of Lys and Met 
limitation and to determine the effect o f stage o f lactation on the sequence of Lys and 
Met limitation. Their results indicated that during peak lactation, Lys was first-limiting 
and Met was second-limiting. During early lactation, Lys again appeared to be first-
6
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limiting, however, Met did not appear to be limiting for protein synthesis. In 
midlactation, Lys was observed to be either slightly first-limiting or co-limiting with Met. 
During late lactation, there appeared to be no EAA deficiency, therefore, neither Lys nor 
Met were found to be limiting. Overall, results indicated that Lys and Met were the first 
and second limiting AA for milk protein synthesis throughout peak and mid-lactation, but 
only Lys was limiting during early lactation, and no AA were limiting during late 
lactation.
Despite the research which indicates that Lys is most likely the first-limiting AA 
for milk protein production or at least co-limiting with Met or another AA when low 
protein corn-based diets are fed, there are currently no rumen protected Lys (RP-Lys) 
products commercially available. This is due to the high cost associated with 
synthetically encapsulating Lys for commercial use. Therefore, to meet the Lys 
requirement for milk protein synthesis, feeds containing high concentrations o f rumen 
undegradable Lys, such as blood meal and fish meal, are used. However, even though a 
product such as blood meal can provide adequate amounts o f supplemental Lys to meet 
the requirement for maximizing protein production, it also supplies rather large amounts 
of the other EAA. As a result, an excess of EAA other than Lys and Met (blood meal is 
low in Met) are supplied which exacerbates the deficiency in Met. Fortunately, Met 
products are relatively inexpensive to produce and are commercially available. If a more 
economical commercially available form of RP-Lys does become available, the goal of 
feeding the ideal profile o f EAA will become more attainable and the amount of excess N 
will be reduced. This is important not only for improving production efficiencies on 
farm, but also for public perception as products such as blood meal, which are derived
7
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from animal proteins, are viewed negatively because o f the possible perceived risk of 
bovine spongiform encephalopathy being spread to humans through cows which are fed 
animal proteins.
RUMEN-PROTECTED METHIONINE PRODUCTS
Several methods for ruminally protecting Met have been developed. These 
methods vary in their mode o f action as well as their efficacy in providing supplemental 
post-ruminal Met. The methods which have gained commercial acceptance and regular 
use are Met products which contain a lipid-based or pH-sensitive coating resistant to 
ruminal degradation and Met hydroxy analogs which contain an hydroxyl group in place 
of the amino group of Met.
Improvements in N utilization with Met supplementation were observed 60 years 
ago by Loosli and Harris (1945). This is one of the earliest instances of the realization 
that AA, specifically Met, may be the key to improving growth and production 
efficiencies. Since this time, commercial development o f RP-AA, specifically Met, have 
gained interest.
Feeding supplemental AA to ruminants has proven difficult because without 
protecting supplemental AA to allow them to escape ruminal degradation, free AA are 
quickly utilized by rumen microbes. Free AA in rumen fluid can arise from proteolysis 
of dietary protein, microbial synthesis, AA catabolism and microbial lysis. Despite the 
array of sources from which free AA in the rumen originate, studies by Velle et al. (1997) 
and Volden et al. (2001) have shown that the concentration of free AA in rumen fluid and
8
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the contribution o f free AA to intestinal digesta are negligible. This is the result of 
extensive deamination of any AA originating from hydrolysis o f degradable protein in the 
rumen (Lewis and Emery, 1962). These results clearly demonstrate the need for 
developing Lys and Met products, as these two AA are commonly considered to be the 
first two limiting AA for milk and milk protein production (NRC, 2001).
Currently, only Met is available commercially as a ruminally-protected product. 
A combination o f rumen-protected Lys and Met was available for a short period of time, 
but due to high costs associated with encapsulating Lys, it is no longer manufactured. 
The review papers of Schwab (1995; 2003) provide detailed information regarding the 
history, types, and efficacy of protected Met products. The following sections were 
adapted from Schwab (1995; 2003) and highlights details on the history, description, and 
efficacy of protected Met products.
Lipid-protected Methionine Products
Most attempts at encapsulating Met and Lys have focused on using a lipid-based 
coating containing carbohydrates and inorganic materials as stabilizers, as well as 
softening agents and fillers. These ingredients are readily available and are non-toxic, 
therefore, gaining government approval for use in dairy cow diets is generally not 
restrictive.
Lipid-protected Met products are effective at providing absorbable Met to the 
small intestine; however, the efficacy o f these products depends on physical action and 
abrasion to degrade their outer coating. As a result, their protective coating does not 
completely prevent release of Met in the rumen. Therefore, depending upon conditions
9
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in the rumen, more or less Met may be released resulting in the efficacy of the products 
being compromised. Additionally, storage o f these products must be considered given 
their high content o f fatty acids which are also susceptible to mechanical and thermal 
stresses (Schwab, 1995). Products with fatty acid-based coatings must find a balance 
between rumen protection and intestinal release so that a maximum amount of Met is 
released in the small intestine (Schwab, 1995; Schwab, 2003).
The original Met product was produced in the 1960’s by Delmar chemicals of 
Canada. Their product consisted o f a core of DL-Met with a coating o f colloidal kaolin 
and tristearin wrapped around it in a continuous film of tristearin with the final product 
containing 20% Met, 20% colloidal kaolin, and 60% tristearin. The product was a small 
bead with a diameter o f 0.3 to 1.0 mm and a specific gravity of 1.18-1 -20g cm 
Research demonstrated that approximately 60-65% of the Met bypassed the rumen and 
was available for intestinal absorption, resulting in only 12-13% of the original as fed 
product being bioavailable Met.
Several years later, another product called Ketionin was introduced by Rumen 
Kjemi A/S o f Oslo, Norway. Ketionin contained a greater amount o f Met and had an 
improved protective coating which allowed for a greater amount o f Met to be released 
and absorbed in the small intestine compared to the Delmar product. Ketionin was 
available in 2.1 and 3.5 mm particle sizes and contained 30% DL-Met, 2% glucose, 4% 
stabilizer, antioxidant and flavoring agents, 6% CaC0 3 , and 58% tristearin and oleic acid. 
Research indicated that approximately 80% of Ketionin escaped ruminal degradation and 
20% was lost in the feces of lactating cows. Other research conducted with non-lactating, 
growing heifers indicated that approximately 72% of the product escaped ruminal
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degradation and 19% was lost in the feces. Overall, approximately 19% of the original as 
fed product was bioavailable Met when fed to lactating dairy cows.
Mepron M85 (Degussa Corporation, Germany) consists o f a core containing a 
minimum of 85% DL-Met coated with thin layers of ethylcellulose combined with stearic 
acid. The pellets are small and cylindrical (1.8 mm diameter, 3-4 mm length), have a 
density of 1.2g cm , and have the thinnest coating on the comers. The final product 
contains 85% DL-Met, 8.5% nonstructural carbohydrates, 3.5% neutral detergent fiber,
1.5% ash, 1.0% moisture, and 0.5% crude fat. This product contains the highest 
concentration o f Met available in a commercially produced Met product. Its’ mode of 
degradation relies on physical action and abrasion to wear away the ethylcellulose outer 
coat as a result o f ethylcellulose being resistant to enzymatic digestion. The result is a 
slow-release Met product which begins degradation in the rumen and then slowly releases 
Met in the small intestine. The Met bioavailability value o f Mepron M85 is 
approximately 40%.
Met-Plus (Nisso America, Inc.) consists of a core containing a minimum of 65% 
DL-Met which is embedded in a matrix o f calcium salts o f long-chain fatty acids, lauric 
acid, and butylated hydroxytoulene which is used as a fatty acid preservative. This 
product also relies on physical action and abrasion in the rumen to wear away the outer 
coating so the Met can be slowly released in the small intestine. Met-Plus has been the 
least researched of the Met products and as a result, only a few studies have been 
conducted in which a Met bioavailability value was determined. Bach and Stem (2000) 
determined a bioavailability value of approximately 40%, while Olley et al. (2004)
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determined a bioavailability value of approximately 33%, resulting in an average 
bioavailability value o f approximately 37%.
pH-sensitive-protected Methionine Products
The most technologically advanced surface-coating product is the rumen-inert 
pH-sensitive synthetic polymer coating. Not only is this coating technology the most 
advanced, but it has been shown to be the most effective in terms o f rumen-protection 
and release of Met in the small intestine. These polymers are unaffected by the rather 
neutral pH of the rumen and by enzymatic digestion. Instead, they are sensitive to the 
low pH environment o f the abomasum and small intestine. The coating resists 
degradation in the rumen, but is quickly degraded in the abomasum as a result of the 
large decline in pH as the product flows from the rumen to the abomasum. This type of 
product allows for rapid release and delivery of Met in the small intestine.
The Eastman Kodak Company (USA) pioneered the development and use of 
commercially produced pH-sensitive polymer coatings. Originally, two types of 
polymers were tested, DL-Met coated with cellulose propionate morpholinobutyrate and 
DL-Met or L-Lys coated with a copolymer of styrene and 2-methyl-5-vinyl pyridine. 
Both showed promising results with research indicating that under in vitro conditions 
where pH was maintained near 5.5 for 17 h and in nylon bags incubated in the rumen of 
sheep for 24 h, the DL-Met coated with cellulose propionate morpholinobutyrate product 
was greater than 96% resistant to ruminal degradation as indicated by the amount of 
product remaining after incubation. Similarly, the DL-Met or L-Lys coated with a 
copolymer of styrene and 2-methyl-5-vinyl pyridine product remained 94-95% resistant
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to degradation when incubated for 24 h in an acetate buffer o f pH 5.4. Under more 
severe acidic conditions, such as those found in the abomasum, the DL-Met coated with 
cellulose propionate morpholinobutyrate product was completely degraded within 30 
min, while the DL-Met or L-Lys coated with a copolymer of styrene and 2-methyl-5- 
vinyl pyridine product was approximately 95% degraded after 1 h in pH of 2.9.
The major concern regarding the coating technologies was that the coating of 
these products would degrade when mixed with acidic feeds such as silages. Using the 
copolymer o f styrene and 2-methyl-5-vinyl pyridine, research by Papas et al. (1984) 
reported Met recovery values of 80% and 70% after incubation with a silage diet of pH 
4.6 for 2 and 18 h, respectively. Other researchers (Polan et al., 1991) using the same 
copolymer consistently observed that Met and Lys incubated in a silage based diet for 8- 
12 h greatly resisted degradation and recorded recovery values exceeding 90%.
Currently, Adisseo Animal Nutrition (Antony, France) holds the patent rights to 
the polymer technology and is currently manufacturing a commercially protected form of 
Met called Smartamine M. Previously, they also marketed a protected Lys and Met 
product called Smartamine ML, but have discontinued its’ production.
Smartamine M is a surface coated Met product containing a minimum of 75% 
DL-Met. The pellets are 2-mm in length and are slightly rounded with no hard edges. 
They consist of a core o f 75% DL-Met and ethylcellulose which is coated with stearic 
acid containing droplets o f 2-vinyl-pyridine-co-styrene. This copolymer contributes only 
3% of the final weight o f the product, but appears to alter the stereochemistry of the 
stearic acid in such a way that the outer surface’s resistance to ruminal degradation is 
improved. However, under very acidic conditions, such as those found in the abomasum,
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the copolymer is rapidly solubilized and degraded, thus allowing for rapid release of the 
Met in the abomasum and subsequent availability for absorption in the small intestine. 
Smartamine M is considered to be the most efficacious Met product and has a Met 
bioavailability o f 80% (Robert et al., 2002; Rulquin and Kowalczyk, 2003).
Methionine Analogs
Another method of supplementing Met is to use Met analogs. Methionine analogs 
are similar to Met except that they have a non-nitrogenous group substituted for the a- 
amino group. The Met analog which has been studied most extensively is the acid form 
of the analog or more specifically, 2-hydroxy-4-methylthio butanoic acid (HMB). More 
recently, a derivative o f HMB, 2-hydroxy-4-methylthio butanoic acid isopropyl ester 
(HMBi) was developed which has been shown to provide a greater amount of 
metabolizable Met than HMB (Schwab et al., 2005a,b).
In the late 1960’s, Griel et al. (1968) observed a stimulatory effect on milk 
production when HMB was fed to lactating dairy cows. This finding was coincidental as 
the original objective of the study was to feed HMB as a preventative supplement for 
ketosis. However, these researchers observed an increase in milk production with HMB 
feeding. These researchers hypothesized that either HMB had a stimulatory effect on 
rumen microorganisms or that part o f the HMB was absorbed across the gut and 
converted to Met based on observed increases of free Met concentration in plasma and 
may have beneficial effects if  supplemented in the diet.
The effects o f HMB on ruminal fermentation have been varied. For example, 
Deswysen et al. (1991) fed 0 or 5 g/d HMB to young and mature wethers. Significant
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increases in apparent DM, OM, and CP digestibility in young wethers but observed no 
effect on these parameters in mature wethers was observed. Using continuous culture 
fermenters, Vazquez-Anon et al. (1999) reported that HMB did not elicit any changes in 
rumen fermentation. In a more recent study, Vazquez-Anon et al. (2001) increased the 
concentration o f HMB from 0 to 0.88% o f DM and again did not observe any changes in 
DM, CP, ADF, or starch and sugar digestibility or VFA concentration. However, they 
did observe increases in NDF digestibility, ruminal ammonia-N concentration and 
bacterial protein synthesis with increasing concentration of HMB.
One o f the most controversial effects o f HMB is its’ ability to stimulate milk fat 
synthesis. Results of several studies have reported increased milk fat synthesis with 
HMB supplementation (Patton et al., 1970b; Polan et al., 1970; Lundquist et al., 1983), 
however, several other studies have indicated no impact o f feeding HMB on milk fat 
synthesis (Pullen et al., 1989; Phillips et al., 2003; Piepenbrink et al., 2004; Noftsger et 
al., 2005; Schwab et al., 2005a,b). The studies conducted by Noftsger et al. (2005) and 
Schwab et al. (2005a,b) utilized Latin square designs while the other studies utilized 
randomized block designs, which does not indicate that the effects o f HMB were 
impacted by the statistical design o f the studies. Early hypotheses of the mechanism by 
which HMB may affect fatty acid synthesis focused on an increase in fatty acid synthesis 
in the rumen and/or an alteration in the fatty acid composition of plasma lipoproteins 
(Griel et al., 1968; Patton et al., 1970a,b; Polan et al., 1970). More recent research has 
indicated that HMB does not effect lipid metabolism (Pullen et al., 1989; Phillips et al., 
2003; Piepenbrink et al., 2004); as there was no effect of HMB supplementation on 
nonesterified fatty acids (NEFA), glucose or triglyceride (TG) concentrations. The only
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significant effect o f HMB was an increase in the incorporation o f labeled 14C (from 
labeled palmitic acid) in milk fat (Pullen et al., 1989). However, no effect of MHA on 
NEFA metabolism or on NEFA and TG plasma concentrations was observed. 
Subsequently, no differences in milk or milk fat production were observed. The authors 
did not speculate as to whether there was any significance of the increased incorporation 
of labeled 14C in milk fat; however, Piepenbrink et al. (2004) suggested that this effect 
may have resulted in a greater use of NEFA for milk fat synthesis occurred (Piepenbrink 
et al., 2004). In the study by Pullen et al. (1989), the authors acknowledged that the 
concentration of TG in plasma was only approximately 10% of what they had expected. 
They attributed to the apparent loss o f TG concentration to an incomplete recovery in the 
HPLC fractions. They stated that the quantity and radioactivity o f TG were determined 
in the same fraction which means the error in recovery did not affect TG specific activity. 
However, they did point out that any changes in TG concentration which may have 
occurred due to treatment or lactation effects would influence the estimates of the 
percentage o f NEFA incorporated into TG since the authors assumed a constant plasma 
TG concentration. This error is most likely the reason for the observed effect of HMB on 
the incorporation of palmitate into milk fat.
Altering the VFA profile in the rumen may be another method through which 
HMB can increase milk fat synthesis. Robert et al. (2003) recently demonstrated that the 
amount of HMB available in HMBi for ruminal degradation is sufficient to cause an 
alteration in VFA pattern of non-lactating dairy cows. Noftsger et al. (2003) observed an 
increase in the acetate :propionate ratio when incremental amounts o f HMB was added to 
diets fed to continuous culture fermenters. This increase was the result of a linear
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decrease in propionate concentrations as no effect on acetate concentrations was 
observed. Furthermore, no effect of incremental amounts o f HMB was observed on fiber 
digestibility, NH3 concentrations, or flows of nitrogen from the rumen fermenter. 
Noftsger et al. (2005) did not observe any changes in VFA concentrations in the rumen of 
lactating cows nor did they observe any changes in rumen pH, NH3, total VFA 
concentrations, or flow o f NH3-N, microbial N, or nonbacterial non-ammonia N to the 
omasum with HMB, HMBi, or DL-Met supplementation. They did, however, observe an 
increase in apparent organic matter digestibility as well as an increase in NDF 
digestibility with HMB, HMBi, or DL-Met supplementation. Addition of HMBi resulted 
in greater concentrations o f milk protein, but no effect o f feeding HMBi, HMB or DL- 
Met were observed for milk yield, milk fat concentration or milk fat yield. Given the 
more recent research results indicating that HMB does not affect lipid metabolism, as 
well as the number o f studies which have not reported any effects o f HMB on milk fat 
synthesis, it would appear that HMB does not provide a significant benefit to increasing 
milk fat synthesis or improving fatty acid metabolism. Despite the results which 
demonstrate that HMB can alter VFA patterns in the rumen, this alteration does not 
appear to affect fatty acid metabolism or milk fat synthesis in vivo (Pullen et al., 1989; 
Phillips et al., 2003; Piepenbrink et al., 2004; Noftsger et al., 2005; Schwab et al., 
2005a,b).
The most likely explanation for this is that when HMB is fed in a total mixed 
ration (TMR), the majority of the product is degraded rapidly in the rumen and does not 
pass into the abomasum or get absorbed across the rumen wall. When HMB is pulse- 
dosed into the rumen, the enzymes in the rumen which degrade HMB become saturated,
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which results in an abnormally large amount escaping the rumen compared to when it is 
fed in a TMR and more physiological conditions exist in the rumen.
Researchers (Belasco, 1980; Patterson and Kung 1988) have demonstrated that 
HMB is less sensitive to ruminal degradation than unprotected DL-Met, however, the 
extent to which HMB is absorbed and converted to metabolizable Met and is used for 
milk protein synthesis, remains uncertain. There have been large variations in the 
bioavailability o f HMB as reported in the scientific literature. Several researchers have 
not observed an increase in milk protein synthesis in cows fed Met-deficient diets 
supplemented with HMB (Piepenbrink et al., 2004; Schwab et al., 2005a,b; Noftsger et 
al., 2005). These results indicate that HMB is most likely degraded in the rumen with 
very little being absorbed across the rumen wall and subsequently converted to Met for 
milk protein synthesis. In a study by Jones et al. (1988), researchers concluded that 99% 
of HMB was either degraded or altered in the rumen as a result o f observing less than 1% 
HMB recovery in duodenal digesta samples. However, other researchers have observed 
22 to 50% of dietary HMB escaping ruminal degradation (Koenig et al. 1999, Vasquez- 
Anon et al., 2001; Koenig et a l ,  2002). These differences are most likely attributable to 
the method of HMB administration or supplementation to the cow (i.e., administered via 
the diet or pulse-dosed in the rumen) as it appears that residence time has a large effect 
on the degradability o f  HMB in the rumen (Vasquez-Anon et al., 2001). As previously 
discussed, the enzyme system in the rumen for degrading HMB are most likely saturated, 
which greatly increases the rumen-bypass characteristics o f the product compared to 
normal physiological doses.
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Robert et al. (200Id) examined the bioavailability of eleven different esters of 
Met and HMB using a blood kinetics method to determine which, if  any, of the esters was 
most effective at increasing plasma Met concentrations. They concluded that HMBi 
resulted in the greatest bioavailability o f the esters examined. In addition to this study, 
subsequent research has demonstrated that HMBi is effective at increasing plasma Met 
concentrations (Robert et al., 2001c; Ordway et al., 2004; Schwab et al., 2005b) and milk 
protein concentrations (Guyot et al., 2004; Ordway et al., 2004; Noftsger et al., 2005; 
Schwab et al., 2005a). Both Schwab et al. (2005a,b) and Noftsger et al. (2005) observed 
that HMBi is not only an effective source of bioavailable Met, but that it is more effective 
at increasing plasma Met and milk protein production than HMB.
Alimet (Novus International, Inc., St. Louis, MO, USA) and Rhodimet AT88 
(Adisseo, Antony, France) are both liquid forms of HMB which are available 
commercially and are used extensively as Met supplements in the poultry and swine 
industries. Both products are also labeled for use in dairy cow rations, however, the 
extent o f their use in dairy rations is considerably less than in poultry and swine rations. 
Alimet is promoted as an Met source, but as previously stated, its’ ability to resist 
ruminal degradation is questionable. The bioavailability value o f HMB is considered to 
be negligible (Schwab et al., 2005a).
Adisseo (Antony, France) has recently introduced a commercially available form 
of HMBi under the trade name MetaSmart. As previously stated, it has been shown to be 
a more efficacious source of bioavailable Met and is being marketed as such. It is 
currently available for use in dairy cow rations and is considered to have a bioavailability 
of approximately 50%.
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METHIONINE ANALOG VS. DL-METHIONINE METABOLISM
Research has demonstrated that not only is supplemental Met utilized differently 
than Met analogs within species, but it is also utilized differently between ruminants and 
non-ruminants as well (Baker, 1986; Lobley et al., 2001). Traditionally in non­
ruminants, it has been postulated that HMB is absorbed from the gastrointestinal tract and 
transported to the liver where it is removed from circulation and transaminated to form L- 
Met (Bottje et al., 1998, Robert et al., 2001b). However, more recent research (Wester et 
al., 2000a,b) has demonstrated, using sheep, that this pathway may be incorrect, 
especially in ruminants.
Wester et al. (2000a) infused labeled (l-13C)Met into the jugular vein of growing 
lambs for 12 h and then from 3 h onward, infused successive 3 h infusions of 0.55 
mg/min saline and 4.4 mg/min HMB into the mesenteric vein. They took continuous 
plasma samples every 20 min during the last 80 min of each infusion. They recovered all 
o f the infused HMB at the portal vein, but 25% was subsequently extracted by the liver. 
Results indicated that portal appearance o f Met and Cys was unaltered by HMB infusion, 
however, net splanchnic output of Met decreased while Cys output increased with 
increasing rates o f HMB infusion. Although dietary Met did not appear to be released 
into peripheral circulation, arterial concentrations of Met as well as the Met irreversible 
loss rate linearly increased. They calculated that the increase in Met irreversible loss rate 
was equivalent to 40% of the HMB delivered past the liver which was metabolized by 
peripheral tissues and entered the plasma Met pool. These researchers concluded that the 
liver does not secrete the Met which was transaminated from the extracted HMB,
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however, the liver may increase Cys output. It appears from their results that HMB is 
metabolized extensively by peripheral non-hepatic tissues.
In another study conducted by Wester et al. (2000b), unlabeled HMB was infused 
into the abomasum of growing lambs for 24 h followed by a 6 h infusion o f labeled (1- 
13C)HMB into the abomasum with another infusion of (2H3)Met into the mesenteric 
vein. Continuous samples of plasma were collected at 30-min intervals during the last 2 
h of infusion from the aorta, portal and hepatic veins. Recovery of infused HMB was 
75% at the portal vein with 36% being subsequently extracted by the liver. They 
observed that HMB contributed 10% to overall irreversible Met loss rate which was 
equivalent to 40% of absorbed Met and similar to the concentration of HMB observed 
post-hepatically. Results indicated that labeled (l-13C)Met enriched arterial plasma 
more than portal or hepatic plasma and the ratio of 13C:2H Met enrichments were also 
greater in arterial compared to portal or hepatic plasma. The authors concluded, based on 
analysis of 13C:2H3 free Met enrichments from visceral tissues where Met synthesized 
from HMB represented 22 to 26% of Met present these tissues, that post-splanchnic 
tissues were involved in the synthesis of Met from HMB and the involvement was in the 
order o f kidney > liver > rumen > jejunum > duodenum > ileum. They also found that 
the lungs, brain, muscle and skin also synthesized Met from HMB but this accounted for 
less than 5% of intracellular Met. This study provides further evidence that HMB is 
being utilized by peripheral tissues to meet their Met requirements. It also provides 
evidence that any increases in plasma Met concentrations observed with supplemental 
MetaSmart feeding (HMB is not assumed to bypass the rumen under normal feeding 
conditions) is most likely the result o f a Met-sparing effect and not necessarily the result
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of a net export of Met from tissues such as the liver which transaminates HMB into L- 
Met.
METHIONINE, CYSTEINE, AND HOMOCYSTEINE METABOLISM
The metabolism of Met, cysteine (Cys), and homocysteine (Hcys) is a complex 
interconnected network o f metabolic pathways. The interactions o f these three AA is 
complicated even further when Met analogs such as HMB or MetaSmart are fed. The 
overall pathways of Met and Hcys metabolism are depicted in Figure 1. From this figure, 
it is apparent that there are several other cofactors which are intimately related to these 
pathways, such as vitamin B 12, folic acid (a B-vitamin), serine (Ser), and ATP. Choline, 
a methyl group donor, is another potentially vital cofactor for the synthesis of Met from 
S-adenosylmethionine (SAM) if  Met becomes severely deficient in the diet.
As shown in Figure 1, there are methyl acceptors and resultant methylated 
products in the conversion of SAM into S-adenosylhomocysteine. Examples of methyl 
acceptors and their subsequent methylated products are: phosphatidylethanoloamine and 
phosphatidylcholine, norepinephrine and epinephrine, guanidinoacetate and creatine, and 
'y-aminobutyric acid and carnitine.
Homocysteine and Ser condense to form Cys in the transulfuration pathway 
(Figure 1). The carbon skeleton of Cys is derived from Ser while the sulfhydryl group is 
transferred from Met via Hcys. This process intimately relates the transulfuration and 
transmethylation pathways. Homocysteine can also be synthesized from homoserine and 
Cys which can then be synthesized into Met in the transmethylation pathway (Figure 1).
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METHODS OF DETERMINING METHIONINE BIOAVAILABILITY
Perhaps, the most important aspect of designing Met analogs and Met products is 
to be able to determine their bioavailability. Once a bioavailability value has been 
generated, it is possible to compare the efficacy o f one product against another and to 
determine if the product is providing the animal with post-ruminal absorbable Met.
Several methods have been used to determine the effectiveness o f Met analogs 
and Met products in providing absorbable Met to lactating dairy cows. These include in 
situ incubation coupled with an enzymatic in-vitro procedure, spot-dosing the Met 
product and determining the changes in plasma Met using a technique called area-under- 
the-curve (AUC). Other methods include feeding the Met product to cows fed Met- 
adequate diets and observing the subsequent changes in plasma Met and feeding the Met 
product to cows fed Met-deficient diets and observing the subsequent changes in milk 
protein production. Regardless of the methodology employed, it is essential that the 
procedure is repeatable and that it provides a true measure o f differences in Met 
availability to the animal. Each technique has its’ benefits and drawbacks. To date, there 
is no single procedure for determining the bioavailability o f Met products which is 
universally accepted. However, some techniques are considered more effective than 
others over a wide-range o f Met products.
There are two major categories for determining the bioavailability of Met 
products. The first category involves using changes in plasma Met concentrations while 
the second category utilizes changes in milk protein concentration.
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Within the category of using changes in plasma Met concentrations to determine 
the bioavailability o f Met products, two techniques have been developed. The first 
technique is called AUC (Robert et a l ,  2001a,d; Robert et al., 2002; Graulet et al., 2005). 
This technique relies on determining a basal plasma Met concentration for each cow on 
the study by generating a mean plasma Met concentration from plasma Met samples 
taken over a period o f several hours prior to pulse-dosing Met with the Met product being 
tested. The basal plasma Met concentrations are then subtracted from the plasma Met 
concentrations quantified for each cow after Met supplementation. The resultant values 
correspond to increases in plasma Met concentrations resulting from Met 
supplementation. A curve based on increases in plasma Met concentrations over time is 
determined using these values. The AUC is calculated mathematically by multiplying the 
average increase in plasma Met concentration between two consecutive sampling times 
and the length o f time between the samplings. Total AUC is determined as the sum of 
the individual AUC calculated along the sampling kinetics. In order to calculate a 
bioavailability value for the Met product being tested, a Met digestibility value must be 
calculated using the resultant AUC values. Robert et al. (2001a) derived an equation to 
model this. Their original equation was in the form of [Digestible Met - a x  In (1 + AUC 
/ b)]. In a more recent study, Graulet et al. (2005) observed large variations in basal 
plasma Met concentrations among individual cows. As a result, a correction factor was 
added to the equation to help account for differences in the basal plasma Met 
concentrations (BPMC) prior to infusion or feeding of the supplemental Met source. The 
first parameter, a, which was a constant value o f (19.7406) in the initial equation was 
replaced by a variable coefficient, A, which is calculated from each individual BPMC
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value, where A -  -0.5895 x BPMC + 32.5073. Therefore, the final adjusted equation is 
[Digestible Met = (-0.5895 x  BPMC + 32.5073) x  In (1 + AUC / 925.74). This equation 
allows for a corrected AUC value by accounting for variation in the basal plasma Met 
concentration o f individual cows prior to infusion or supplementation of Met products. 
However, it is important to note that this equation was based on data derived from non- 
lactating dairy cows. This equation has not been evaluated using lactating dairy cows; 
therefore, the adjustment factor which accounts for variation in basal plasma Met 
concentration may be different depending upon state o f lactation.
The second technique utilizes changes in plasma Met concentrations when Met 
products are fed in incremental amounts to cows receiving a Met-adequate diet (Olley et 
al., 2004; Schwab et al, 2005b). Lactating cows are fed a diet adequate in Met to ensure 
that absorption of additional supplies or sources of Met will elicit increases in plasma 
Met concentrations and that the increases in plasma will not be compromised by 
increased uptake of Met by body tissues, such as the mammary gland. Methionine 
bioavailabilities are calculated by regressing plasma Met concentrations on levels of 
supplemental Met. Smartamine M has been used as the reference Met source with an 
assumed bioavailability value of 80% (Robert et al., 2002; Rulquin and Kowalczyk, 
2003). The slopes of the other Met sources being tested are divided by the slope for 
Smartamine M to obtain a bioavailability relative to that of Smartamine M.
The second category o f determining the bioavailability o f Met products utilizes 
changes in milk protein production when cows are fed a diet deficient in Met and 
supplemented with increasing levels o f Met (Schwab et al., 2005a). This method requires 
that cows are fed a Met deficient diet to ensure that a response in milk protein to Met
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supplementation will be observed. Changes in milk protein concentrations are regressed 
on the increasing levels o f supplemental Met. Similar to the method o f Schwab et al. 
(2005b), Smartamine M was used as the reference Met source with an assumed 
bioavailability of 80% (Robert et al., 2002; Rulquin and Kowalczyk, 2003). The slopes 
of the other Met sources being tested are divided by the slope for Smartamine M to obtain 
a bioavailability value relative to that of Smartamine M.
A combination approach of using in situ incubation and the in vitro three-step 
procedure of Calsamiglia and Stern (1995) has been examined by Bach and Stem (2000) 
to determine the ruminal degradation and intestinal digestion of Met products. The 
limitation to using this combination approach is that it cannot be used for soluble forms 
of Met sources, such as HMB and HMBi, because the pore size of the in situ bags allows 
the product to escape (Bach and Stem, 2000). Overall there appears to be a strong 
correlation between in situ and in vitro estimates of bioavailability and bioavailability 
estimates obtained from measuring changes in plasma Met concentrations and measuring 
their area under the curve. Both techniques have utility and some variation in results 
should be expected given that both bioavailability values are estimated from observed 
changes in plasma Met concentrations.
CHALLENGES AND LIMITATIONS RELATED TO USING CURRENT 
BIO AVAILABILITY METHODOLOGIES
There are many challenges and limitations involved with determining the 
bioavailability o f Met analogs and Met products. Using changes in milk protein
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concentration is an indirect approach and is dependent upon the Met status of the basal 
diet. If the diet is not deficient in Met, supplying additional amounts or sources of Met 
would not be expected to increase milk protein concentrations. This makes it impossible 
to calculate bioavailability values based on linear increases in slope of milk protein 
concentrations in response to feeding incremental amounts o f Met analogs or Met 
products. This problem was encountered in a recent study by Schwab et al. (2005a). No 
linear increases in milk protein concentrations in response to feeding incremental 
amounts of Smartamine M, HMB, HMBi, or Mepron M85 were observed. Therefore, 
bioavailability calculations based on changes in slope of milk protein concentrations 
could not be made.
Another disadvantage o f this methodology is the large variation of the 
bioavailability calculation. Schwab et al. (2005b) calculated a Met bioavailability for 
HMBi based on changes in milk protein concentrations o f approximately 42 ± 16.0% and 
a bioavailability for MetaSmart relative to that o f Smartamine M of 53 ± 20.0%, 
assuming an 80% bioavailability for Smartamine M. This variation (based on calculated 
95% confidence intervals) could most likely be reduced through more replication or more 
blood sampling time points which would help reduce the fluctuations in plasma Met 
concentrations which occur throughout the day (Graulet et. al., 2005). Despite these 
disadvantages, a decided advantage o f using changes in milk protein concentration is its’ 
applicability. While it may not be the most precise method of determining Met 
bioavailabilities in terms o f standard error, it does provide a practical value for dairy 
nutritionists and producers who may be looking for responses in actual production 
parameters as a means by which to gauge the efficacy of Met analogs or Met products.
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The use o f changes in plasma Met concentrations in response to feeding 
incremental amounts o f Met analogs or Met products also has challenges and limitations. 
Similar to using changes in milk protein concentrations, using changes in plasma Met 
concentrations may be dependent upon the Met status o f the basal diet. Theoretically, the 
more Met-adequate the basal diet is; the more pronounced the response in plasma Met 
will be. Assuming the Met requirement has been met; tissues would not be expected to 
continue to utilize Met from the plasma, thus allowing Met to accumulate in plasma. If 
the basal diet is not as adequate as was predicted, there may not be a significant linear 
increase in plasma Met concentrations resulting in the inability to calculate 
bioavailability values. Schwab et al. (2005a) intended to feed Met-deficient diets to cows 
receiving incremental amounts of Smartamine M, Mepron M85, HMB and HMBi; 
however, a lack o f response in milk protein concentrations may have indicated that the 
basal diet was bordering on Met-adequacy. With this being the case, Met-bioavailability 
values were calculated based on changes in plasma Met concentrations. The authors 
calculated a Met bioavailability for HMBi of approximately 35 ± 6 .6% (44 ± 8.3% 
relative to that o f Smartamine M). These values are lower than the values of 42 ± 16.0% 
(53 ± 20.0% relative to that of Smartamine M) calculated by Schwab et al. (2005b) but 
the variation is considerably less.
This process may be further complicated when Met analogs are fed. The 
metabolism o f HMB is different than DL-Met (Lobley et al. 2001). Once HMB is 
absorbed, a portion o f it bypasses the liver and is taken up by peripheral tissues for 
anabolic uses with only the kidney being a major exporter of Met synthesized from HMB 
de novo. If this is the case, it would exacerbate the problem of generating linear
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increases in plasma Met concentrations when incremental amounts o f Met analogs such 
as HMBi are fed. The question which has not been properly addressed is whether the 
Met status of the basal diet affects the metabolism of Met analogs. Schwab et al. 
(2005a,b) intended to feed Met-deficient diets, but Schwab et al. (2005a) may have failed 
to make the diets sufficiently Met-deficient as indicated by the lack of response in milk 
protein concentrations. However, because the diet was not intentionally made to be Met- 
adequate, this explanation remains to be only speculative and the full effect of a Met- 
adequate diet on HMB metabolism remains unanswered.
The AUC technique also has challenges and limitations. One challenge is 
determining whether pulse-dosing large amounts of Met analogs or Met products into the 
rumen, such as the 50 g Met equivalent amount of Graulet et al. (2005), saturates the 
enzyme system which results in non-physiological conditions. As previously discussed, 
DL-Met and HMB are not metabolized similarly. As a result, pulse-dosing large amounts 
of Met analogs or Met products may be metabolized differently than feeding smaller 
amounts in a TMR, thus limiting a direct comparison between the two techniques. A 
definitive benefit of using the AUC technique is the ability to generate definitive 
responses in plasma Met concentrations. Pulse-dosing large amounts of Met analogs or 
Met products is an effective method for increasing plasma Met concentrations (Koenig et 
al., 1999; Graulet et al., 2005).
Calculating bioavailability values for different Met products brings into question 
the accuracy and precision o f the methodology. As demonstrated by Graulet et al. 
(2005), the AUC technique is precise. These researchers calculated a bioavailability 
value o f approximately 48 ± 2.1% for HMBi (71% relative to that of Smartamine M). On
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the contrary, the precision o f using changes in milk protein concentrations for HMBi is 
much lower with a bioavailability value of 42 ± 16.0% as calculated by Schwab et al. 
(2005b). Using changes in plasma Met concentrations has a greater precision compared 
to using changes in milk protein concentrations but it is still less than the AUC method 
when calculating bioavailability values and has a bioavailability value of approximately 
35 ± 6 .6% as calculated by Schwab et al (2005a).
CONCLUSIONS
Using changes in milk protein concentrations is the easiest and most farm-friendly 
method for determining the effectiveness of an Met product for delivering absorbable 
Met to lactating dairy cows. It is easily obtainable and does not require invasive blood 
collection; however, it lacks precision. However, this method is dependent upon the 
basal diet being deficient in Met. The AUC method is very precise and based on the 
research conducted to date, it generates similar values as using changes in milk protein 
concentrations and changes in plasma Met concentrations which would indicates that it is 
also accurate. However, it requires intensive blood sampling and relies on pulse-dosing 
Met analogs or Met products which is not similar to the manner in which the products 
would be fed on a production dairy facility. It also does not provide any indication of 
whether the product is increasing milk protein synthesis which is the ultimate indicator of 
its’ effectiveness as deemed by dairy nutritionists and dairy producers. Given the 
differences in metabolism between Met analogs and Met products, it has not been 
ascertained if  pulse-dosing Met analogs, as opposed to feeding them in a TMR, further
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affects the metabolism of the product. Using changes in plasma Met concentrations in 
response to feeding incremental amounts of Met analogs or Met products is more precise 
than using changes in milk protein concentrations but is less precise than the AUC 
method. However, using changes in plasma Met concentrations is a more practical 
approach in terms o f comparability with the amount and feeding method of the Met 
product to a commercial dairy facility compared to the AUC method. But, it does not 
permit for changes in milk protein production to be observed, assuming a Met-adequate 
diet is fed.
From a research standpoint, it is most important to develop a methodology which 
will yield both accurate and precise bioavailability calculations which are easily 
replicated or reproduced in a variety of research settings to determine the amount of 
absorbable Met or Met precursor. From an on-farm, production standpoint, it is an 
increase in milk protein yields which will ultimately indicate the utility o f Met analogs or 
Met products. However, it is also important to note that having a high Met 
bioavailability value is not a prerequisite for increasing milk protein production. The 
overall diet must be balanced for both Met and Lys is changes in milk protein production 
are to be expected.
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CHAPTER II
EFFECTS OF PROVIDING TWO FORMS OF SUPPLEMENTAL METHIONINE 
TO PERIPARTURIENT HOLSTEIN DAIRY COWS ON FEED INTAKE AND
LACTATIONAL PERFORMANCE
ABSTRACT
Eighteen primiparous and 42 multiparous Holstein cows were blocked according 
to parity and expected calving date and assigned randomly to one of three dietary 
treatments: 1) basal diet (negative control), 2) basal diet plus 2-hydroxy-4-methylthio 
butanoic acid isopropyl ester (HMBi; hereafter, referred to as, MetaSmart), or 3) basal 
diet plus rumen protected Met in the form of Smartamine M. Treatments were initiated 
21 d before expected calving and continued through 140 d postpartum. Diets were 
similar in ingredient and chemical composition except for the content of Met in 
metabolizable protein (MP). HMBi and Smartamine M were added to the basal diet in 
amounts needed to achieve a 3.0:1 ratio of Lys to Met in MP as predicted by the NRC 
(2001) model. It was assumed that 50% of the HMB in dietary HMBi is absorbed and 
converted to metabolizable Met and that 80% of the Met in Smartamine M is absorbed. 
Prepartum dry matter intake (DMI) (13.5 kg/d), body weight (BW) (687 kg), and body 
condition score (BCS) (3.81), and postpartum milk yield (42.0 kg/d), milk fat yield (1549 
g/d), milk fat content (3.66%), milk true protein yield (1192 g/d), and milk urea nitrogen 
(MUN) content (12.9 mg/dl) were not different among treatments. Postpartum DMI and 
BCS score were greater and the ratio o f milk/DMI and milk N/feed N were less for cows
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fed MetaSmart than for cows fed the control and Smartamine M diets (22.9 vs. 22.0 and
21.4 kg/d, P  = 0.01; 3.37 vs. 3.26 and 3.28, P = 0.09; 1.92 vs. 2.00 and 1.98, P = 0.09; 
0.32 vs. 0.33 and 0.34, P = 0.003, respectively). Milk protein content (P < 0.001) was 
greater for Smartamine M (2.87%) and HMBi (2.81%) than for control (2.72%). 
Concentrations o f Met and Met+Cys in total plasma amino acids were different among 
treatments with values for Smartamine M being the highest followed by HMBi and 
control (2.10, 1.43, and 1.15%, P < 0.001; and 3.92, 3.12, and 2.73%, P < 0.001, 
respectively). The results indicated that both HMBi and Smartamine M are effective in 
providing metabolizable Met, but clarification of their relative contributions to 
metabolizable Met is still needed.
(Key words: methionine, methionine analog, dairy cow)
Abbreviation key: EAA = essential amino acid, 3.5% FCM = 3.5% fat corrected milk, 
HMB = 2-hydroxy-4-methylthio butanoic acid, HMBi = 2-hydroxy-4-methylthio 
butanoic acid isopropyl ester, MP = metabolizable protein.
INTRODUCTION
The ability of a dairy cow to utilize MP for protein synthesis is dependent upon 
how well the essential amino acid (EAA) profile in MP meets the EAA requirements of 
the animal as well as by the total amount o f EAA in MP (NRC, 2001). Research has 
indicated that Met is often a limiting amino acid for ruminants fed corn silage or haylage 
based diets such as those typically fed in the United States (Schwab et ah, 1992; NRC, 
2001). Increasing postruminal supplies o f Met to the small intestine has been shown to
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be effective in increasing protein synthesis in the mammary gland (Guinard and Rulquin, 
1995; Pisulewski et al., 1996). Research has indicated that milk protein content is 
sensitive to changes in the adequacy o f Met in MP (NRC, 2001); therefore, increasing the 
concentration of Met in MP may lead to increased milk protein production. Another 
benefit of using rumen protected Met to improve the profile o f EAA in MP is that the 
overall amount of RUP in the diet may be reduced (NRC, 2001). Reducing the amount of 
dietary N may result in an overall reduction in the amount o f N excreted into the 
environment. Given the environmental concerns and regulations related to food 
production in the US, this benefit may be valuable and useful.
Supplemental sources o f Met have been developed in an effort to increase 
postruminal supplies o f Met. These sources include ruminally protected Met, Met 
hydroxy analogs such as 2-hydroxy-4-methylthio butanoic acid (HMB), and more 
recently, the isopropyl ester of HMB, MetaSmart. The latter has been shown to increase 
plasma Met concentrations more than HMB (Graulet et al., 2005; Robert et al., 2003). 
Although results have been variable, studies have demonstrated that feeding HMB may 
increase milk (Piepenbrink et al., 2004; Rode et al., 1998) and fat yields (Patton et al., 
1970; Rode et al., 1997), but not protein concentrations.
Lysine and Met have been shown to be the two most often limiting AA for milk 
protein production in lactating dairy cows (NRC, 2001). The NRC (2001) suggests that 
the optimal ratio o f Lys to Met in MP to ensure that neither AA is limiting milk protein 
production responses is 3.0:1. The objective of this study was to compare the effects on 
animal performance o f feeding Smartamine M and MetaSmart in amounts that result in a 
predicted 3.0:1 ratio o f Lys to Met in MP to prepartum and early lactation dairy cows fed
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a Met-deficient diet. We hypothesized that both products would increase milk protein 
production. However, because approximately 50% of the HMB in MetaSmart appears to 
be available for use by rumen microorganisms (Schwab et al., 2005a,b), we further 
hypothesized that a greater response in milk fat production may be observed for cows fed 
MetaSmart.
MATERIALS AND METHODS 
Experimental Design and Treatments
Eighteen primiparous and 42 multiparous Holstein cows were assigned to a 
completely randomized block design and were blocked according to age (primiparous or 
multiparous) and expected date of calving. Cows were assigned randomly within parity 
to one of three dietary treatments: 1) basal diet (negative control: no supplemental Met 
and Met deficient), 2) basal diet plus MetaSmart (Adisseo USA, Antony, France), or 3) 
basal diet plus Smartamine M (Adisseo USA, Alpharetta, GA) beginning 21 d before 
expected calving date and continued on their respective treatments through 140 d 
postpartum. All cows received the same prepartum (Table 1) and postpartum (Table 2) 
Met-deficient basal diets.
Preparation and Feeding of Dietary Treatments
Smartamine M and MetaSmart were supplied by Adisseo USA, Inc. (Alpharetta, 
GA). MetaSmart was supplied as a dry powder consisting o f 30% of active ingredient on 
sepiolite which was used as a carrier. Adjusted Met supplementation levels, based on
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Met equivalency o f Smartamine M or MetaSmart, were added to the prepartum and 
postpartum diets of each cow to result in predicted concentrations o f Lys and Met in 
metabolizable protein (MP) of 3.0:1 according to the NRC (2001) diet evaluation (Tables 
2.1-2.4). The final treatment mixtures consisted o f laboratory weighed mixtures of the 
test products. The amount of Smartamine M and MetaSmart in the final diet treatment 
mixtures, as weighed for each cow for each feeding, varied according to: (1) test product 
(due to differences in Met equivalency), (2) treatment level, and (3) DMI.
It was assumed that MetaSmart contained no less than 70% HMB and that 50% of 
the HMB in MetaSmart was absorbed and converted to metabolizable Met. It was also 
assumed that Smartamine M contained 75% Met and that 80% of the Met was absorbed 
(Rulquin and Kowalczyk, 2003).
Management of Cows
Cows were housed in a naturally ventilated tie-stall bam, fed individually, and 
milked in a milking parlor equipped with automatic take-offs and milk meters. 
Prepartum cows were fed twice daily, once during the morning feeding (approximately 
0700 h) and once during the noon feeding (approximately 1400 h).
All procedures related to animal care were conducted with approval of the 
University o f New Hampshire Institutional Animal Care and Use Committee (IACUC # 
010803). The first four blocks of cows were injected every 14 d with bST (Monsanto 
Company, St. Louis, MO) beginning 84 d after calving. The remaining sixteen blocks of 
cows were not injected with bST due to changes in the Fairchild Dairy Teaching and 
Research Center standard operating procedure.
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Lactating cows were fed and milked three times each day at 8-h intervals. 
Weather permitting; lactating cows were exercised for 15-20 min before the second 
milking in a dry lot. Body weight and BCS (scale of 1-5, with 1 being emaciated and 5 
being obese; Wildman et al., 1982), were recorded each week beginning 21 d before 
expected calving date and continued through 140 d postpartum. Body condition score 
was originally intended to be evaluated by three independent scorers, however, BCS from 
one scorer were not included in the final statistical analyses based on the results of a 
statistical outlier test (SAS, version 8.2).
The basal diet (Tables 2.1-2.2) was fed as a TMR and prepared by weighing each 
ingredient and mixing in a mobile tumble drum mixer (Data Ranger; American Calan, 
Inc., Northwood, NH). Treatments were top-dressed onto the TMR of each cow and 
were fed 20% of their total daily feed allotment and treatment at 0600 h, 50% at 1400 h, 
and 30% at 2100 h for ad libitum feed intake using fresh feed at each feeding. Feed 
offered was adjusted daily to achieve 5-10% orts. Orts were collected and weighed daily 
at 1130 h so that DMI could be calculated daily.
Feed Sampling and Analysis
All feed ingredients were sampled 14 d before the start of the experiment and 
analyzed for DM (60°C in forced air oven for 4 h for silages and NIR AO AC 991.03 for 
grains and hay and residual moisture on silages), CP (AOAC 990.03; Leco App. Note 
203-821-146), ADF (AOAC 973.18), NDF (Van Soest et al., 1991) using wet chemistry 
by Dairy One Forage Testing Laboratory (Ithaca, NY) to assist in determining the final 
formulation of the diets. Thereafter, silages were sampled daily during the a.m. feeding
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and analyzed for DM using a microwave oven according to the procedure of the National 
Forage Testing Association (Undersander, 2004). Total mixed ration samples were taken 
at each feeding each day from Sunday 1200 h through Friday 0600 h and composited 
(Sunday 1200 h through Wednesday 0600 h, and Wednesday 1200 h through Friday 0600 
h) and evaluated for DM and particle size using the Penn State Particle Size Separator 
(Heinrichs, 1996). Ort samples were collected at 1100 h Monday through Friday and 
composited (Monday through Wednesday and Thursday through Friday) for DM analysis 
and particle size.
Each month, concentrate feeds and silages were sampled on 2 consecutive days, 
every other week, composited as collected, and a portion of the composited feed was 
analyzes for CP (AOAC 990.03; Leco App. Note 203-821-146), ADF (AOAC 973.18), 
NDF (Van Soest et al., 1991) using wet chemistry by Dairy One Forage Testing 
Laboratory (Ithaca, NY) for ration adjustment. A composite sample of each o f the 
forages and grains at the conclusion o f the study was sent for analysis of DM (60°C in 
forced air oven for 4 h for silages and NIR AOAC 991.03 for grains and hay and residual 
moisture on silages), CP (AOAC 990.03; Leco App. Note 203-821-146), ADF (AOAC 
973.18), NDF (Van Soest et al., 1991), ADICP (AOAC 2001.11; Foss App. Note AN 
300), NDICP (AOAC 2001.11; Foss App. Note AN 300), NEL, NFC (100 - (CP + NDF + 
ash + ether extract), lignin (AOAC 973.18), starch (YSI 2700 SELECT Biochemistry 
Analyzer, YSI App. Note 319), sugar (Hall et al., 1999), fat (Tecator Soxtec System HT6, 
FOSS Tecator App. Note AN301; Subnote AN 3414), ash (AOAC 942.05) and minerals 
(Thermo Jarrell Ash IRIS Advantage Inductively Coupled Plasma Radial Spectrometer)
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using wet chemistry by Dairy One Forage Testing Laboratory (Ithaca, NY; 
www. dairy one. com/ forage/procedures).
A portion of the composited forage and grain samples were also dried to 
approximately 90% DM in a forced air oven at 55°C (VWR Scientific, West Chester, PA), 
allowed to equilibrate for 2-4 h to room temperature, and ground to pass through a 1-mm 
screen using a Wiley Mill (Thomas Scientific, Swedesboro, NJ) for analysis of AA at the 
conclusion of the study. A composite sample of each o f the ground forage and grain 
samples were sent for analysis o f AA using a Beckman system 6300 High Performance 
Amino Acid Analyzer (Beckman-Coulter Instruments, CA) by the Experimental Station 
Chemical Laboratories, University o f Missouri-Columbia (Columbia, MO).
Milk Sampling and Analysis
Milk samples were collected from each cow during all 3 milkings 1 d each week 
from d-4 postpartum through 140 d postpartum. A milk sample was not taken until cows 
reached a minimum of 4 DIM. Samples were refrigerated until composited by milk 
weight for the sample date. Samples were preserved with 2-bromo-2-nitropropane-l,3- 
diol (1 tablet per 40 ml o f milk). Samples were analyzed for CP, true protein, fat, lactose, 
and MUN by mid-infrared spectrophotometric analysis with a Foss 4000 (Foss North 
America, Eden Prairie, MN) (Dairy One Cooperative, Inc., Ithaca, NY).
Blood Sampling and Analysis
Blood samples were drawn at 112 and 119 DIM, 2 h after the 0600 h feeding via 
venipuncture o f the coccygeal vein into 10 ml evacuated tubes containing sodium heparin
45
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
(Becton Dickinson and Co., Rutherford, NJ). Samples were immediately placed in an ice 
bath and centrifuged within 45 min at 3300 x g  for 20 min at 5°C. An aliquot of 4 ml of 
plasma was deproteinized (four volumes of plasma was vortexed with one volume of 
15% sulfosalicylic acid) and then placed in the centrifuge for 10 min at 5°C prior to 
centrifuging at 3300 x g  for 20 min at 5°C. The supernatant was collected and 0.25-ml 
aliquots were placed into Nunc CryoTube vials (Nalge Nunc International, Denmark) and 
stored at -80°C until analyzed for plasma free AA using a Beckman system 6300 High 
Performance Amino Acid Analyzer (Beckman-Coulter Instruments, CA) by the 
Experimental Station Chemical Laboratories, University o f Missouri-Columbia 
(Columbia, MO). Between the 112 and 119 d samplings, the deproteinized plasma 
samples taken at 112 d were stored at -20°C until composited with the 119-d 
deproteinized samples. Plasma AA concentrations (pg/ml) were adjusted to account for 
the use of 15% sulfosalicylic acid which was used in a 1:4 ratio with plasma to 
deproteinize the original plasma sample.
Statistical Methods
Production and intake data were analyzed using the MIXED procedure of SAS 
[Version 8.2 (2001); (SAS Institute, Inc., Cary, NC)] according to the following model:
Y ijidm — p + T; +  Pj +  TPjj + Bk + Cijkl + W m +  TWjm +  TPW jjm + eijklm
where,
Yijkim is the dependent, continuous variable, 
p is the overall mean,
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Tj is the fixed effect of the ith treatment (i = 1, 2, 3),
, Pj is the fixed effect o f the jth parity (i = 1, 2 ),
TPij is the fixed effect o f the ith treatment by jth  parity,
Bk is the random effect of the kth block (k = 1,.. .20),
Cyi is the random effect o f the 1th cow within the ith treatment, within the jth 
parity, and within the kth block (1 = 1 , . . nljk),
Wm is the fixed effect of the mth week of experiment (m =1, . .  .20),
TWjm is the fixed effect of the ith treatment by mth week of experiment 
interaction,
TPWjjm is the fixed effect of the ith treatment by jth  parity by mth week of 
experiment interaction, and 
ejjkim is the residual error.
In this model, the random effect o f cow within treatment subclasses is used as the 
error term for the effect of treatments. Residual errors, which are error within cow across 
time and represent error from repeated measurements in the experimental unit (cow) were 
modeled using a first-order autoregressive covariance structure. Autoregressive (1) 
resulted in the smallest Bayesian information criterion of the three covariate structures 
tested: autoregressive (1), compound symmetry, and unstructured (Littell et al., 1996). 
Data for multiparous cows were analyzed with and without covariates: previous 305-d 
mature equivalent milk yield, milk protein yield and percent, and milk fat yield and 
percent. Analyzing the data without covariates resulted in similar Bayesian information 
criterion values; therefore, covariates were not included in the final statistical model.
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Degrees of freedom were calculated using the Kenward-Roger option o f MIXED (SAS, 
2001).
Data for AA concentrations were analyzed using the MIXED procedure of SAS 
[Version 8.2 (2001); (SAS Institute, Inc., Cary, NC)] according to the following model: 
Yijkim = p + T; + Pj + TPij + Bk + Cjjki + ejjki
where,
Yjjkim is the dependent, continuous variable, 
p is the overall mean,
Tj is the fixed effect of the ith treatment (i = 1, 2, 3),
Pj is the fixed effect o f the jth  parity (i = 1, 2),
TPy is the fixed effect o f the ith treatment by jth  parity,
Bk is the random effect o f the kth block (k -  1,...20),
Cjji is the random effect o f the 1th cow within the ith treatment, within the jth 
parity, and within the kth block (1 = 1,..., nyk), and 
eyki is the residual error.
The Univariate Procedure of SAS was used to determine outlier cows. An
observation, which was greater than 2.5 standard deviations from the mean for milk
production and DMI, was considered an outlier. The results of the outlier analysis 
indicated that three multiparous cows were outliers due to erratic milk production and 
DMI; therefore these cows were removed from the final statistical analyses.
Overall treatment differences were examined using least squares means (SAS, 
Version 8.2 (2001); (SAS Institute, Inc., Cary, NC)].
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. Significance was declared at P < 0.10 and a trend in the data was declared at P  < 0.15. 
Week and block were included in the final statistical model for all analyses. The DIFF 
option o f was used to test treatment differences among least squares means, and the 
SLICE option was used to analyze differences among weekly treatment means (SAS, 
Version 8.2 (2001); (SAS Institute, Inc., Cary, NC)].
RESULTS 
Ingredient and Chemical Composition of Diets
The ingredient composition o f the prepartum and postpartum diets are shown in 
Tables 2.1 and 2.2. Prepartum and postpartum basal diets were similar in ingredient and 
chemical composition among treatments and differed only in their Met content.
The chemical composition o f the forages used during the study is shown in Table 
2.5. The chemical composition of the consumed prepartum and postpartum diets and the 
AA composition of the feed ingredients are shown in Tables 2.3, 2.4, and 2.6, 
respectively. The chemical composition of the consumed diets was determined by 
analyzing each individual feed ingredient for its chemical composition and then entering 
the feed analysis results into the NRC (2001) model. Particle size estimation of the 
mixed mostly grass silage, com silage, prepartum TMR and orts, and postpartum TMR 
and orts are shown in Table 2.7. Orts as a percent of DMI averaged 20.8% prepartum 
and 12.1% postpartum and were not different among treatments (Table 2.7).
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Prepartum Dry Matter Intake, Body Weight, and Body Condition Score
The average days on trial prior to calving was 18,8 ± 0.89 d and were not 
observed to be different among treatments. Prepartum DMI, BW, and BCS were not 
observed to be different among treatments and averaged 13.5 ± 0.45 kg/d, 687 ± 16.5 kg 
and 3.81 ± 0.051, respectively (Table 2.8). Prepartum DMI as a percent o f BW was not 
different among treatments and averaged 1.97% (Table 2.8).
Postpartum Dry Matter Intake, Body Weight, and Body Condition Score
A significant effect on postpartum DMI was observed (Table 2.8). 
Supplementation with MetaSmart resulted in greater DMI compared to control and 
Smartamine M (22.9 vs. 22.0 and 21.4 ± 0.41 kg/d, respectively); however, 
supplementation with Smartamine M was not observed to elicit an effect on DMI 
compared to control. There was a significant parity by treatment interaction observed for 
postpartum DMI indicating that primiparous and multiparous cows responded differently 
to dietary treatments (Figure 2.1; Table 2.8). For primiparous cows, DMI was observed 
to be greater for cows fed MetaSmart (20.7 ± 0.68 kg/d) compared to control (18.4 ± 0.68 
kg/d) and Smartamine M (18.2 ± 0.68 kg/d) (Figure 2.1; Table 2.8). For multiparous 
cows, MetaSmart supplementation did not increase DMI (25.2 ± 0.47 kg/d) compared to 
control (25.6 ±  0.47 kg/d) or Smartamine M (24.5 ± 0.47 kg/d); however, multiparous 
cows supplemented with Smartamine M had lower DMI compared to controls.
Dry matter intake was also analyzed weekly. Primiparous cows receiving 
MetaSmart were observed to consume more feed during weeks 4-7 postpartum (20.5 ± 
1,11 kg/d) than did control (17.0 ± 1.11 kg/d) or Smartamine M (16.6 ± 1.11 kg/d) cows
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and multiparous cows receiving Smartamine M had lower DMI during weeks 11, 13, and 
14 compared to control (25.9 vs. 28.2 ± 0.77 kg/d, respectively).
Differences in overall postpartum BW were not observed to be different among 
treatments and averaged 578 ± 12.7 kg during the first 140 d postpartum (Table 2.8), but 
a significant parity by treatment interaction was observed. Body weights for primiparous 
cows were greater for cows supplemented with MetaSmart (554 ± 20.9 kg) compared to 
both control (515 ± 20.9 kg) and Smartamine M supplemented cows (512 ± 20.9 kg). 
Multiparous cows fed the control (644 ± 14.4 kg) treatment had significantly greater BW 
compared to Smartamine M (620 ± 14.4 kg) with MetaSmart (622 ± 14.4 kg) being 
intermediate and similar to both control and Smartamine M. Cows supplemented with 
MetaSmart (3.37 ± 0.053) had greater BCS than both control (3.26 ± 0.053) and 
Smartamine M supplemented cows (3.28 ± 0.053) (Table 2.8). Postpartum DMI as a 
percent o f BW was not different among treatments and averaged 3.82%
Milk Production and Composition
Milk yield (43.0 ± 0.99 kg/d), milk fat concentration (3.66 ± 0.074%) milk true 
protein yield (1192 ± 26.8 g/d), lactose yield (2075 ± 45.6 g/d), MUN yield (5.7 ± 0.18 
g/d), and MUN concentration (12.9 ± 0.29 mg/dl) were not observed to be significantly 
different among treatments (Table 2.9). When analyzed on a weekly basis, cows 
receiving Smartamine M produced less milk during weeks 9-11 and 13 (trend for week 
12: P  = 0.11) compared to control.
Fat corrected milk (3.5% FCM) averaged 43.7 ± 0.80 kg/d and was not observed 
to be different among treatments; however, a parity by treatment interaction was
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observed (Table 2.9). Primiparous cows supplemented with MetaSmart had greater 
yields of 3.5% FCM (39.0 ± 1.32 kg/d) compared to Smartamine M (36.5 ± 1.32 kg/d), 
while the control treatment (36.9 ± 1.32 kg/d) was similar to both MetaSmart and 
Smartamine M. Supplementation with MetaSmart and Smartamine M did not increase 
3.5% FCM yields compared to control (49.4 and 49.3 vs. 51.3 ± 0.91 kg/d, respectively) 
in multiparous cows.
Milk fat yield was similar among treatments (Table 2.9); however, a parity by 
treatment effect was observed. Supplementation with MetaSmart (1382 ± 49.2 g/d) in 
primiparous cows did not increase milk fat yield compared to control (1320 ± 49.2 g/d) 
but did increase milk fat yield compared to Smartamine M (1288 ± 49.2 g/d). 
Smartamine M did not increase milk fat yield compared to control in primiparous cows. 
Supplementation with MetaSmart (1744 ± 33.6 g/d) and Smartamine M (1757 ± 33.6 g/d) 
in multiparous cows did not increase milk fat yield compared to control (1806 ± 33.6 g/d) 
cows. Control cows produced more milk fat than MetaSmart supplemented cows with no 
difference being observed between control and Smartamine M.
As expected, supplementation with MetaSmart and Smartamine M increased milk 
protein concentrations similarly compared to control (2.81 and 2.87 vs. 2.72 ± 0.031%, 
respectively) (Table 2.9).
Feed Efficiency and Nitrogen Conversion
Feed efficiency (kg of milk/kg of DMI) and conversion o f feed N to milk N (g of 
feed N/g of milk N) differed among treatments (Table 2.10). Supplementation with 
MetaSmart resulted in a lower feed efficiency compared to Smartamine M and control
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(1.92 vs. 1.98 and 2.00 ± 0.032, respectively). Smartamine M supplementation improved 
the conversion of feed N into milk N compared to control and MetaSmart (0.34 vs. 0.33 
and 0.32 ± 0.004, respectively).
Energy balance as predicted by the NRC (2001) model was observed to be 
negative for all treatments for the duration of the study (Table 2.10). When energy 
balance was calculated by treatment (energy required for milk and maintenance was 
subtracted from net energy intake), MetaSmart supplementation resulted in the least 
severe energy deficit and was significantly different than both control and Smartamine M 
(-2.9 vs. -3 .9  and -4.2 ± 0.41 Mcal/d, respectively) (Figure 2.2; Table 2.10).
Plasma Amino Acids
Supplementation with both MetaSmart and Smartamine M increased the 
concentration of Met in total plasma AA compared to control (1.43 and 2.10 vs. 1.15 ± 
0.078%, respectively). However, Smartamine M supplementation resulted in an even 
greater increase in the concentration o f Met in total plasma AA compared to MetaSmart. 
Concentrations o f Met+Cys in total plasma AA were also observed to be different among 
treatments with Smartamine M being the greatest followed by MetaSmart and control 
(3.92 vs. 3.12 vs. 2.73 ± 0.102%, respectively). Concentrations of total sulfur AA in total 
plasma AA were also greatest for Smartamine M followed by MetaSmart and control 
(5.98 vs. 5.01 vs. 4.25 ± 0.160%, respectively) (Table 2.11).
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DISCUSSION
There is limited data available on the effects of providing supplemental Met in the 
form of HMB (Griel et al., 1968; Rode et al., 1998; Johnson et al., 1999; Phillips et al., 
2003; Piepenbrink et al., 2004) or rumen protected Met (Luhman et al., 1997; Socha et 
al., 2005) when supplemented during the prepartum and postpartum periods and in no 
cases has MetaSmart been fed to dairy cows during the prepartum period. Socha et al. 
(2005) observed that feeding Met during the prepartum period did not decrease prepartum 
DMI during the last week before parturition, however, it tended to decrease postpartum 
DMI. Cows fed Smartamine M averaged 14.2 kg/d DMI during the week before 
parturition while control cows and Smartamine ML cows averaged 15.1 and 15.2 kg/d, 
respectively. While not significant (P > 0.10), there was a numerical trend for lower 
DMI when cows were fed Smartamine M prepartum. To further highlight this point, 
cows were blocked into six groups of 14 cows each prior to calving and although there 
were only 3 basal diets fed prior to parturition (one control diet, one Smartamine M diet, 
one Smartamine ML diet) the animals were still analyzed as six separate groups of cows. 
The decrease in DMI prior to parturition for Smartamine M compared to control and 
Smartamine ML (13.9 vs. 15.1 and 15.1 ± 0.7, respectively, and 14.5 vs. 15.0 and 15.3, 
respectively) still exists.
In the current study, differences in mean prepartum DMI were not observed; 
however when the data were analyzed by week, prepartum DMI during the last 2 wk 
before calving for Smartamine M was significantly less than control and MetaSmart, 
which is in agreement with the trend observed by Socha et al. (2005). Overall dietary CP
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content for the prepartum diet averaged 13.8% in the current study compared to 15.6% 
for the prepartum diet o f Socha et al. (2005). Overall flows of MP-Lys and MP-Met were 
also lower in the current study for Smartamine M compared to Socha et al. (2005) for 
Smartamine M (82 and 27 g/d vs. 101 and 37 g/d, respectively). When DMI as a percent 
of BW was analyzed as a means o f adjusting for any numerical differences in BW, no 
differences between treatments were observed. There were also no treatment by week, 
parity by week, or parity by treatment by week interactions observed. These results 
indicate that any numerical differences in DMI prepartum were most likely the result of 
differences in BW between the cows, however, when adjusted for BW, no differences 
existed.
A parity by treatment interaction was observed for postpartum DMI and the 
results indicate that primiparous cows on the MetaSmart treatment consumed more feed 
than either control or Smartamine M and multiparous cows consuming the MetaSmart 
and control treatments had greater DMI than cows supplemented with Smartamine M 
(Figure 2.1). When DMI was taken as a percent o f BW, no differences existed among 
treatments and there were no treatment by week, parity by week, or parity by treatment 
by week interactions observed. These results indicate that the observed differences in 
DMI were due to numerical differences in BW, but when DMI was adjusted for BW, no 
effect of treatment existed.
Prepartum and postpartum diets were evaluated using the NRC (2001) model 
assuming the average chemical composition o f the feeds used throughout the duration of 
the study. The diet was formulated to be adequate in energy and protein, however, 
according to NRC (2001) model predictions using the results o f the study, energy content
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of the diet was lower than expected. The NRC (2001) model predicted energy to be 
limiting by 4.4, 3.6, and 4.6 Mcal/d for the control, MetaSmart, and Smartamine M diets, 
respectively, and consequently, predicted energy to limit milk production (Figure 2.2). 
Actual milk yields compared to NRC (2001) predicted NEL-allowable milk and MP- 
allowable milk yields were 43.4 vs. 37.0 and 40.2 kg/d, respectively, for control, 43.5 vs.
38.4 and 40.6, respectively, for MetaSmart, and 42.0 vs. 35.4 and 37.0, respectively, for 
Smartamine M. These results indicate that cows produced more milk than the NRC
(2001) model predicted was possible based on supplies of energy and MP. Regardless, 
the NRC (2001) model still predicted that milk production was limited more by energy 
than by MP. A possible explanation for this may be attributable to the corn silage used 
throughout the study which was found to be relatively low in starch and sugar content 
compared to levels from previous year's com silage fed at the University of New 
Hampshire (Table 2.3).
The lower DMI observed for multiparous Smartamine M cows compared to 
control cows during weeks 11 and 13-14 may help to explain why milk yields for 
multiparous control cows during weeks 9-11, and 13 (trend for week 12; P = 0.11) were 
greater than multiparous Smartamine M cows. It appears that the lower DMI for cows 
consuming Smartamine M were accompanied by lower milk yields.
No overall differences between treatments were observed and no parity by 
treatment interactions were detected for milk yield. However, when the data was 
analyzed by parity, there was a tendency for a difference among treatments. More 
specifically, primiparous MetaSmart cows, which consumed more feed than both control 
and Smartamine M, were observed to have significantly greater BCS but not milk yield.
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It is possible that the greater amount of feed consumed was utilized for replenishing body 
condition and not partitioned towards milk production. When the milk production data 
for multiparous cows was analyzed separately, control cows, which had greater DMI than 
Smartamine M cows, also produced more milk (50.9 vs. 48.0 kg/d) even though their 
BCS was observed to be similar. It is plausible that the greater DMI was utilized for milk 
production and did not contribute to improving body condition score. A trend (P = 0.15) 
was observed for multiparous control cows to produce more milk than multiparous 
MetaSmart cows despite having similar DMI and lower BCS. Again, it appears that 
control animals converted more DMI into milk than animals consuming the MetaSmart 
diet. In addition, control cows were observed to have greater efficiency at converting 
feed into milk than did MetaSmart cows. As previously discussed, MetaSmart cows 
appeared to utilize more feed for replenishing body condition than for milk production. 
Assuming that all cows were in a negative energy balance during the entire postpartum 
period, it is difficult to explain why we observed that multiparous control cows were in 
greater negative energy balance compared to MetaSmart cows and similar to Smartamine 
M cows but produced more milk.
The effects of HMB on ruminal fermentation have been varied. For example, 
Deswysen et al. (1991) fed 0 or 5 g/d HMB to young and mature wethers. Significant 
increases in apparent DM, OM, and CP digestibility in young wethers but observed no 
effect on these parameters in mature wethers was observed. Using continuous culture 
fermenters, Vazquez-Anon et al. (1999) reported that HMB did not elicit any changes in 
rumen fermentation. In a more recent study, Vazquez-Anon et al. (2001) increased the 
concentration o f HMB from 0 to 0.88% of DM and again did not observe any changes in
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DM, CP, ADF, or starch and sugar digestibility or VFA concentration. However, they 
did observe increases in NDF digestibility, ruminal ammonia-N concentration and 
bacterial protein synthesis with increasing concentration of HMB.
Feeding Met products has been shown to increase milk fat synthesis. Patton et al. 
(1970) and Polan et al. (1970) observed increases in milk fat production with HMB 
supplementation and attributed this effect to an increase in fatty acid synthesis in the 
rumen and an alteration in the fatty acid composition of plasma lipoproteins. An 
analogous explanation to that proposed by Patton et al. (1970) and Polan et al. (1970) 
would be that increasing milk fat synthesis with HMB and MetaSmart supplementation 
may be related to an increase in mammary uptake o f triacylglycerols (TAG) as a result of 
an increase in the secretion o f triacylglycerol-rich lipoproteins by the small intestine 
and/or liver as observed in preruminant calves (Auboiron et al., 1994). While this 
explanation may be plausible for MetaSmart which has been demonstrated to resist 
ruminal degradation (Robert et al., 2001), HMB has not been shown to resist ruminal 
degradation to any appreciable amount (Schwab et al., 2005a,b). As a result, when 
feeding HMB in a TMR where very little product would be expected to resist ruminal 
degradation, an alteration in the ruminal ecosystem by HMB may be the route o f action 
for altering milk fat production.
Altering the VFA profile in the rumen may be another method through which 
HMB can increase milk fat synthesis. Robert et al. (2003) recently demonstrated that the 
amount of HMB available in MetaSmart for ruminal degradation is sufficient to cause an 
alteration in VFA pattern of non-lactating dairy cows. Noftsger et al. (2003) observed an
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increase in the acetate:propionate ratio from 3.57:1 to 4.22:1 when HMB was added to 
diets fed to continuous culture fermenters.
We originally hypothesized that feeding MetaSmart would increase milk fat 
concentration as a result o f an increase in the acetate to propionate ratio as well as an 
increase in the uptake o f TAG by the mammary gland for reasons previously discussed. 
Although there was no overall increase in milk fat concentration or yield with 
MetaSmart, when the data was analyzed on a week by week basis, a significant increase 
in milk fat concentration was observed during wk 9, 11, and 12 for multiparous cows fed 
Smartamine M compared to control. In addition, a parity by treatment interaction in milk 
fat yield and 3.5% FCM was observed. For primiparous cows, MetaSmart 
supplementation produced numerically more milk compared to Smartamine M 
supplementation, which resulted in significantly greater milk fat and 3,5% FCM 
production for MetaSmart compared to Smartamine M. This effect was not observed in 
multiparous cows receiving MetaSmart or Smartamine M supplementation. This resulted 
in a significant difference between control and MetaSmart for 3.5% FCM and milk fat 
yield and between control and Smartamine M for 3.5% FCM. Despite the evidence 
previously discussed, and because no ruminal measurements were taken to evaluate 
ruminal fermentation, it is not possible to determine whether or not MetaSmart altered the 
ruminal environment in such a way as to promote increased milk fat synthesis.
As predicted, milk protein concentrations were greater for MetaSmart and 
Smartamine M compared to the control. There was no difference between MetaSmart 
and Smartamine M; however, there was a numerical trend for Smartamine M to increase 
milk protein concentration more than MetaSmart (2.87 vs. 2.81, P -  0.12). It was
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originally assumed that 50% of the HMB in dietary MetaSmart was absorbed and 
converted to metabolizable Met (Schwab et al., 2005a,b) and that 80% of the Met in 
Smartamine M was absorbed (Rulquin and Kowalczyk, 2003). Based on these 
assumptions, MetaSmart and Smartamine M diets were formulated to supply similar 
amounts of metabolizable Met. However, because a trend existed for Smartamine M to 
increase milk protein concentration more than MetaSmart, it would appear that the Met- 
bioavailabilities of the two products may be different than assumed. However, despite 
this observation, results demonstrate that MetaSmart is effective in providing 
metabolizable Met based on its ability to increase milk protein concentrations compared 
to the control diet.
Future research should be conducted to determine a more accurate value for the 
Met bioavailability of MetaSmart. While the current study did not directly measure 
changes in plasma Met concentrations, it is possible that evaluating changes in plasma 
Met concentrations may improve the precision when evaluating the Met contribution of a 
rumen protected Met product than compared to changes in milk protein concentration. In 
the current study, Smartamine M supplementation resulted in a larger numerical, but not 
statistical increase in milk protein concentrations compared to MetaSmart. However, it 
must be noted that there can be large variation when using changes in milk protein 
concentrations to estimate the bioavailability of Met products. Therefore, when using 
changes in milk protein concentrations to compare the efficacy o f Met products some 
precision may be lost. However, one of the objectives o f feeding Met products is to 
increase milk protein concentrations; therefore, using changes in milk protein 
concentrations may be the most applicable methodology to employ.
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In the current study and in previous studies, an assumed 80% bioavailability value 
for Smartamine M has been used (Schwab et al., 2005a,b). In all research studies at the 
University o f New Hampshire, Smartamine M was top-dressed onto the TMR resulting in 
no physical damage to the product. However, under typical feeding conditions, the 
bioavailability of Met from Smartamine M may be less because of disruption of the 
protective coating via physical abrasion caused by mechanical mixing/feeding equipment 
such as TMR mixers. A product such as MetaSmart, which comes in a liquid form and is 
spray-dried onto the feed, does not experience any loss in efficacy due to physical 
abrasion. Therefore, under typical feeding situations, the effectiveness of MetaSmart as a 
percentage o f Smartamine M may be greater than 54%. This suggests an advantage to 
using a product such as MetaSmart, which does not lose efficacy due to mechanical 
mixing/feeding.
Particle size was estimated for forages, TMR, and orts. Heinrichs and Kononoff
(2002) suggested that approximately 3-8% of the total TMR remain on the top sieve (19- 
mm) when using the Penn State Particle Separator or sorting may occur. They also 
suggested that there should be no more than a 20% difference between the amount of 
TMR and orts remaining on the top sieve. In the current study, approximately 27% of the 
prepartum TMR and 22% of the postpartum TMR and approximately 38% of the 
prepartum orts and 44% of the postpartum orts remained on the top sieve. The difference 
between the prepartum TMR and orts was within the 20% allowable range; however 
there was a 22% difference between the postpartum TMR and orts. This difference was 
attributed to the low quality alfalfa hay that was included in the postpartum diet which 
cows did appear to sort. Because the basal diet was similar for all treatments, any
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negative effects o f particle size would have affected all treatment groups the same, 
therefore the difference was not considered detrimental in this study.
CONCLUSIONS
It is concluded that both MetaSmart and Smartamine M are effective in providing 
metabolizable Met as indicated by increased milk protein concentrations and plasma 
sulfur A A concentrations. However, clarification o f their relative contributions to 
metabolizable Met is still needed. Future research should concentrate not only on 
determining the best methodology for predicting the bioavailability of methionine 
products, but also on reducing the variation associated with predicting bioavailability of 
Met analogs and Met products.
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Table 2.1. Ingredient composition of prepartum diets fed to cows receiving two forms of
Met.
% of DM
Item Control MetaSmart Smartamine M
Alfalfa hay 7.99 8.01 7.99
MMG silage1 13.24 13.24 13.21
Corn silage 33.38 33.38 33.33
Soyhulls 12.81 12.79 12.83
Ground corn meal 7.05 7.06 7.07
Ground barley meal 19.21 19.19 19.20
Soybean meal 3.67 3.68 3.69






Smartamine M4 - - 0.06
MMG silage = mixed mostly grass silage
2 Contains: 2.50% dried corn distillers grains (carrier), 0.50% oil, 18.50% salt, 23.68% 
magnesium oxide, 48.85% magnesium sulfate, 1.02% maganous oxide, 1.77% zinc sulfate, 
0.02% iron sulfate, 0.75% red iron oxide, 0.50% copper sulfate, 0.02% cobalt carbonate, 0.01% 
calcium iodate, 0.08% selenium 3%, 0.10% flavoring, 0.17% vitamin A, 0.06% vitamin D, 1.47% 
vitamin E. ). The custom mineral premix contains (percent or amount of custom mineral DM): 
294 KlU/kg of vitamin A, 68 KlU/kg vitamin D, 1131 IU/kg vitamin E, 13.5% Ca, 1.1% P, 
6.6%Mg, 0.03% K, 0.27% S, 10 ppm Se, 1558 ppm Mn, 1648 ppm Zn, 1055 ppm Fe, 219 ppm 
Cu, 31 ppm Co, 9.2% Cl, and 6.0% Na.
3 MetaSmart was supplied as a dry powder containing 30% of active ingredient on a sepiolite 
carrier. A 70% methionine equivalence for MetaSmart with a bioavailability of 50% was 
assumed. The quantity of MetaSmart added to the diet was that needed to increase Met in MP 
from 1.99% (Table 3) to 2.43%.
4 A 75% methionine equivalence for Smartamine M with a bioavailability of 80% was assumed. 
The quantity of Smartamine M added to the diet was that needed to increase Met in MP from 
1.99% (Table 3) to 2.38%.
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Table 2.2. Ingredient composition o f the postpartum diets fed to cows receiving two
forms of Met.
% of DM
Item Control MetaSmart Smartamine M
Alfalfa hay 4.57 4.57 4.57
MMG silage1 11.44 11.44 11.44
Corn silage 33.38 33.39 33.38
Soyhulls 7.91 7.91 7.91
Corn meal 15.69 15.69 15.69
Barley grain 11.04 11.04 11.04
Soybean meal 7.73 7.73 7.73
Urea 0.36 0.36 0.36
Blood meal 2.22 2.22 2.22






Smartamine M4 - - 0.102
MMG silage = mixed mostly grass silage
2 Contains: 30.30% sodium sesquicarbonate, 30.30% calcium carbonate, 15.15% salt, 10.91% 
magnesium oxide, 4.85% monosodium phosphate, 3.03% trace mineral and vitamin premix, 
4.24% yeast culture (Diamond V XP, Diamond Mills, Inc., Cedar Rapids, IA), and 1.21% 
MTB100 (Alltech, Inc., Nicholasville, KY). The custom mineral premix contains (percent or 
amount of custom mineral DM): 294 KlU/kg of vitamin A, 68 KlU/kg vitamin D, 1131 IU/kg 
vitamin E, 13.5% Ca, 1.1% P, 6.6%Mg, 0.03% K, 0.27% S, 10 ppm Se, 1558 ppm Mn, 1648 ppm 
Zn, 1055 ppm Fe, 219 ppm Cu, 31 ppm Co, 9.2% Cl, and 6.0% Na.
3 MetaSmart was supplied as a dry powder containing 30% of active ingredient on a sepiolite 
carrier. A 70% methionine equivalence for MetaSmart with a bioavailability of 50% was 
assumed. The quantity of MetaSmart added to the diet was that needed to increase Met in MP 
from 1.79% (Table 4) to 2.30%.
4 A 75% methionine equivalence for Smartamine M with a bioavailability of 80% was assumed. 
The quantity of Smartamine M added to the diet was that needed to increase Met in MP from 
1.79% (Table 4) to 2.33%.
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Table 2.3. Chemical composition and NRC (2001) evaluation of prepartum diets fed to
cows receiving two forms o f M et1.___________________________________________
Item Control MetaSmart Smartamine M
NDF, % DM 38.7 38.7 38.7
ADF, % DM 24.4 24.4 24.3
RDP, % DM 10.1 10.2 10.2
RUP, % DM 3.6 3.6 3.6
CP, % DM 13.7 13.8 13.8
Energy balance, Mcal/d 8.6 8.4 7.5
RDP balance, g/d -8 -3 -1
RUP balance, g/d 431 432 381
MP supplied, g/d 1196 1195 1133
MP balance, g/d 325 326 288
Lys, g/d 87 87 82
Met, g/d 24 29 27
His, g/d 26 26 25
Lys, % of MP 7.26 7.28 7.24
Met, % of MP 1.99 2.43 2.38
His, % of MP 2.20 2.18 2.21
Lys/Met in MP 3.6/1 3.0/1 3.0/1
1 NRC evaluation of diet was based upon final production data and feed analyses of study.
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Table 2.4. Chemical composition and NRC (2001) evaluation of postpartum diets fed to
cows receiving two forms of M et1._______________________________________________
Item Control MetaSmart Smartamine M
NDF, % DM 32.9 32.9 32.9
ADF, % DM 20.4 20.4 20.4
RDP, % DM 10.0 10.0 10.0
RUP, % DM 6.3 6.4 6.4
CP, % DM 16.3 16.4 16.4
Energy balance, Mcal/d -4.4 -3.6 -4.6
RDP balance, g/d 23 24 21
RUP balance, g/d -160 -136 -250
MP supplied, g/d 2412 2525 2360
MP balance, g/d -129 -107 -199
Lys, g/d 168 174 164
Met, g/d 43 58 55
His, g/d 64 66 62
Lys, % of MP 6.96 6.89 6.95
Met, % of MP 1.79 2.30 2.33
His, % of MP 2.64 2.61 2.63
Lys/Met in MP 3.9/1 3.0/1 3.0/1
NRC evaluation of diet was based upon final results of study.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
70
Table 2.5. Chemical composition of the forages fed to cows receiving two forms of Met.
Alfalfa hay________ MMG silage Corn silage
Chemical, % DM
DM 91.8 28.0 30.2
CP 16.2 16.5 7.9
Sol. CP, % CP 43.0 58.3 56.7
NEl, Mcal/kg 1.3 1.4 1.6
ADF 35.3 39.9 26.6
NDF 45.7 57.2 45.1
NFC2 - 29.2 20.1 38.9
NSC3 - - 33.3
Starch4 - - 30.3
Sugar5 - - 3.0
Ca 1.7 0.8 0.2
P 0.2 0.3 0.2
Mg 0.2 0.2 0.1
K 2.3 2.7 1.4
Na 0.07 0.04 0.01
S 0.2 0.2 0.1
Fe, ppm 127.0 324.0 243.3
Zn, ppm 17.0 27.3 20.3
Cu, ppm 7.0 13.5 6.5
Mn, ppm 22.5 57.0 15.5
Mo, ppm 1.6 1.6 1.0
MMG silage = mixed mostly grass silage
2 Nonfibrous carbohydrate = 100 - (CP + NDF + ash + ether extract).
3 Nonstructural carbohydrate = starch + sugar,
4 Starch was analyzed by Dairy One Forage Testing Laboratory using a YSI 2700 SELECT 
Biochemistry Analyzer - YSI Incorporated, Application Note Number 319.
5 Sugar was analyzed by Dairy One Forage Testing Laboratory according to the procedure 
described in Hall et al. (1999). J. Sci. Food Agric. 79:2079-2086.
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Arg 0.17 0.43 0.71 0.48 0.65 0.56 3.75 3.85
His 0.13 0.24 0.33 0.37 0.29 0.30 1.41 6.66
lie 0.25 0.66 0.64 0.31 0.43 0.43 2.36 0.32
Leu 0.67 1.20 1.15 1.31 0.89 0.78 4.10 13.03
Lys 0.19 0.59 0.83 0.45 0.46 0.75 3.29 9.57
Met 0.12 0.23 0.24 0.21 0.22 0.14 0.74 1.23
Phe 0.28 0.68 0.76 0.57 0.62 0.45 2.65 7.27
Thr 0.24 0.53 0.66 0.39 0.43 0.42 1.98 4.17
Trp 0.04 0.09 0.23 0.10 0.13 0.09 0.66 1.99
Val 0.36 0.88 0.85 0.62 0.64 0.53 2.57 8.85
Ala 0.62 1.32 0.80 0.79 0.51 0.50 2.18 7.99
Asp 0.43 1.16 1.85 0.79 0.80 1.08 5.91 10.11
Cys 0.10 0.15 0.22 0.21 0.29 0.21 0.79 0.72
Glu 0.87 1.17 1.50 1.81 2.86 1.34 9.65 8.07
Gly 0.29 0.74 0.73 0.43 0.52 0.95 2.20 4.38
Pro 0.45 0.72 1.14 0.84 1.26 0.63 2.70 3.46
Ser 0.22 0.40 0.61 0.44 0.47 0.55 2.17 4.14
Tyr 0.16 0,33 0.47 0.30 0.34 0.46 1.83 2.56
Percent of ingredient DM.
2 Ring-dried blood meal.
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Table 2.7. Particle size o f TMR, orts, and forages used in prepartum and postpartum diets
fed to cows receiving two forms o f Met._________________________________________





top 14 57 27 38 22 44
middle 68 31 28 29 29 28
bottom 18 12 45 33 49 28
Orts as a % DMI Control MetaSmart Smartamine SE1
n 20 18 19
prepartum2 20.2 21.1 21.1 1.24
postpartum3 12.1 11.9 12.2 0.37
Highest standard error of treatment means is shown.
2 Prepartum = -21 d through calving.
3 Postpartum = 1 d through 140 d after calving.












Table 2.8. Effects o f feeding two forms o f Met on least squares means of DMI, BW, and BCS for prepartum and postpartum cows.
jP-value
Item Control MetaSmart Smartamine M SE1 Treatment Parity Parity*trt2
11 20 18 19
Prepartum
DMI, kg 13.8 13.7 13.0 0.45 NS <0.0001 NS
BW, kg3 689 692 679 16.5 NS <0.0001 NS
Primiparous 615 650 615 27.0
Multiparous 763 734 744 19.0
DMI, %BW 2.00 1.98 1.92 0.076 NS NS NS
BCS3 3.79 3.85 3.80 0.051 NS <0.0001 NS
Postpartum
DMI, kg 22.0b 22.9a 21.4b 0.41 0.01 <0.0001 0.04
Primiparous 18.4b 20.7a 18.2b 0.68
Multiparous 25.6a 25.2a,b 24.5b 0.47
BW, kg4 580 588 567 12.7 NS <0.0001 0.06
Primiparous 515b 554a 512b 20.9
Multiparous 644a 622a,b 620b 14.4
DMI, % BW 3.79 3.90 3.76 0.065 NS <0.001 NS
BCS4 3.26b 3.37a 3.28b 0.053 0.09 <0.0001 NS
Highest standard error of treatment means is shown.
2 Parity*trt = parity by treatment.
3 Prepartum BW and BCS were obtained weekly for each cow during the last 3 wk (21 d) prepartum.
4 Postpartum BW and BCS were obtained weekly for each cow during the first 20 wk (140 d) postpartum. 











Item Control MetaSmart Smartamine M SE1 Treatment
P-value
Parity Parity*trt2
n 20 18 19
Milk yield, kg 43.4 43.5 42.0 0.99 NS <0.0001 NS
3.5% FCM 44.1 44.2 42.9 0.80 NS <0.0001 0.09
Fat, g/d 1563 1563 1522 29.8 NS <0.0001 0.10
Protein, g/d3 1170 1215 1192 26.8 NS <0.0001 NS
Lactose, g/d 2095 2106 2025 45.6 NS <0.0001 NS
MUN, g/d 5.68 5.68 5.68 0.176 NS <0.0001 NS
Fat, % 3.65 3.65 3.68 0.074 NS NS NS
Protein, %3 2.72b 2.8 la 2.87a 0.031 0.001 NS NS
Lactose, % 4.84 4.84 4.83 0.018 NS <0.0001 0.03
MUN, mg/dl 12.7 12.7 13.2 0.29 NS NS NS
2 Parity*trt = parity by treatment.
3 Protein = true protein.











Table 2.10. Effects o f feeding two forms of Met on postpartum feed efficiency and conversion of feed N into milk N.
Item Control MetaSmart Smartamine M SE1 Treatment
/ ’-value
Parity Parity*trt2
n 20 18 19
Milk/DMI, kg/kg 2.00a 1.92b 1.98a 0.032 0.09 NS NS
MilkN/feedN3 0.33b 0.32b 0.34a 0.004 0.003 NS NS-
Energy balance4, Mcal/d
l T T -  ,  . 1 ,... ; ........................n
-3.85b -2.86a -4.15b 0.409 0.03 NS NS
2 Parity*trt = parity by treatment.
3 Milk N yield (kg) per kg N intake.
4 Calculated for using equations from NRC (2001): Net energy for lactation intake (NEL predicted from NRC (2001) model x DMI) -  [milk energy 
(0.0929 x fat % + 0.0563 x true protein % + 0.0395 x lactose %) + maintenance energy (0.08 Mcal/kg BW0'75)].












Table 2.11. Effects of feeding two forms of Met on postpartum plasma AA concentrations.
Item Control MetaSmart Smartamine M SE1 Treatment
P-value
Parity Parity*trt2
n 14 15 15
pg/ml3
Met 3.34° 4.26b 5.96a 0.250 <0.0001 NS NS
Met+Cys 1.9T 9.23b i i . n a 0.353 <0.0001 NS NS
Total sulfur 12.46° 14.87b 16.933 0.582 <0.0001 0.05 NS
Total EAA 145.85 140.38 135.84 6.949 NS NS NS
TAA 293.18 295.73 284.14 9.025 NS NS NS
% of total AA
Met 1.15° 1.43b 2.10a 0.078 <0.0001 NS NS
Met+Cys 2.73° 3.12b 3.92a 0.102 <0.0001 NS NS
Total sulfur 4.25c 5.01b 5.98a 0.160 <0.0001 0.03 NS
Total EAA 49.46 47.16 47.67 1.113 NS NS NS
1 Highest standard error of treatment means is shown.
2 Parity*trt = parity by treatment.
3 Samples were analyzed on an as received basis; therefore, AA concentrations shown here have been adjusted to account for the use of 15% 
sulfosalicylic acid which was used in a 1:4 ratio with plasma to deproteinize the original plasma sample.
ab c = Means in same row with different superscripts differ (P < 0.10).
- " j
- 'O
Figure 2.1. Effects of feeding two forms of Met on postpartum DMI for primiparous,
multiparous, and all cows by week.
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Figure 2.2. Effects o f feeding two forms of Met on postpartum energy balance for
primiparous, multiparous, and all cows by week.
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CHAPTER III
USE OF CHANGES IN PLASMA METHIONINE (MET) CONCENTRATIONS 
COMPARED TO CHANGES IN MILK PROTEIN CONCENTRATIONS TO 
COMPARE THE EFFECTIVENESS OF MET PRODUCTS IN THEIR ABILITY 
TO PROVIDE ABSORBABLE MET TO LACTATING DAIRY COWS FED MET- 
DEFICIENT OR MET-ADEQUATE DIETS
ABSTRACT
This study was conducted to compare the effects o f providing supplemental Met 
to lactating dairy cows fed Met-deficient or Met-adequate diets on plasma sulfur and milk 
protein concentrations. This effort was designed to determine the most effective method 
o f measuring the efficacy o f Met products. Forty multiparous lactating Holstein dairy 
cows were used in a replicated randomized complete block split plot 5 x 5  Latin square 
design with a 2 x 2 x 5 factorial arrangement of treatments and a covariate adjustment of 
the main plots. The main effects were: 1) Met-adequate or Met-deficient diet, 2) rumen 
protected Met in the form of Smartamine M or 2-hydroxy-4-methylthio butanoic acid 
isopropyl ester (HMBi; hereafter referred to as, MetaSmart), and 3) five levels (0, 3, 6, 9, 
or 12 g/d) of Met or Met analog supplementation. The basal diets were formulated to 
meet NRC (2001) requirements for energy and nutrients and were identical except for 
predicted Met in MP which were either adequate (i.e., 3.0:1 Lys:Met ratio) or deficient 
(>3.0:1 Lys/Met ratio) in MP-Met. Smartamine M was used to make the basal diet 
adequate in MP-Met. Milk protein concentrations for the five respective levels of
80
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supplementation were: Met-adequate MetaSmart (3.05, 3.07, 3.04, 3.06, 3.05 ± 0.044; 
NS), Met-adequate Smartamine M (3.01, 3.04, 3.06, 3.04, 3.02 ± 0.044; NS), Met- 
deficient MetaSmart (2.90, 2.92, 2.93, 2.96, 3.01 ± 0.044; linear, P  < 0.05), and Met- 
deficient Smartamine M (2.98, 2.96, 3.03, 3.04, 3.03 ± 0.044; linear, P < 0.05). Plasma 
Met concentrations (% of total AA) for the five respective levels of supplementation 
were: Met-adequate MetaSmart (1.6, 1.6, 1.6, 1.6, 1.6 ± 0.06; NS), Met-adequate 
Smartamine M (1.6, 1.8, 2.0, 2.2, 2.4 ± 0.06; linear, P  < 0.0001), Met-deficient 
MetaSmart (0.8, 0.9, 0.9, 0.9, 1.0 ± 0.06; linear, P  < 0.001), and Met-deficient 
Smartamine M (0.8, 1.0, 1.1, 1.3, 1.4 ± 0.06; linear, P < 0.0001). Plasma Met+Cys 
concentrations (% of total AA) for the four respective treatments were:: Met-adequate 
MetaSmart (3.4, 3.5, 3.5, 3.4, 3.5 ± 0.10; NS), Met-adequate Smartamine M (3.5, 3.7, 
3.9, 4.0, 4.3 ± 0.10; linear, P < 0.0001), Met-deficient MetaSmart (2.4, 2.4, 2.5, 2.5, 2.6 ± 
0.10; linear, P < 0.0001), and Met-deficient Smartamine M (2.4, 2.6, 2.8, 3.1, 3.2 ± 0.10; 
linear, P < 0.0001). Plasma total sulfur AA concentrations (% of total AA) for the four 
respective treatments were:: Met-adequate MetaSmart (5.5, 5.7, 5.8, 5.6, 5.8 ± 0.13; 
trend, P  = 0.1141), Met-adequate Smartamine M (5.9, 6.1, 6.4, 6.5, 7.1 ± 0.13; linear, P < 
0.0001), Met-deficient MetaSmart (4.2, 4.4, 4.5, 4.4, 4.6 ± 0.13; linear, P < 0.001), and 
Met-deficient Smartamine M (4.3, 4.6, 4.9, 5.2, 5.6 ± 0.13; linear, P < 0.0001). The Proc 
Reg procedure o f SAS was used to generate regression equations for responses in milk 
protein concentration, plasma Met, plasma Met+Cys, and plasma total sulfur AA 
concentrations and concentrations of these AA as a percent o f total AA. Bioavailability 
calculations were calculated by dividing the change in slope of MetaSmart by the change 
in slope for Smartamine M. Using changes in milk protein concentrations for Met-
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deficient cows resulted in a bioavailability calculation of 132 ± 152% which was not 
considered to be accurate. The bioavailability of MetaSmart relative to that of 
Smartamine M using plasma Met (% total AA), plasma Met+Cys (%  total AA) and 
plasma total sulfur AA (% total AA) was 27 ± 12.4, 24 ± 16, and 28 ± 9%, respectively. 
The results of this study demonstrated that using changes in milk protein concentrations 
to determine Met bioavailability values for MetaSmart relative to that o f Smartamine M 
was not as precise as using changes in plasma sulfur AA concentrations. These results 
provide further evidence that methionine analogs are metabolized differently than DL- 
methionine sources and that more research is needed to determine the best response 
criteria to use for determining the efficacy of methionine analogs.
(Key words: methionine, methionine analog, bioavailability)
Abbreviation key: BCAA = branched chain amino acid, EAA = essential amino acid, 
HMBi = 2-hydroxy-4-methylthio butanoic acid isopropyl ester, MMG = mixed mostly 
grass, MP = metabolizable protein, NEAA = non-essential amino acid, SSA = sulfur 
amino acid, THF = tetrahydrofolate.
INTRODUCTION
Several methods have been used to determine the effectiveness of Met analogs 
and protected Met products in providing absorbable Met to lactating dairy cows. 
However, regardless of the methodology employed, it is essential that the procedure is 
repeatable and that it provides a true measure of differences in Met availability to the 
animal.
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There are two major categories for determining the bioavailability of Met 
products. The first category involves using changes in plasma Met concentrations while 
the second category utilizes changes in milk protein production.
Within the category of using changes in plasma Met concentrations to determine 
the bioavailability o f Met analogs and Met products, two techniques have been 
developed. The first technique is called area under the curve (AUC) (Bach and Stem, 
2000; Robert et al., 2001a,b; Robert et al., 2002; Graulet et al., 2005). This technique 
relies on determining a basal plasma Met concentration for each cow on the study by 
generating a mean plasma Met concentration from plasma Met samples taken over a 
period of several hours prior to pulse-dosing Met with the Met analog or the Met product 
being tested. The basal plasma Met concentrations are then subtracted from the plasma 
Met concentrations determined for each cow after Met supplementation. The resultant 
values correspond to increases in plasma Met concentrations resulting from Met 
supplementation. The second technique utilizes changes in plasma Met concentrations 
when Met products are added to the diet in incremental amounts (Olley et al., 2004; 
Schwab et al, 2005b). Methionine bioavailabilities are compared by regressing plasma 
Met concentrations on levels o f supplemental Met. Smartamine M, a protected form of 
supplemental Met, has been used as the reference Met source and it is assumed that it has 
a bioavailability of 80% (Rulquin and Kowalczyk, 2003). The slopes of the other Met 
analogs or Met sources being tested are divided by the slope for Smartamine M to obtain 
a bioavailability relative to that o f Smartamine M.
The second category of determining the bioavailability of Met analogs and Met 
products utilizes changes in milk protein production (Schwab et al., 2005a) when cows
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are fed a diet deficient in Met and supplemented with increasing levels of Met. Changes 
in milk protein concentrations are regressed on the increasing levels o f supplemental Met. 
Similar to the method of Schwab et al. (2005b), Smartamine M is used as the reference 
Met source and the slopes of the other Met analogs or Met sources being tested are 
divided by the slope for Smartamine M to obtain a bioavailability relative to that of 
Smartamine M.
A summary of the results o f Schwab et al. (2005a,b) and Olley et al. (2004) are 
presented in Tables 3.1, 3.2, and 3.3. These studies indicate that supplementing Met at 
levels above 10-12 g/d once Met adequacy in the diet has been met does not provide any 
benefit in determining the bioavailability o f Met analogs and Met products using the 
differences in slope technique described by Schwab et al (2005a,b). It is more beneficial 
to have all of the Met supplementation levels result in points which lie on the linear part 
of the slope line because it provides more data points from which to make the 
bioavailability calculation. Once a plateau in plasma Met concentrations or milk protein 
production is reached, any points beyond the break-point cannot be used in the 
bioavailability calculation.
Using changes in milk protein concentrations is the easiest and most farm-friendly 
method for determining the effectiveness of a Met analog or Met product for delivering 
absorbable Met to lactating dairy cows. However, this method is dependent upon the 
basal diet being deficient in Met. In contrast, the AUC method is precise (Graulet et al., 
2005) and generates values for MetaSmart similar to using changes in milk protein 
concentrations (Schwab et al., 2005b) and changes in plasma Met concentrations 
(Schwab et al., 2005a) which would indicate that it is also accurate. However, it is more
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difficult to perform and relies on pulse-dosing Met analogs or Met products which is less 
similar to the manner in which the products would be fed on a production dairy facility. 
Using changes in plasma Met concentrations in response to feeding incremental amounts 
of Met analogs or Met products is more precise than using changes in milk protein 
concentrations (Schwab et al., 2005b) but is less precise than the AUC method (Graulet et 
al., 2005). However, using changes in plasma Met concentrations is a more practical 
approach than the AUC method in terms of comparability with the amounts of product 
fed and the method o f feeding the Met product to dairy cows.
From a research standpoint, it is most important to develop a methodology for 
comparing the efficacy of Met products which will yield both accurate and precise 
bioavailability calculations which are easily replicated or reproduced. However, from an 
on-farm, production standpoint, it is an increase in milk protein concentrations which will 
ultimately indicate the effectiveness and utility o f Met analogs or Met products. We 
hypothesize that using changes in plasma Met concentrations to measure the ability of 
Met products to provide absorbable Met to lactating dairy cows fed a Met-adequate diet 
is more accurate than using changes in milk protein production when lactating dairy cows 
are fed a Met-deficient diet.
MATERIALS AND METHODS 
Experimental Design and Treatments
Forty multiparous lactating Holstein dairy cows were used 
randomized complete block split plot 5 x 5  Latin square design with a 2
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arrangement o f treatments and a covariate adjustment o f the main plots. The main effects 
were: 1) Met-adequate or Met-deficient diet, 2) rumen protected Met in the form of 
Smartamine M or 2-hydroxy-4-methylthio butanoic acid isopropyl ester (HMBi; 
hereafter referred to as, MetaSmart), and 3) five levels o f Met or Met analog 
supplementation. Cows were blocked into 5 groups of 4 cows each according to milk 
production recorded the week before the study. Cows were randomly selected from each 
block and assigned to one o f the four 5 x 5  Latin squares. The 4 squares of cows were 
randomly assigned to the: 1) Met-deficient diet/MetaSmart treatments, 2) Met-deficient 
diet/Smartamine M treatments, 3) Met-adequate diet/MetaSmart treatments, and the 4) 
Met-adequate diet/Smartamine M treatments. The basal diets (Table 3.4) were 
formulated to meet NRC (2001) model predicted requirements for energy and nutrients 
and were identical in ingredient composition except for NRC (2001) predicted Met in 
metabolizable protein (MP) which were either adequate (i.e., 3.0:1 Lys:Met ratio) or 
deficient (>3.0:1 Lys/Met ratio) in MP-Met. Smartamine M was used at 0.088% of diet 
DM to make the basal diet adequate in Met. The five dietary treatments within squares 
were 0, 3, 6, 9, or 12 g/d o f supplemental metabolizable Met from Smartamine M or the 
molecular equivalents o f HMB from MetaSmart (Table 3.5). Each experimental period 
was 10 d in length with d 1-6 being used for adjustment to treatment levels and d 7-10 
being used for sample collection. Cows were allowed to adapt to the Met-deficient and 
Met-adequate diets for a period of 28 d before initiation o f treatments. Smartamine M 
and MetaSmart were supplied by Adisseo USA, Inc. MetaSmart was supplied as a dry 
powder consisting of 60% of active ingredient on a silicate carrier.
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Preparation and Feeding of Dietary Treatments
The dietary treatments consisted of laboratory weighed mixtures of the test 
products. The amounts of test product as weighed for each cow for each feeding varied 
according to: (1) test product (because of differences in Met equivalency; Table 3.5), (2) 
supplementation level (Table 3.5), and (4) DMI. A basal level o f 22 g/d of Smartamine 
M per 24.0 kg DMI was added to dietary treatments for the Met adequate cows to create 
the Met-adequate diets. This amount of Smartamine M was deemed necessary before the 
start o f the experiment to achieve a predicted 3.0:1 ratio o f Lys:Met in MP (NRC, 2001).
MetaSmart was supplied as a dry powder containing 60% of active ingredient on 
a silicate carrier. It was assumed that MetaSmart contains a minimum of 78% HMB, is 
95% pure, and that 50% of the HMB in dietary MetaSmart was absorbed and converted 
to metabolizable M et [57% (60% x 95%) MetaSmart monomer x 77.8% HMB x 50% 
bioavailability = 22% metabolizable Met], Smartamine M was assumed to contain 75% 
Met and that 80% of the Met is absorbed resulting in a metabolizable Met content of 60% 
(75% x 80%) o f the original amount of product supplied (Rulquin and Kowalczyk, 
2003).
Management of Cows
All procedures related to animal care were • conducted with approval of the 
University of New Hampshire Institutional Animal Care and Use Committee (IACUC # 
040403).
Cows were housed in a naturally ventilated tie-stall bam, fed individually, and 
milked in a milking parlor equipped with automatic take-offs and milk meters. Lactating
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cows were fed and milked three times daily at 8-h intervals. Weather permitting lactating 
cows were exercised for 15-20 min before each milking in a dry lot. Body weights and 
BCS were recorded on the same day during the first and last week of the study. Body 
condition scores were evaluated by two independent scorers and averaged across scorers 
to obtain one score.
The basal diet (Table 3.4) was fed as a TMR and prepared by weighing each 
ingredient and mixing in a mobile feed mixer (Super Data Ranger; American Calan, Inc., 
Northwood, NH). Treatments were top-dressed onto the TMR of each cow and were fed 
20% of their total daily feed allotment and treatment at 0600 h, 50% at 1400 h, and 30% 
at 2100 h for ad libitum feed intake. The basal diet was mixed using fresh feed at each 
feeding. Feed offered was adjusted daily to achieve 5-10% orts. Orts were collected and 
weighed daily at 1130 h so that DMI could be calculated daily.
Feed Sampling
All feed ingredients were sampled 14 d before the start o f the experiment and 5 d 
before the end of the 28-d adjustment period and analyzed for DM (60°C in forced air 
oven for 4 h for silages and NIR AOAC 991.03 for grains and hay and residual moisture 
on silages), CP (AOAC 990.03; Leco App. Note 203-821-146), ADF (AOAC 973.18), 
NDF (Van Soest et al., 1991) using wet chemistry by Dairy One Forage Testing 
Laboratory ((Ithaca, NY; www.dairyone.com/forage/procedures) to assist in determining 
the final formulation of the diets. Silages were sampled daily for daily DM analysis and 
for evaluation of particle size twice during each period (d 1-5 and d 6-10). A sample of 
each forage was retained and used to make period composites. Most feed ingredients
88
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
were combined together in a mix at the feed mill and delivered to the research facility; 
therefore, individual feed ingredients were sampled at the feed mill before delivery. 
Alfalfa hay was core-sampled at time o f delivery and was delivered twice during the 
study for a total o f two core samples. A composite o f forages and grains were also 
analyzed for AA at the conclusion of the study.
Total mixed ration samples were taken daily at each feeding and orts samples 
were taken daily at 1100 h throughout the Latin square portion o f the study and 
composited twice weekly (d 1-5 and d 6-10 o f each period) for analysis of DM and 
particle size distribution.
Feed Analysis
Analysis o f forage DM for ration adjustment was accomplished by using a 
microwave oven according to the procedure of the National Forage Testing Association 
(Undersander, 2004). Particle size distribution was evaluated using the Penn State 
Particle Size Separator (Heinrichs, 1996). A composite sample of each o f the forages and 
grains was sent for analysis of DM (60°C in forced air oven for 4 h for silages and NIR 
AOAC 991.03 for grains and hay and residual moisture on silages), CP (AOAC 990.03; 
Leco App. Note 203-821-146), ADF (AOAC 973.18), NDF (Van Soest et al., 1991), 
ADICP (AOAC 2001.11; Foss App. Note AN 300), NDICP (AOAC 2001.11; Foss App. 
Note AN 300), NEL, NFC (100 - (CP + NDF + ash + ether extract), lignin (AOAC 
973.18), starch (YSI 2700 SELECT Biochemistry Analyzer, YSI App. Note 319), sugar 
(Hall et al., 1999), fat (Tecator Soxtec System HT6, FOSS Tecator App. Note AN301; 
Subnote AN 3414), ash (AOAC 942.05) and minerals (Thermo Jarrell Ash IRIS
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Advantage Inductively Coupled Plasma Radial Spectrometer) using wet chemistry by 
Dairy One Forage Testing Laboratory (Ithaca, NY; 
www. dairyone. com/forage/procedures).
A portion o f the composited forage and grain samples were also dried to 
approximately 90% DM in a forced air oven at 55°C (VWR Scientific, West Chester, PA), 
allowed to equilibrate for 2-4 h to room temperature, and ground to pass through a 1-mm 
screen using a Wiley Mill (Thomas Scientific, Swedesboro, NJ) for analysis o f AA. A 
composite sample o f each o f the ground forage and grain samples were sent for analysis 
of AA using a Beckman system 6300 High Performance Amino Acid Analyzer 
(Beckman-Coulter Instruments, CA) by the Experimental Station Chemical Laboratories, 
University of Missouri-Columbia (Columbia, MO).
Milk Sampling and Analysis
Milk yields were recorded at each milking throughout the entire study. On d 7-10 
of each experimental period, milk samples were taken during the a.m. and noon milkings 
and were refrigerated until composited by milk weight according to the respective 
milking from which the sample was taken during the sampling period. Samples were 
preserved with 2-bromo-2-nitropropane-l,3-diol (1 tablet per 40 ml o f milk). Samples 
were analyzed for CP, true protein, fat, lactose, and MUN by mid-infrared 
spectrophotometric analysis with a Foss 4000 (Foss North America, Eden Prairie, MN) 
(Dairy One Cooperative, Inc., Ithaca, NY).
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Blood Sampling and Analysis
Blood samples were taken via venipuncture o f the coccygeal vein 3x daily at 2-h 
intervals after the morning feeding on d 7-10 of each experimental period. Blood 
samples were taken at 0700, 0900, and 1100 h on d 7 and 9 and at 0800, 1000, and 1200 
h on d 8 and 10. Plasma samples were composited within and across days and analyzed 
in duplicate for A A content. Because cows were fed at 8-h intervals, the sampling 
protocol was designed to generate average concentrations o f plasma AA to eliminate 
variations in concentration which can occur over time (Graulet et al., 2005). Blood 
samples were collected via venipuncture of the coccygeal vein into 10-ml evacuated 
tubes (Vacutainer, Becton Dickinson, Rutherford, NJ) containing sodium heparin. Blood 
tubes were placed immediately into an ice bath and centrifuged within 45 min at 3300 x g 
for 20 min at 5°C. An aliquot o f 4ml o f plasma was deproteinized (four volumes of 
plasma was vortexed with one volume of 15% sulfosalicylic acid) and then placed in the 
centrifuge for 10 min at 5°C prior to centrifuging at 3300 x g  for 20 min at 5°C. The 
supernatant was collected and 0.35-ml aliquots were placed into Nunc CryoTube vials 
(Nalge Nunc International, Denmark) and stored at -80°C until analyzed for plasma free 
AA using a Beckman system 6300 High Performance Amino Acid Analyzer (Beckman- 
Coulter Instruments, CA) by the Experimental Station Chemical Laboratories, University 
of Missouri-Columbia (Columbia, MO). Plasma AA concentrations (pM) were adjusted 
to account for the use o f 15% sulfosalicylic acid which was used in a 1:4 ratio with 
plasma to deproteinize the original plasma sample.
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Statistical Methods
Production and intake data were analyzed as a randomized complete block split 
plot 5 x 5  Latin square design with a 2 x 2 x 5 factorial arrangement o f treatments with a 
covariate adjustment of the main plots using the MIXED procedure o f SAS [Version 8.2 
(2001); (SAS Institute, Inc., Cary, NC)] according to the following model:
Yjjklm ~  p  +  Bj +  Mj +  Skij +  Ciijk "F L m +  L B ira +  LM jm +  LBMjjm +  ejjklm
where:
Yjjkim = the continuous, dependent variable, 
p = the overall mean,
Bj = the fixed effect of the ith base diet, i = 1,2,
Mj = the fixed effect of the jth methionine source, j = 1, 2,
Skij -  the random effect of the kth square, k = 1, 2, 3, 4, 5,
Ciyk = the random effect of the 1th cow on the ith base diet, within the j* 
methionine source, within the kth square, 1 = 1, 2, 3, 4, 5,
Lm = the fixed effect of the mth level of methionine supplementation, m -  0, 3, 6,
9, 12,
LBim = the fixed effect of the interaction between the mth level of methionine 
supplementation and the i* base diet,
LMjm ~ the fixed effect of the interaction between the mth level of methionine 
supplementation and the j th methionine source,
LBMjjm = the fixed effect of the interaction between the mth level of methionine 
supplementation, the j*  methionine source, and the i* base diet, 
epim = the random residual error.
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The effect o f level of Met source was partitioned into single degree o f freedom 
orthogonal contrasts within each Met source. Linear, quadratic, cubic and quartic 
contrasts were fitted within each source. The Univariate Procedure o f SAS was used to 
determine outlier cows [Version 8.2 (2001); (SAS Institute, Inc., Cary, NC)]. An 
observation, which was greater than 2.5 standard deviations from the mean for milk 
production, milk protein concentration and milk protein yield was considered an outlier. 
The results o f the outlier analysis indicated that one cow was an outlier due to low milk 
production and low milk protein yield; therefore, this cow was removed from the final 
statistical analysis.
The Proc Reg procedure o f SAS was used to generate regression equations for 
determining the slope of the changes in milk protein concentration, plasma Met 
concentrations (pM and % total AA), plasma Met+Cys concentrations (pM and % total 
AA), plasma total sulfur AA concentrations (pM and % total AA) [Version 8.2 (2001); 
(SAS Institute, Inc., Cary, NC)]. The change in slope o f AA concentrations for the 
MetaSmart cows was divided by the change in slope of AA concentrations for the 
Smartamine M cows to determine a relative bioavailability value for MetaSmart relative 
to Smartamine M. A bioavailability o f 80% was assumed for Smartamine M. 
Significance was declared at P < 0.05 and a trend in the data was declared at P< 0.15.
RESULTS 
Chemical Composition of Diets
The chemical and AA composition of the dietary feed ingredients are presented in 
Tables 3.6 and 3.7, respectively. Because replicates 1 and 2 were not conducted
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simultaneously, results o f the feed analyses from each replicate were averaged in order to 
generate an overall chemical composition for each ingredient. However, between periods 
3 and 4 o f replicate 1, a new mixed mostly grass silage (MMG) bunker silo was opened. 
As a result, the chemical composition of the MMG silage used during periods 1 through 3 
of replicate 1 was different from that used during periods 4 and 5 o f replicate 1 and all of 
replicate 2. To account for these differences, the basal diet had to be adjusted, resulting 
in a higher inclusion rate o f alfalfa hay and a lower inclusion rate o f MMG silage during 
periods 4 and 5 of replicate 1 and all o f replicate 2 compared to periods 1-3 of replicate 1. 
The ingredient composition of the basal diets (Table 3.5) was weighted accordingly to 
reflect the ration adjustment which was made between periods 3 and 4 of replicate 1. A 
weight o f 30% was placed on the inclusion rate o f alfalfa hay and MMG silage used 
during periods 1 through 3 of replicate 1 and a weight of 70% was placed on the 
inclusion rate of alfalfa hay and MMG silage used during the last 7 periods of the study 
(periods 4 and 5 of replicate 1 and periods 1 through 5 of replicate 2). Because the same 
basal diet was used for both the Met-adequate and Met-deficient diets, all cows were 
affected similarly by the changes to the ingredient composition o f the basal diets. The 
mean concentrations o f NDF, ADF, NFC, RDP, RUP and CP in diet DM for the overall 
study were 34.2, 22.2, 43.7, 9.5, 6.1 and 15.6%, respectively. Forage NDF averaged 
24.1% of diet DM and the AA composition o f the dietary ingredients (Table 3.7) were 
similar to those reported in NRC (2001).
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Body Weight, Body Condition Score, and Days in Milk
Body condition scores were similar among cows fed Met-adequate and Met- 
deficient diets and averaged 3.3 ± 0.16 at the beginning o f the study and 3.4 ± 0.16 at the 
end of the study. Body weights were also similar among cows Met-adequate and Met- 
deficient diets and averaged 662 ± 52.3 kg at the beginning of the study and 674 ± 48.5 at 
the end of the study.
Because both replicates were not conducted simultaneously, an attempt was made 
to ensure that cows were similar in lactation number and stage of lactation. Cows in the 
first replicate averaged 3.4 lactations and were 160 DIM after the 4-wk adjustment 
period; cows in the second replicate averaged 3.2 lactations and were 159 DIM after the 
4-wk adjustment period.
Feed Intake and Milk Yield
Feeding incremental amounts o f Smartamine M to cows fed Met-deficient diets 
and feeding incremental amounts o f MetaSmart to cows fed Met-adequate or Met- 
deficient diets did not affect DMI, milk yield or milk yield to DMI ratios (Table 3.9). 
Feeding incremental amounts of Smartamine M to cows fed Met-adequate diets did not 
affect DMI, however, it did result in a linear (P <0.05) decrease in milk yield and milk 
yield to DMI ratio (Table 3.9).
Milk Composition and Yield of Milk Components
Feeding incremental amounts o f MetaSmart to cows fed Met-adequate diets did 
not affect milk protein concentration (Table 3.10), milk protein yield (Table 3.10), milk
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fat concentration (Table 3.10), milk fat yield (Table 3.10), MUN concentration (Table
3.11), lactose concentration (Table 3.11) or lactose yield (Table 3.11). However, feeding 
incremental amounts of Smartamine M to cows fed Met-adequate diets decreased milk 
protein yield (linear, P < 0.01; Table 3.10), increased milk fat concentration (linear, P < 
0.001; quadratic, P < 0.01; Table 3.10) and decreased lactose yield (linear, P < 0.01; 
Table 3.11). A trend for a quadratic effect was observed for MUN concentration (P = 
0.07; Table 3.11). Feeding Smartamine M to cows receiving a Met-adequate diet had no 
effect on milk protein concentrations (Table 3.10), milk fat yield (Table 3.10) or lactose 
concentrations (Table 3.11).
Feeding MetaSmart to Met-deficient cows increased both milk protein 
concentration (linear, P < 0.01; Table 3.10) and milk protein yield (linear, P < 0.01; 
Table 3.10), but did not affect milk fat concentration (Table 3.10), milk fat yield (Table 
3.10), or MUN (Table 3.11). A trend for a cubic effect on lactose concentration (P = 
0.09; Table 3.11) and a significant cubic effect on lactose yield (P < 0.05; Table 3.11) 
were also observed.
Feeding Smartamine M to cows fed Met-deficient diets increased milk protein 
concentration (P < 0.01; Table 3.10) but did not affect milk protein yield, MUN 
concentration, or lactose yield. There was an effect o f treatment on milk fat 
concentration (quadratic, P < 0.05; Table 3.10), a trend for a quadratic effect (P = 0.10) 
and a significant cubic effect on milk fat yield (P < 0.05 Table 3.10), and a trend for a 
decrease in lactose concentration (linear, P = 0.0901; Table 3.11).
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Plasma AA Concentrations (pM)
Overall, feeding incremental amounts of MetaSmart to Met-adequate cows did 
not affect plasma Met concentrations or total plasma AA concentrations (Tables 3.12-
3.13). However, there was a trend for a linear increase in Met+Cys concentrations (P -  
0.11), which was the result of an increase in plasma Cys concentrations (P < 0.05; Table
3.13), and not in plasma Met concentrations. There was also a trend towards an increase 
in plasma total sulfur AA (SAA) concentrations (P = 0.07; Table 3.13). In addition to an 
increase in plasma Cys concentrations, a linear increase in plasma Gly and Ser 
concentrations was observed (P < 0.05; Table 3.13) as well as a trend for a linear increase 
in Asn (P = 0.06; Table 3.13), Asp (P = 0.10; Table 3.13), and Pro (P = 0.06; Table 3.13) 
concentrations. These changes were responsible for the observed trend for increased total 
nonessential AA (NEAA) concentrations (P = 0.06; Table 3.13).
Feeding incremental amounts of Smartamine M to Met-adequate cows resulted in 
a highly significant increase in plasma Met concentrations (P < 0.0001; Table 3.12). This 
increase led to a highly significant linear increase in SAA concentrations (P < 0.0001; 
Table 3.13). There was a trend for a quadratic response in total plasma AA 
concentrations (P = 0.07; Table 3.13). This trend was most likely the result of a 
significant quadratic response in plasma Thr concentrations (P < 0.05; Table 3.12) and a 
trend for a quadratic response in Val concentrations (P = 0.06; Table 3.12). These 
responses most likely are responsible for the trend towards a quadratic response in 
plasma essential AA (EAA) concentrations (P = 0.09; Table 3.13) and a trend for a 
quadratic response in plasma branched chain AA (BCAA) concentrations (P = 0.11; 
Table 3.13).
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Total plasma A A concentrations decreased linearly when Met-deficient cows 
were fed incremental amounts o f MetaSmart (P < 0.05; Table 3.13). This decrease was 
the result of a significant decrease in plasma NEAA concentrations (P < 0.05; Table
3.13). Total plasma EAA concentrations were unaffected by treatment. Decreased 
plasma concentrations of Gly and Ser (P < 0.05; Table 3.13) and a trend for decreased 
plasma concentrations o f Ala (P = 0.11; Table 3.13), Asn (P -  0.06; Table 3.13), Gin (P 
= 0.07; Table 3.13), and Pro (P = 0.067; Table 3.13) were observed.
Feeding incremental amounts of Smartamine M to Met-deficient cows resulted in 
linear increases in plasma Met concentrations (P < 0.0001; Table 3.12), plasma Met+Cys 
concentrations (P < 0.0001; Table 3.12), total plasma SAA concentrations (P < 0.05; 
Table 3.13), and a linear decrease in plasma total NEAA concentrations (P = 0.09; Table
3.13). Quadratic responses in plasma total EAA, BCAA, Arg, lie, Leu, and Lys (P < 
0.05; Table 3.12) and a trend for quadratic responses in plasma total AA (P = 0.12; Table
3.13), Phe (P = 0.12; Table 3.12), Tbr (P = 0.06; Table 3.12), Val (P = 0.09; Table 3.12), 
Asn (P = 0.08; Table 3.13), Cys (P = 0.11; Table 3.13), and Tyr (P = 0.12; Table 3.13) 
were also observed.
Estimates of “Bioavailability” of Met from MetaSmart
Changes in milk true protein concentration (Figure 3.1; Table 3.16), Met 
concentration in plasma (pM) (Figure 3.2; Table 3.16), Met concentration in plasma total 
AA (%) (Figure 3.3; Table 3.16), Met+Cys concentration in plasma (pM) (Figure 3.4; 
Table 3.16), Met+Cys concentration in plasma total AA (%) (Figure 3.5; Table 3.16), 
total sulfur AA concentration in plasma (pM) (Figure 3.6; Table 3.16) and total sulfur
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A A in plasma total A A (%) (Figure 3.7; Table 3.16) in response to feeding incremental 
amounts of MetaSmart or Smartamine M were used to estimate the Met-bioavailability of 
MetaSmart. The slope o f the change in each of the aforementioned parameters in 
response to feeding MetaSmart to Met-adequate or Met-deficient cows was divided by 
the slope of the change in each o f the aforementioned parameters in response to feeding 
Smartamine M to Met-adequate or Met-deficient cows. Therefore, the bioavailability of 
MetaSmart was calculated as a percentage of the bioavailability o f Smartamine M. If the 
change in slope was not significant, a bioavailability was not calculated.
The linear slope increase for Met-deficient cows fed incremental amounts of 
MetaSmart was steeper than the slope for Smartamine M. As a result, the bioavailability 
of MetaSmart calculated from using changes in milk protein concentrations was greater 
than 100% (132 ± 152%; Table 3.16). The bioavailability o f MetaSmart relative to that 
of Smartamine M using significant linear increases in the slope of plasma Met (% total 
AA), plasma Met+Cys (% total AA), and plasma total sulfur AA (% total AA) for cows 
fed Met-deficient diets were approximately 24 ± 16%, 27 ± 12%, and 28 ± 9%, 
respectively (Table 3.16). These values equate to overall Met bioavailabilities of 19 ± 
13%, 21 ± 10% and 22 ± 7%, respectively.
DISCUSSION
There are many challenges and limitations involved with determining the 
bioavailability of Met analogs and Met products. Several methods have been developed 
including using changes in milk protein concentrations in response to feeding Met- 
deficient diets (Schwab et al., 2005a,b), using changes in plasma Met concentrations in
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response to feeding Met-adequate diets (saturation technique; Olley et al., 2004), and 
using the area under the curve (pulse-dose technique; Graulet et al., 2005). Each method 
has advantages and disadvantages but none have been universally accepted as the best 
method for determining bioavailabilities of Met analogs and/or Met products. The most 
important aspect o f developing a methodology for determining bioavailabilities is that it 
is universally accepted, it has the ability to accurately and precisely predict the 
bioavailability of both Met analogs and Met products, and that it is capable of being 
applied to a variety o f different research settings.
Using changes in milk protein concentrations has proven to be somewhat 
problematic as a result o f the lack o f precision of the bioavailability calculations as well 
as problems with ensuring that the basal diet is Met-deficient. In a study conducted by 
Schwab et al. (2005b) using Met-deficient lactating Holstein cows fed incremental levels 
of Smartamine M, HMB, MetaSmart, or 1/3 HMB, 2/3 MetaSmart bioavailabilities were 
calculated based on changes in milk protein concentrations. However, HMB did not 
elicit a linear increase in milk protein, therefore, a bioavailability estimate was not made 
which is one of the major disadvantages of using this technique. The bioavailability 
estimates for MetaSmart and 1/3 HMB, 2/3 MetaSmart were approximately 42 ± 16% 
and 34 ± 25%, respectively, and relative to that o f Smartamine M were 53 ± 20% and 43 
± 30%, respectively, assuming an 80% bioavailability for Smartamine M. An obvious 
problem with this method is the lack of precision in the bioavailability estimate. Despite 
these disadvantages, a decided advantage of using changes in milk protein concentration 
is its’ applicability. While it may not be the most precise method of determining Met 
bioavailabilities in terms of variation, it does provide a practical value for dairy
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nutritionists and producers who may be looking for responses in actual production 
parameters as a means by which to gauge the efficacy o f M et analogs or Met products.
The saturation technique which utilizes changes in plasma Met concentrations in 
response to feeding incremental amounts o f Met analogs or Met products to Met- 
adequate cows also has advantages and disadvantages. Although possibly not as 
dependent on diet as using changes in milk protein concentrations, using changes in 
plasma Met concentrations is dependent upon the Met status o f the basal diet. 
Theoretically, the more Met-adequate the basal diet is, the more pronounced the response 
in plasma Met will be. If the Met requirement has been met, then additional supplies of 
MP-Met will no longer be utilized as rapidly, allowing Met to accumulate in the blood. If 
the basal diet is not as adequate as was predicted, there may not be a significant linear 
increase in plasma Met concentrations resulting in the inability to calculate 
bioavailability values. Schwab et al. (2005a) intended to feed Met-deficient diets to cows 
receiving incremental amounts of Smartamine M, Mepron M85, HMB and MetaSmart; 
however, a lack o f response in milk protein concentrations may have indicated that the 
basal diet was bordering on Met-adequacy. With this being the case, Met-bioavailability 
values were calculated based on changes in plasma Met concentrations. Feeding HMB 
did not increase plasma Met concentrations, therefore, bioavailability values could not be 
calculated. The calculated Met bioavailability values for MetaSmart and Mepron M85 
were 35 ± 7% and 35 ± 3%, respectively, and 44 ± 8% and 43 ± 4%, respectively, relative 
to that of Smartamine M (assuming an 80% bioavailability). In regards to MetaSmart, 
these values are lower than the values of 42 ± 16% and 53 ± 20% calculated by Schwab
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et al. (2005b) but the variation is considerably less which is an advantage of using the 
saturation technique compared to changes in milk protein concentrations.
The AUC technique which utilizes pulse-dosing Met analogs or Met products, is 
more precise than using changes in milk protein concentrations or the saturation 
technique. Graulet et al. (2005) demonstrated this in a recent study where MetaSmart, 
HMB and Smartamine M were pulse-dosed into the rumen o f non-lactating Holstein 
cows in 50 g Met equivalent amounts. The resultant Met bioavailability calculations 
using the AUC technique and a modified Met digestibility equation of Robert et al. 
(2001a) determined that the bioavailabilities o f MetaSmart, HMB, and Smartamine M 
were 42 ± 1.3%, 19 ± 1.7% and 64 ± 3.2%, respectively. It is readily apparent that the 
AUC technique has a high level o f precision.
However, a concern of using the AUC technique is whether or not large amounts 
o f  Met analogs or Met products when introduced into the rumen behave physiologically 
similar to feeding smaller incremental amounts in a TMR. The metabolism of HMB has 
been demonstrated to be different than that o f DL-Met (Lobley et al., 2001); thereby 
raising the question of whether pulse-dosing large amounts o f Met analogs or Met 
products further affects the metabolism beyond the normal metabolic differences between 
the products. However, a definitive benefit o f using the AUC technique is the ability to 
generate responses in plasma Met concentrations. Pulse-dosing large amounts o f Met 
analogs or Met products is an effective method for increasing plasma Met concentrations 
as has been demonstrated previously (Koenig et al., 1999; Graulet et al., 2005).
Calculating bioavailability values for different Met products brings into question 
the accuracy and precision o f the methodology. The accuracy being whether the
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bioavailability value is correct or not and the precision being the amount of error 
surrounding the bioavailability value. As demonstrated by Graulet et al. (2005), the AUC 
technique is precise. On the contrary, the precision of using changes in milk protein 
concentrations is much lower. Using changes in plasma Met concentrations has a greater 
precision compared to using changes in milk protein concentrations but it is still less than 
the AUC method when calculating bioavailability values. Despite these differences in 
precision, accuracy is the most important aspect of calculating bioavailability values. If 
the calculated bioavailability value is incorrect (i.e., not accurate), it is irrelevant how 
precise the value is. Interestingly, the bioavailability calculations are all somewhat 
similar with the values for changes in milk protein concentrations and AUC both being 
approximately 42% (Graulet et al., 2005; Schwab et al., 2005b) and the value for changes 
in plasma Met concentrations being 35% (Schwab et al., 2005a).
In the current study, we hypothesized that using changes in plasma Met 
concentrations to measure the ability o f Met products to provide absorbable Met to 
lactating dairy cows fed a Met adequate diet is more accurate than using changes in milk 
protein production when lactating dairy cows are fed a Met deficient diet.
Met Status of the Basal Diets
According to the NRC (2001) evaluation of the basal diets, the Met-deficient diet 
was deficient in MP-Met by approximately 12 g/d (Table 3.8). As indicated by the lower 
plasma Met concentrations, the Met-deficient diets were deficient in MP-Met (Table
3.12). Plasma Met concentrations for the 12 g/d supplemental Met level for Met- 
deficient Smartamine M cows is similar to the 0 g/d supplemental Met level for Met-
103
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
adequate Smartamine M cows which indicates that the NRC (2001) was accurate in 
predicting the flow o f MP-Met to the small intestine.
Changes in Milk Protein Production
Cows fed diets that provide adequate amounts o f MP-Met would not be expected 
to respond with higher percentages or yields of milk protein to additional supplies o f MP- 
Met, whereas cows which are deficient in MP-Met would be expected to respond. In a 
recent study, Schwab et al. (2005a) fed a Met-deficient diet to cows receiving 
incremental amounts of Smartamine M, HMB, MetaSmart, or Mepron M85. The goal of 
the study was to utilize the subsequent changes in milk protein concentration as a result 
of feeding Met-deficient cows incremental amounts o f Met products to calculate 
bioavailability values for HMB, MetaSmart and Mepron M85 relative to that of 
Smartamine M. However, none of the Met products elicited a response in milk protein 
concentration, therefore precluding the accurate use o f changes in milk protein 
concentration to calculate bioavailability values. A possible explanation, despite the 
results of the NRC (2001) evaluation of the diets, would be that the cows were not as 
deficient in MP-Met as predicted at the beginning of the study.
In the current study, feeding incremental amounts o f MetaSmart or Smartamine M 
to Met-deficient cows increased milk protein concentrations in a linear fashion, thus 
indicating that the diets were deficient in Met. No response in milk protein concentration 
was observed for Met-adequate cows fed incremental amounts of Met from MetaSmart or 
Smartamine M, which indicated that the diets were adequate in Met.
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Interestingly, the linear change in slope for MetaSmart was greater than the 
change in slope for Smartamine M. This resulted in a bioavailability calculation of 132% 
for MetaSmart relative to that o f Smartamine M. The bioavailability calculation for the 
current study of approximately 132 ± 152% is not in accordance with previous research 
findings and appears to be inaccurate especially considering the standard error which is 
larger than the mean bioavailability. These results clearly demonstrate a potential 
inadequacy o f using the slope of the changes in milk protein concentration resulting from 
feeding incremental amounts of an Met product to Met-deficient cows. Using the slope 
of one product, such as MetaSmart, and comparing it to the slope of Smartamine M to 
determine a bioavailability value does not take into consideration the overall level of 
protein concentration, but only the degree of change in milk protein concentration.
The extent o f the response in milk protein concentration to feeding incremental 
amounts of Met to Met-deficient cows was not as great as expected. Because the study 
consisted of two replicates which were not conducted simultaneously, differences in 
ingredient or chemical composition of the diets may have influenced the results. 
Therefore, for interpretation purposes only, each replicate was analyzed separately to 
determine if the limited response in milk protein concentration was dependent upon 
replicate. Body weight, BCS, and DIM were similar between the two replicates; 
however, two different batches o f blood meal were used in replicates 1 and 2. When the 
diets were evaluated in NRC (2001), the Lys to Met ratio for the Met-deficient diet was 
greater in the second replicate compared to the first replicate (3.84 vs. 3.69). Flows of 
digestible Lys in the first replicate were 188 g/d compared to 192 g/d in the second 
replicate. However, when the milk production data was analyzed by replicate, there was
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a clear linear response in milk protein concentration in the first replicate but no response 
was observed in the second replicate. This was an unexpected finding, given the similar 
results of the NRC (2001) evaluations of the diets.
Given that the diets in replicate 2 had greater flows o f MP-Lys compared to 
replicate 1 (192 vs. 188 g/d, respectively) according to the NRC (2001) evaluation and 
that the cows responded differently in milk protein concentration between the two 
replicates, a physiological manifestation must have arisen as a result of the differences in 
flows of MP-Lys. Therefore, plasma A A data were analyzed by replicate to determine if 
a difference in plasma Lys concentrations existed. The results demonstrated a significant 
difference between the first and second replicates with the first replicate cows having 
greater plasma Lys concentrations compared to the second replicate cows (98.8 vs. 91.0 ± 
2.61 pM; P < 0.05). However, plasma Met concentrations were nearly identical for both 
replicates (34.6 vs. 34.5 ± 1.26 pM; P = 0.961). Concentrations o f Lys as a percent of 
total AA for replicate 1 were also greater than replicate 2 (4.78 vs. 4.41 ± 0.127%; P = 
0,04) while concentrations of plasma Met as a percent o f total AA remained similar 
between the replicates (1.71 ± 0.062%). Plasma Lys concentrations (pM) were 7.9% 
lower in replicate 2 compared to replicate 1 and as a percent of total A A were 7.7% lower 
in replicate 2 compared to replicate 1. To help elucidate whether an 8% difference was 
sufficient enough as to elicit a biological response in milk protein concentrations, we 
examined the results o f a study conducted by McLaughlin et al. (2002) where incremental 
levels of LysHCl were infused into the duodenum of lactating dairy cows. The study was 
a balanced split-plot 5 x 5  Latin square with two primiparous and 3 multiparous lactating 
Holstein cows averaging 69 DIM. Cows were fed a Lys-deficient diet (5.1% Lys and
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2.4% Met in MP according to NRC (2001) evaluation) and averaged 24.6 kg/d DMI and 
45.4 kg/d milk yield. Lysine (% of total AA) increased in a linear fashion (P < 0.001; 
Figure 3.8). Lysine as a percent of total AA was regressed on measured flows of MP-Lys 
to the duodenum and a subsequent regression equation was derived to fit the data: y = 
0.0258x -  1.6664; R = 0.97. Using this regression equation, the difference in Lys 
concentrations as a percent of total AA between replicates 1 and 2 (4.78 vs. 4.41, 
respectively) indicated that there were 14 g/d more MP-Lys flowing to the small intestine 
in replicate 1 than in replicate 2. This indicates that the NRC (2001) predicted flows of 
MP-Lys of 188 and 192 g/d for replicates 1 and 2, respectively, may not be correct. As 
previously discussed, two different batches o f blood meal were used in replicates 1 and 2. 
The chemical analysis of the blood meal used in replicate 2 indicated that it was of higher 
quality as a result o f having a higher overall CP, RUP, RUP digestibility, AA, and AA 
digestibility than the blood meal used in replicate 1. However, the physical 
characteristics of the blood meal may offer a possible explanation as to why it did not 
appear to supply the amount o f MP-Lys predicted by NRC (2001). The blood meal used 
in replicate 1 was a ring-dried product and had a larger particle size compared to the 
spray-dried product used in replicate 2 which had a powdery consistency. It is possible 
that the increased surface area of the spray-dried blood meal allowed for greater 
microbial attachment which resulted in a higher ruminal degradability thus reducing the 
RUP content o f the CP. These results indicate more research is needed to develop a feed 
analysis procedure that will better model the effect of particle size on ruminal 
degradability and digestibility of high RUP feed sources such as spray dried blood meal.
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However, the original intention prior to conducting the study was to include both 
replicates in the final statistical analyses. Therefore, analyzing the data by replicate 
would not be statistically accurate and as a result, the statistical analyses were conducted 
based on the combined data from the first and second replicates to maintain the statistical 
principles which were originally intended. In addition, dietary differences are ubiquitous 
real-world problems, which can affect the overall efficacy of Met products, especially 
when using production parameters such as changes in milk protein concentration to gauge 
their performance. The results of this study reinforce the notion that more detailed feed 
analyses must be developed which can better characterize the differences and similarities 
between high RUP feed sources such as blood meal.
MetaSmart vs. Smartamine M Metabolism
Research has demonstrated that not only is supplemental Met utilized differently 
than Met analogs within species, but it is also utilized differently between ruminants and 
non-ruminants as well (Baker, 1986; Lobley et al., 2001). In non-ruminants, it has been 
postulated that HMB is absorbed from the gastrointestinal tract and transported to the 
liver where it is removed from circulation and transaminated to form Met (Bottje et al., 
1998). However, more recent research (Wester et al., 2000a,b) has demonstrated, using 
sheep, that this pathway may be incorrect, especially in ruminants.
Wester et al. (2003a) infused labeled (l-13C)Met into the jugular vein of growing 
lambs for 12 h, and then from 3 h onward, infused successive 3 h infusions of 0.55 
mg/min saline and 4.4 mg/min HMB into the mesenteric vein. Continuous plasma 
samples were taken every 20 min during the last 80 min o f each infusion. All o f the
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infused HMB was recovered at the portal vein, with 25% being subsequently extracted by 
the liver. Results indicated that portal appearance of Met and Cys was unaltered by HMB 
infusion, however, net splanchnic output o f Met decreased while Cys output increased 
with increasing rates o f HMB infusion. Although dietary Met appeared to not be released 
into peripheral circulation, arterial concentrations of Met increased linearly as well as 
Met irreversible loss rate. They calculated that the increase in Met irreversible loss rate 
was equivalent to 40% of the HMB delivered past the liver which was metabolized by 
peripheral tissues and entered the plasma Met pool. These researchers concluded that the 
liver does not secrete the Met which was transaminated from the extracted HMB, 
however, the liver may increase Cys output. It appears from their results that HMB is 
metabolized extensively by peripheral non-hepatic tissues.
In another study conducted by Wester et al. (2000b), unlabeled HMB was infused 
into the abomasum of growing lambs for 24 h followed by a 6 h infusion of labeled (1- 
13C)HMB into the abomasum with another infusion of (2H3)Met into the mesenteric 
vein. Continuous samples o f plasma were taken at 30 min intervals during the last 2 h of 
infusion from the aorta, portal and hepatic veins. The researchers recovered 75% of the 
infused HMB at the portal vein with 36% being extracted by the liver. Based on the 
results of the study, it was concluded that post-splanchnic tissues were involved in the 
synthesis of Met from HMB and the involvement was in the order o f kidney > liver > 
rumen > jejunum > duodenum > ileum. They also found that the lungs, brain, muscle and 
skin also synthesized Met from HMB but this accounted for less than 5% of intracellular 
Met. This study provides further evidence that HMB is being utilized by peripheral 
tissues to meet their Met requirements. It also provides evidence that any increases in
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plasma Met concentrations observed with supplemental MetaSmart feeding (HMB is not 
assumed to escape ruminal fermentation under normal feeding conditions) is most likely 
the result of a Met-sparing effect and not necessarily the result of a net export of Met 
from tissues such as the liver that transaminates HMB into Met.
Effects of Methionine Analogs and Methionine on Plasma Sulfur Amino Acids
Plasma Met and Met+Cys concentrations did not increase when Met-adequate 
cows were fed incremental amounts of MetaSmart. Therefore, a bioavailability value for 
MetaSmart based on changes in plasma Met and Met+Cys concentrations and plasma 
Met and Met+Cys (% total AA) could not be calculated.
An interesting observation was that although feeding incremental amounts of 
MetaSmart to Met-adequate cows did not increase plasma Met concentrations it did result 
in significant increases in plasma Cys, Ser, and Gly concentrations. Feeding incremental 
amounts of MetaSmart to Met-deficient cows led to a trend towards increased plasma 
Met concentrations (P  = 0.0539) and linearly decreased Ser and Gly concentrations (P < 
0.05). Plasma Cys concentrations remained unaffected. Interestingly, this relationship 
may be explained by examining the metabolic interrelationships o f Cys, Ser, and Gly. 
The carbon skeleton of Cys is derived from Ser and the sulfhydryl group is transferred 
from Met via Hcys. The enzymes involved in the reaction of Ser to Cys (cystathionine 
synthase and y-cystathionase) both require pyridoxal phosphate. Serine is the major 
source of Gly and can be converted into Gly in a reaction catalyzed by serine 
hydroxymethyltransferase (also requires pyridoxal phosphate). This reaction results in a 
chemically reactive formaldehyde group that is transferred to tetrahydrofolate (THF)
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forming N 5, N 10-methylene tetrahydrofolate and intimately linking the reaction with Met 
metabolism. Perhaps, MetaSmart is metabolized differently under Met-adequate 
conditions than under Met-deficient conditions. Our results indicate that when Met is 
limiting, MetaSmart dissociates in the blood to HMB and is then transaminated to Met 
(McCollum et al., 2000; Robert et al., 2001), which would explain the trend for an 
increase in plasma Met concentrations observed in the current study. We hypothesize 
that under Met-adequate conditions, such as in the Met-adequate diet; MetaSmart is 
absorbed into the blood and dissociates to HMB but is transaminated to Cys instead of 
Met.
In a recent study conducted by Noftsger et al. (2005), cows were fed either a Met- 
deficient diet or the same diet supplemented with MetaSmart at 0.13% of diet DM. No 
changes in plasma EAA or plasma NEAA, except for a significant decrease in plasma 
Tau concentrations were observed. This supplementation level is similar to the 6 g Met 
equivalent supplementation rate (0.11% of diet DM) in the current study and is 
approximately half that of the highest level o f MetaSmart supplementation (12 g Met 
equivalent supplementation rate). No effects on plasma Tau concentrations were 
observed in the current study for Met-adequate or Met-deficient cows fed incremental 
amounts o f MetaSmart. Concentrations o f plasma Cys were not reported; therefore, it is 
not known whether feeding MetaSmart had an effect on plasma Cys concentrations. 
These researchers hypothesized that a negative energy balance may have been 
responsible for the lack o f effect of feeding MetaSmart on plasma Met concentrations. 
Indeed, a negative energy balance may have been culprit considering other researchers 
have observed increased plasma Met concentrations (Sylvester et al., 2003) or trends for
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increased plasma Met concentrations (current study; Schwab et al., 2005a) when Met- 
deficient cows were fed supplemental amounts o f MetaSmart.
Effects on Milk Yield and Dry Matter Intake
A significant linear decrease in milk yield and a subsequent linear decrease in the 
ratio of milk to DMI were observed for Met-adequate cows receiving incremental 
amounts of Smartamine M. This effect has not been observed in previous studies 
conducted in our laboratory (Schwab et al., 2005a,b) where incremental amounts of 
Smartamine M were fed, however, Socha et al. (2005) and Ordway et al. (2004) observed 
numerically lower milk yields when Smartamine M was supplemented.
In the study conducted by Socha et al. (2005), Smartamine M was supplemented 
in a fixed amount o f 15 g/d irrespective o f DMI. As a result, there may have been some 
cows with low DMI which may have been receiving excessive amounts of Met, thus 
causing a depression in DMI and a subsequent depression in milk yield. In fact, these 
researchers did observe significantly lower DMI when cows were supplemented with 
Smartamine M, which is most likely, the reason for the numerically lower milk yields. In 
the study conducted by Ordway et al. (2004), Smartamine M was supplemented in an 
amount to generate a 3.0:1 ratio o f Lys to Met in MP as predicted by NRC (2001) and the 
amount of product each cow received was respective of DMI. Average flow o f digestible 
Met for Smartamine M cows was 55 g/d which equated to 0.26% of DMI. Dry matter 
intake was statistically lower compared to supplementation with HMBi and numerically 
lower compared to the basal control diet. Although not statistically significant, milk 
yield was numerically lower for cows supplemented with Smartamine M compared to the
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HMBi and control diets. In the current study, DMI was not decreased by incremental 
Smartamine M supplementation in either the Met-adequate or Met-deficient diet. 
Whether Smartamine M does have a biological effect on lowering DMI and/or milk yield 
would be dependent upon how much supplemental Smartamine M was offered and if the 
basal diet was adequate in Met.
The potential effects of sulfur toxicity in ruminants are examined in great detail in 
a review by Kandylis (1984). A reduction in DMI is a common symptom of excessive 
Met consumption in cattle and sheep. It also appears that ruminants are less susceptible 
to excessive HMB consumption than DL-Met but decreased feed intake in lambs has 
been observed when HMB was included in the diet at 1.2% (Papas et al., 1974). 
Decreased feed intake in cattle has been observed when DL-Met was infused into the 
rumen at 2.5% of dietary DMI and at 0.6% of dietary DMI when infused into the 
abomasum (Satter et al., 1975).
In the current study, the highest level of Met supplementation on the Met 
adequate diet (12 g/d Met equivalent) resulted in digestible Met flows of 75 g/d according 
to NRC (2001) which equated to approximately 0.3% of dietary DMI for both MetaSmart 
and Smartamine M cows. This amount is similar to the amount Ordway et al. (2004) fed 
to early lactation cows (0.26% of DMI) and is only half o f the amount infused by Satter 
et al. (1975) which resulted in decreased DMI in cattle and therefore, would not be 
expected to lower DMI. In the current study, lower DMI are not responsible for the 
linear decrease in milk production as may have been the case in the study by Ordway et 
al. (2004) where numerically lower DMI were observed. While there is a correlation 
between excessive DL-Met consumption and decreased DMI which may lead to a
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subsequent reduction in milk production, the reason for the decline in milk production in 
the current study is not discernible.
Bioavailability Calculations
Although there were significant increases in milk protein concentrations, the 
bioavailability calculation o f 132 ± 152% is unlikely correct. As previously discussed, 
using changes in plasma Met concentrations does not appear to be an effective method 
for calculating bioavailability values for MetaSmart when cows are fed Met-adequate 
diets, because in the present study, feeding incremental amounts of MetaSmart to Met- 
adequate cows did not increase plasma Met+Cys or total sulfur AA concentrations. 
However, it did result in a significant increase in plasma Cys concentrations, but 
Smartamine M did not increase plasma Cys concentrations; therefore, a bioavailability 
value was unable to be calculated for MetaSmart.
Feeding Met-deficient cows incremental amounts of MetaSmart and Smartamine 
M has been shown to increase plasma Met (% total AA), Met+Cys (% total AA) and 
plasma total sulfur AA (% of total AA) concentrations (Schwab et al., 2005a). In the 
current study, feeding both Smartamine M and MetaSmart to Met-deficient cows also 
increased plasma Met (% total AA), plasma Met+Cys (% total AA) and plasma total 
sulfur AA (% total AA) which allowed for Met bioavailability values for MetaSmart 
relative to that o f Smartamine M to be calculated. Based on these calculations, using 
changes in plasma total sulfur AA (% total AA) is the most precise indicator of 
MetaSmart bioavailability relative to that of Smartamine M compared to changes in
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plasma Met (% total AA) and plasma Met+Cys (% total AA) (28 ± 9 vs. 24 ± 16 and.27 ± 
12%, respectively).
The bioavailability value of 28 ± 9% relative to that of Smartamine M calculated 
from changes in plasma sulfur AA (% total AA) equated to an overall Met bioavailability 
value of 22 ± 7% is considerably lower than previous bioavailability estimates of 42 ± 
1% (Graulet et al., 2005),
CONCLUSIONS
Feeding MetaSmart to cows receiving Met-adequate diets does not increase 
plasma Met concentrations but does increase plasma Cys, Ser, and Gly concentrations. 
More research must be conducted to gain a better understanding of the differences in 
metabolism between Met analogs, such as MetaSmart, and Met products, such as 
Smartamine M. In addition, it appears that MetaSmart is metabolized differently 
depending upon the Met status of the basal diet. More research should be conducted to 
determine the mechanism(s) responsible for these metabolic differences. Smartamine M 
linearly increased plasma Met, Met+Cys, and total sulfur AA when fed to Met-deficient 
and Met-adequate cows regardless of the Met status of the basal diet. As hypothesized, 
feeding MetaSmart and Smartamine M to Met-deficient cows increased milk protein 
concentrations but no increase was observed when fed to Met-adequate cows. The results 
o f this study demonstrate that using changes in milk protein concentrations to determine 
Met bioavailability values for MetaSmart relative to that o f Smartamine M is not as 
accurate or precise as using changes in plasma sulfur AA concentrations.
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Table 3.1. Summary of plasma AA and milk production results from Schwab et al.
(2004a) in which cows were fed incremental amounts of Smartamine M or HMBi1.
Met equivalents (g/d)
0 10 15 20 25 30 SE
Met, pg/ml2
Smartamine M 2.71 3.19 3.50 4.72 5.14 0.31
HMBi 2.73 2.98 2.86 2.65 3.32 0.31
Met+Cys, pg/ml
Smartamine M 6.78 7.37 7.57 9.20 9.76 0.63
HMBi 6.93 7.88 6.99 6.63 7.61 0.63
TSAA, pg/ml
Smartamine M 11.45 11.98 12.73 14.82 15.99 0.93
HMBi 11.70 14.02 11.89 11.12 12.53 0.93
Met, % total AA
Smartamine M 0.99 1.24 1.41 1.65 1.80 0.07
HMBi 1.00 1.02 1.10 1.07 1.29 0.06
Met+Cys, % total AA
Smartamine M 2.47 2.87 3.05 3.21 3.41 0.10
HMBi 2.55 2.73 2.70 2.74 3.03 0.12
TSAA, % total AA
Smartamine M 4.17 4.69 5.20 5.24 5.64 0.19
HMBi 4.34 4.84 4.64 4.64 5.06 0.24
Milk yield3
Smartamine M 43.5 43.6 42.4 43.2 43.3 1.17
HMBi, n=  10 44.8 45.8 44.2 43.4 44.6 1.17
Protein, %
Smartamine M 2.99 3.08 3.15 3.15 3.13 0.039
HMBi 3.05 3.11 3.16 3.17 3.19 0.039
Protein, g/d
Smartamine M 1297 1335 1339 1363 1355 35.9
HMBi 1349 1405 1387 1367 1406 35.9
1 Basal diet was intended to be deficient in Met.
2 Blood data was based on 5 cows per treatment.
3 Milk data was based on 10 cows per treatment.
1
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Table 3.2. Summary o f plasma AA and milk production results from Schwab et al.
(2004b) in which cows were fed incremental amounts of Smartamine M or H M Bi1.____
Met equivalents (g/d)
0 5 10 15 17 24 35 SE
Met, pg/ml2
Smartamine M 3.07 3.48 3.63 4.26 4.32 0.31
HMBi 3.00 2.53 3.39 3.41 3.45 0.31
Mepron 2.54 3.09 2.86 2.69 4.08 0.31
Met+Cys, pg/ml
Smartamine M 7.01 7.22 7.38 8.33 7.99 0.50
HMBi 6.59 5.62 7.52 7.12 6.67 0.50
Mepron 6.13 6.58 6.00 5.65 8.03 0.50
TSAA, pg/ml
Smartamine M 11.26 11.55 11.76 12.99 13.31 0.88
HMBi 11.08 9.78 13.56 12.24 11.72 0.88
Mepron 10.48 11.07 10.10 10.03 13.37 0.88
Met, % total AA
Smartamine M 1.19 1.41 1.61 1.74 1.97 0.06
HMBi 1.14 1.16 1.32 1.44 1.63 0.06
Mepron 1.10 1.33 1.35 1.41 1.66 0.06
Met+Cys, % total AA
Smartamine M 2.76 2.94 3.29 3.47 3.67 0.06
HMBi 2.55 2.66 2.95 3.02 3.17 0.06
Mepron 2.66 2.82 2.87 3.00 3.27 0.06
TSAA, % total AA
Smartamine M 4.43 4.82 5.33 5.48 6.02 0.15
HMBi 4.24 4.65 5.52 5.13 5.69 0.15
Mepron 4.58 4.77 4.83 5.34 5.46 0.15
Milk yield3
Smartamine M 43.3 42.5 42.7 43.2 41.9 1.16
HMBi 42.6 43.7 42.9 44.0 45.1 1.16
Mepron 42.0 42.3 43.0 43.2 42.3 1.16
Protein, %
Smartamine M 3.13 3.20 3.20 3.20 3.16 0.037
HMBi 3.12 3.19 3.17 3.15 3.17 0.037
Mepron 3.16 3.21 3.19 3.200 3.23 0.037
Protein, g/d
Smartamine M 1363 1369 1376 1393 1330 44.0
HMBi 1331 1383 1355 1388 1430 43.5
Mepron 1320 1354 1365 1380 1360 43.6
1 Basal diet was intended to be deficient in Met.
2 Blood data was based on 10 cows per treatment.
3 Milk data was based on 10 cows per treatment.
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Table 3.3. Summary of plasma AA and milk production results from Olley et al. (2004)
in which cows were fed incremental amounts of Smartamine M, Mepron M85, or Met
P lus1.
Met equivalents (g/d)
0 3 6 9 12 SE
Met, pg/ml2
Smartamine M 5.36 5.34 5.91 6.86 6.44 0.46
Met Plus 5.14 4.83 5.32 5.62 4.71 0.46
Mepron 4.83 6.17 6.04 5.74 6.18 0.46
Met+Cys, pg/ml
Smartamine M 8.83 8.90 9.56 10.60 10.23 0.58
Met Plus 8.86 8.58 9.08 9.35 8.36 0.58
Mepron 8.77 10.39 10.14 9.82 9.99 0.58
TSAA, pg/ml
Smartamine M 14.35 14.57 15.44 16.72 16.82 0.79
Met Plus 14.94 15.09 15.71 15.50 14.52 0.79
Mepron 15.82 17.43 17.46 16.98 17.02 0.79
Met, % total AA
Smartamine M 1.95 2.06 2.23 2.48 2.44 0.133
Met Plus 1.88 1.91 1.99 2.05 1.98 0.146
Mepron 1.81 2.16 2.11 2.03 2.23 0.166
Met+Cys, % total AA
Smartamine M 3.21 3.42 3.62 3.84 3.89 0.159
Met Plus 3.25 3.40 3.41 3.41 3.49 0.163
Mepron 3.29 3.65 3.57 3.48 3.62 0.184
TSAA, % total AA
Smartamine M 5.25 5.59 5.84 6.05 6.36 0.246
Met Plus 5.47 5.99 5.91 5.71 6.15 0.284
Mepron 6.01 6.20 6.17 6.03 6.18 0.246
Milk yield3
Smartamine M 35.1 35.3 35.8 36.1 36.4 1.51
Met Plus 36.8 37.1 36.4 35.2 35.2 1.51
Mepron 34.6 34.5 33.4 34.2 37.2 1.51
Protein, %
Smartamine M 2.70 2.76 2.71 • 2.77 2.77 0.14
Met Plus 2.99 3.04 3.01 3.07 2.96 0.14
Mepron 2.93 2.89 2.90 2.97 2.95 0.14
Protein, g/d
Smartamine M 941 982 969 992 1003 44.1
Met Plus 1074 1103 1042 1059 1013 44.1
Mepron 982 961 946 982 1042 44.1
Basal diet was intended to be adequate in Met.
2 Blood data was based on 5 cows per treatment.
3 Milk data was based on 5 cows per treatment.
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Table 3.4. Ingredient composition of the basal diets of mid-lactation cows fed Met- 




Alfalfa hay 9.04 9.04
MMG silage 11.42 11.42
Corn silage 28.01 28.01
Ground com meal 12.25 12.25
Ground barley meal 14.16 14.16
Soyhulls 7.37 7.37
Citrus pulp 2.50 2.50
Soybean meal 9.77 9.77
Blood meal, ring dried 1.21 1.21
Energy Booster 100 1.25 1.25
Minerals2 3.04 3.04
Smartamine M
I n .. __ .__  ,  . ____ . , ,
- 0.088
1 Smartamine M was included in the Met adequate diet in an amount sufficient to 
generate a 3.0:1 Lys/Met ratio in MP.
Contains (as-fed basis): 29.95% sodium sesquicarbonate, 13.65% calcium carbonate, 
15.25% salt, 12.41% magnesium oxide, 12.41% calcium sulfate, 5.78% monosodium 
phosphate, 3.09% trace mineral and vitamin premix, 4.60% yeast culture (Diamond V 
XP, Diamond Mills, Inc., Cedar Rapids, IA), and 1.05% MTB100 (Alltech, Inc., 
Nicholasville, KY), 1.81% Zinpro 4-plex (Zinpro Corp., Eden Prairie, MN). The trace 
mineral and vitamin pre mix contains (percent or amount o f trace mineral and vitamin 
premix DM): 292 KlU/kg of vitamin A, 67 KlU/kg vitamin D, 1122 IU/kg vitamin E, 
10.5% Ca, 1.3% P, 7.5%Mg, 0.02% K, 2.45% S, 10 ppm Se, 1794 ppm Mn, 2135 ppm 
Zn, 1104 ppm Fe, 378 ppm Cu, 64 ppm, 9.2% Cl, and 6.0% Na.
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Table 3.5. A description of dietary treatments of mid-lactation cows fed Met-adequate or
Met-deficient diets supplemented with incremental amounts o f Smartamine M or
MetaSmart1.
Dietary treatments
Met supplement 1 2 3 4 5
Met-deficient diets g/24.0 kg DMI
Assumed MP-Met provided 0 3 6 9 12
MetaSmart product provided2 0 14 27 41 55
Smartamine M provided3 0 5 10 15 20
Met-adequate diets
Assumed MP-Met provided 0 3 6 9 12
MetaSmart product provided 0 14 27 41 55
Smartamine M provided3 0
i „ ; x  x ___• j  • x i.  x ,
5 10 15 20
1 Smartamine M was included in the Met adequate diet in an amount sufficient to 
generate a 3.0:1 Lys/Met ratio in MP.
MetaSmart was supplied as a dry powder containing 60% of active ingredient on a 
silicate carrier. It was assumed that MetaSmart contains a minimum of 78% HMB, is 
95% pure, and that 50% of the HMB in dietary MetaSmart was absorbed and converted 
to metabolizable Met [57% (60% x 95%) MetaSmart monomer x 77.8% HMB x 50% 
bioavailability = 22% metabolizable Met].
3 It was assumed that Smartamine M contains no less than 75% methionine and that it has 
a bioavailability o f 80%.












Table 3.6. Chemical composition of the dietary feed ingredients fed to mid-lactation cows receiving Met-adequate or Met-deficient



















DM 89.7 32.1 28.7 87.6 87.5 89.9 88.6 89.6 91.8
CP 19.8 12.6 7.8 7.6 11.7 11.0 5.9 54.4 98.5
RUP - - - - - - - - 82.3
RUP digestibility - - - - - - - - 70.4
ADF 37.3 43.7 26.6 3.9 8.8 47.8 18.6 6.4 -
NDF 45.4 65.9 44.0 8.8 19.4 66.5 21.1 9.5 -
NFC4 26.6 12.9 41.3 79.3 66.2 21.0 66.3 32.3 -
NSC5 8.0 4.9 34.1 75.1 64.5 3.8 25.7 15.4 -
Starch6 0.8 0.7 32.2 71.7 58.5 1.3 0.9 1.4 -
Sugar7 7.3 4.3 2.0 3.4 6.1 2.5 24.8 14.1 -
Ash 9.1 7.8 4.3 1.4 2.5 4.6 6.9 7.2 -
Fat 1.8 4.3 3.9 4.0 2.1 1.4 2.3 1.2 -
Ca 1.16 0.52 0.27 0.02 0.09 0.69 2.03 0.41 -
P 0.26 0.29 0.26 0.30 0.46 0.13 0.11 0.91 -
Mg 0.35 0.18 0.13 0.10 0.12 0.22 0.11 0.31 -
K 2.26 2.47 1.36 0.42 0.52 1.46 1.10 2.58 -
Na 0.055 0.046 0.006 0.002 0.010 0.003 0.027 0.005 -
S 0.23 0.18 0.10 0.09 0.13 0.09 0.07 0.39 -
Fe, ppm 181 298 270 32 95 444 72 169 -
Zn, ppm 19 23 19 16 26 33 8 43 -
Cu, ppm 10 9 7 2 4 7 6 16 -
Mn, ppm 29 64 11 4 21 13 5 36 -
2 Chemical composition o f feed ingredients is based upon feed analyses o f  composited feeds from replicate 1 and replicate 2.
3 Ring-dried blood meal.
4 Nonfibrous carbohydrate = 100 - (CP + NDF + ash + ether extract).
5 Nonstructural carbohydrate = starch + sugar.
6 Starch was analyzed by Dairy One Forage Testing Laboratory using a Y S I2700 SELECT Biochemistry Analyzer - YSI Incorporated, Application Note Number 319.












Table 3.7. Amino acid composition o f feeds fed to mid-lactation cows receiving Met-adequate or Met-deficient diets supplemented 
with incremental amounts o f Smartamine M or MetaSmart1.
AA Alfalfa hay MMG silage2 Com silage Com  meal Barley meal Soyhulls Citrus pulp Soybean meal Blood meal3
% o f  CP
Arg 5.46 2.78 1.90 5.00 5.37 4.78 4.05 7.40 4.41
His 2.55 1.46 1.42 3.24 2.56 2.74 1.75 2.83 7.29
lie 5.10 3.64 3.57 3.86 3.84 3.76 3.23 4.59 0.94
Leu 8.53 6.55 8.86 13.35 7.43 6.50 5.87 7.74 13.98
Lys 6.34 3.48 2.35 3.38 3.81 6.63 2.67 6.31 9.78
Met 1.77 1.36 1.87 2.28 1.82 1.15 1.20 1.39 1.16
Phe 5.88 3.99 3.50 5.48 5.45 3.84 4.06 5.19 7.52
Thr 5.33 3.34 2.98 3.86 3.62 3.61 3.19 3.87 4.19
Trp 1.31 0.40 0.55 0.88 0.97 0.62 1.11 1.42 1.88
Val 6.83 4.96 4.85 5.44 5.40 4.56 4.34 4.86 9.75
Ala 6.21 6.45 8.69 8.17 4.43 4.41 4.84 4.54 -
Asp 17.19 6.43 5.26 7.21 6.13 9.07 10.00 11.02 -
Cys 1.50 0.83 1.14 2.39 2.30 1.69 1.16 1.42 -
Glu 10.62 7.40 10.25 19.28 23.54 10.54 8.74 17.42 -
Gly 5.46 4.13 3.91 4.12 4.29 8.60 4.25 4.18 -
Pro 13.43 4.04 6.13 9.56 11.01 5.23 11.45 5.02 -
Ser 4.84 2.78 2.63 4.49 3.93 4.83 3.46 4.12 -
Tyr 3.37 2.06 1.70 3.53 2.84 4.06 2.17 3.59 -
Tau 0.36 0.49 0.94 1.51 0.88 0.87 1.57 0.08 -
Hyp 1.05 0.40 0.42 0.29 0.09 4.71 1.66 0.13 -
Om 0.36 0.91 0.80 0.22 0.28 0.27 0.37 0.16 -
1 Smartamine M was included in the Met adequate diet in an amount sufficient to generate a 3.0:1 Lys/Met ratio in MP.
2 MMG = mixed mostly grass.












Table 3.8. Chemical composition and NRC (2001) evaluation o f the basal diets o f mid-lactation cows fed Met-adequate or Met-
Item Deficient Adequate
NDF, % DM 34.2 34.2
ADF, % DM 22.2 22.2
RDP, % DM 9.5 9.5
RUP, % DM 6.1 6.1
CP, % DM 15.6 15.6
Energy balance, Mcal/d 2.9 1.8
RDP balance, g/d -72 -66
RUP balance, g/d -4 -118
MP supplied, g/d 2814 2732
MP balance, g/d -1 -90
Lys, g/d 190 185
Met, g/d 51 63
His, g/d 67 65
Lys, % of MP 6.75 6.77
Met, % of MP 1.81 2.31
His, % of MP 2.38 2.38
Lys/Met in MP
in  . ■ . •  , , , •
3.73:1 2.94:1
Smartamine M was included in the Met adequate diet in an amount sufficient to generate a 3.0:1 Lys/Met ratio in MP.
2 NRC (2001) evaluation o f diet was based upon an assumed DMI o f 24.0 kg/d.
3 Chemical composition o f individual feed ingredients used in NRC (2001) evaluation was based upon feed analyses o f composited 













Table 3.9. Dry matter intake (DMI), milk yield, and milk yield to DMI ratios o f mid-lactation cows fed Met-adequate or Met-deficient 
diets supplemented with incremental amounts o f Smartamine M or MetaSmart1.________________ ______________________________
Item
Methionine equivalents (g/d per 24 kg DMI)
SE2
P =
0 3 6 9 12 L Q C
DMI, kg/d
Adequate MetaSmart 25.9 26.1 25.6 26.5 26.1 0.70 0.4407 1.0000 0.4542
Adequate Smartamine M 26.5 26.6 26.1 26.7 26.4 0.70 0.8691 0.8355 0.6940
Deficient MetaSmart 27.2 26.4 26.8 26.9 26.9 0.70 0.8917 0.1687 0.1711
Deficient Smartamine M 26.6 26.7 26.3 26.4 26.7 0.70 0.8827 0.4045 0.4891
Milk yield, kg/d
Adequate MetaSmart 41.4 42.4 41.8 41.9 42.0 1.43 0.6279 0.5275 0.3161
Adequate Smartamine M 42.4 41.8 41.2 41.8 40.9 1.43 0.0458 0.7588 0.3308
Deficient MetaSmart 43.8 43.1 43.1 44.0 43.1 1.43 0.7764 0.8285 0.0757
Deficient Smartamine M 41.2 41.4 41.1 41.4 41.7 1.43 0.4760 0.6189 0.6577
Milk/DMI, kg/kg
Adequate MetaSmart 1.59 1.62 1.63 1.58 1.61 0.044 0.8204 0.4062 0.0627
Adequate Smartamine M 1.61 1.58 1.57 1.57 1.54 0.044 0.0203 0.9128 0.4577
Deficient MetaSmart 1.61 1.63 1.62 1.64 1.61 0.044 0.9397 0.2922 0.5964
Deficient Smartamine M 1.55 1.55 1.57 1.57 1.57 0.044 0.4164 0.6670 0.6229
Smartamine M was included in the Met adequate diet in an amount sufficient to generate a 3.0:1 Lys/Met ratio in MP. 













Table 3.10. Milk composition and yield o f milk components o f Holstein cows fed Met-adequate or Met-deficient diets supplemented
with incremental amounts o f Smartamine M or MetaSmart1.
Methionine equivalents (g/d per 24 kg DMI)
SE2
P =
Item 0 3 6 9 12 L Q C
Protein, %
Adequate MetaSmart 3.05 3.07 3.04 3.06 3.05 0.044 0.9166 0.9824 0.9374
Adequate Smartamine M 3.01 3.04 3.06 3.04 3.02 0.044 0.7404 0.1438 0.9506
Deficient MetaSmart 2.90 2.92 2.93 2.96 3.01 0.044 0.0013 0.3651 , 0.7935
Deficient Smartamine M 2.98 2.96 3.03 3.04 3.03 0.044 0.0140 0.7234 0.1516
Protein, g/d
Adequate MetaSmart 1267 1301 1272 1293 1274 45.2 0.9203 0.4824 0.7470
Adequate Smartamine M 1272 1265 1263 1248 1188 45.2 0.0098 0.1558 0.4953
Deficient MetaSmart 1252 1231 1264 1335 1308 45.2 0.0015 0.7457 0.0244
Deficient Smartamine M 1225 1232 1238 1248 1251 45.2 0.3150 0.9799 0.9132
Fat, %
Adequate MetaSmart 3.39 3.39 3.39 3.32 3.33 0.097 0.2019 0.7657 0.5482
Adequate Smartamine M 3.29 3.25 3.32 3.27 3.56 0.097 0.0006 0.0040 0.1652
Deficient MetaSmart 3.30 3.38 3.36 3.33 3.31 0.097 0.7989 0.2755 0.4337
Deficient Smartamine M 3.37 3.35 3.28 3.22 3.39 0.097 0.5745 0.0395 0.0672
Fat, g/d
Adequate MetaSmart 1405 1440 1418 1404 1395 59.7 0.5105 0.4269 0.4748
Adequate Smartamine M 1384 1354 1368 1335 1398 59.7 0.9258 0.1982 0.5866
Deficient MetaSmart 1421 1427 1443 1493 1438 59.7 0.2482 0.3835 0.1846
Deficient Smartamine M 
I o . • * r ,
1384 1394 1342 1314 1396 59.7 0.5201 0.1020 0.0498
1 Smartamine M was included in the Met adequate diet in an amount sufficient to generate a 3.0:1 Lys/Met ratio in MP.













Table 3.11. Milk composition and yield o f milk components o f Holstein cows fed Met-adequate or Met-deficient diets supplemented
with incremental amounts o f Smartamine M or MetaSmart1.
Methionine equivalents (g/d per 24 kg DMI)
SE2
P =
Item 0 3 6 9 12 L Q C
MUN
Adequate MetaSmart 11.8 11.8 11.4 11.7 11.7 0.49 0.7651 0.6168 0.9123
Adequate Smartamine M 11.6 12.5 12.0 12.3 11.7 0.49 0.8940 0.0691 0.6568
Deficient MetaSmart 12.6 12.0 12.1 11.9 12.4 0.49 0.6223 0.1185 0.9916
Deficient Smartamine M 12.9 12.7 12.8 12.9 12.8 0.49 0.9791 0.8908 0.5296
Lactose, %
Adequate MetaSmart 4.77 4.78 4.74 4.77 4.74 0.044 0.2551 0.9525 0.8547
Adequate Smartamine M 4.78 4.77 4.75 4.75 4.76 0.044 0.4435 0.5607 0.9388
Deficient MetaSmart 4.69 4.70 4.67 4.64 4.69 0.044 0.3391 0.3183 0.0901
Deficient Smartamine M 4.74 4.70 4.69 4.70 4.68 0.044 0.0901 0.4538 0.5451
Lactose, g/d
Adequate MetaSmart 1987 2037 1986 2026 1985 77.2 0.8700 0.4312 0.8229
Adequate Smartamine M 2027 2001 1971 1963 1883 77.2 0.0017 0.4622 0.5060
Deficient MetaSmart 2039 1993 2033 2099 2048 77.2 0.2003 0.8789 0.0361
Deficient Smartamine M 
1 ^
1952 1967 1924 1935 1934 77.2 0.4938 0.8534 0.6434
1 Smartamine M was included in the Met adequate diet in an amount sufficient to generate a 3.0:1 Lys/Met ratio in MP.












Table 3.12. Plasma essential AA (EAA) concentrations (pM) o f Holstein cows fed Met-adequate or Met-deficient diets supplemented
with incremental amounts o f Smartamine M or MetaSmart1.
Methionine equivalents (g/d per 24 kg DMI) P =
Item 0 3 6 9 12 SE2 L Q C
Arg
Adequate MetaSmart 84.0 82.0 83.1 83.7 83.6 5.00 0.8952 0.6572 0.5431
Adequate Smartamine M 85.6 86.5 86.5 88.4 86.7 5.00 0.5350 0.6761 0.6902
Deficient MetaSmart 92.6 94.6 90.6 91.3 88.3 5.00 0.0700 0.5054 0.7406
Deficient Smartamine M 86.7 89.9 93.4 87.2 87.6 5.00 0.8861 0.0479 0.3289
His
Adequate MetaSmart 58.7 59.6 61.2 62.6 60.8 2.95 0.1910 0.3935 0.4581
Adequate Smartamine M 58.1 60.0 60.1 59.3 58.2 2.95 0.9470 0.3077 0.7956
Deficient MetaSmart 65.1 63.1 62.3 62.5 61.0 2.95 0.1067 0.7474 0.5888
Deficient Smartamine M 
He
Adequate MetaSmart
65.0 66.6 62.8 62.3 62.8 2.95 0.1032 0.8747 0.2347
132.0 124.5 124.7 125.6 124.4 6.70 0.2833 0.3938 0.4508
Adequate Smartamine M 107.8 113.5 111.1 108.6 103.6 6.70 0.3379 0.1909 0.6968
Deficient MetaSmart 125.5 135.8 122.7 132.0 123.5 6.70 0.5499 0.3203 0.6698
Deficient Smartamine M 122.6 130.4 130.7 126.5 118.2 6.70 0.3358 0.0194 0.7866
Leu
Adequate MetaSmart 160.4 150.3 146.8 148.9 150.6 8.31 0.1789 0.1115 0.6493
Adequate Smartamine M 134.2 141.8 136.8 135.4 129.9 8.31 0.3612 0.2461 0.6106
Deficient MetaSmart 153.7 166.8 150.8 163.0 152.0 8.31 0.6457 0.2727 0.7103
Deficient Smartamine M 152.0 159.5 158.7 153.9 142.8 8.31 0.1220 0.0263 0.8942
Lys
Adequate MetaSmart 95.3 93.6 95.2 96.5 95.6 4.48 0.6640 0.8910 0.4916
Adequate Smartamine M 94.1 95.7 96.0 95.7 92.5 4.48 0.7106 0.3027 0.8502
Deficient MetaSmart 94.3 97.3 92.7 95.9 91.0 4.48 0.3167 0.3954 0.9480
Deficient Smartamine M 91.8 96.5 99.3 95.9 92.7 4.48 0.8861 0.0204 0.7955
Smartamine M was included in the Met adequate diet in an amount sufficient to generate a 3.0:1 Lys/Met ratio in MP.











Table 3.12 cont’d. Plasma essential AA (EAA) concentrations (pM) of Holstein cows fed Met-adequate or Met-deficient diets 
supplemented with incremental amounts of Smartamine M or MetaSmart1.___________________________________________________
Item
Methionine equivalents (g/d per 24 kg DMI)
SE2
P =
0 3 6 9 12 L Q C
Met
Adequate MetaSmart 38.9 38.8 40.5 39.5 40.1 2.11 0.3699 0.7760 0.9773
Adequate Smartamine M 38.0 44.7 48.7 51.9 57.4 2.11 <0.0001 0.4516 0.1796
Deficient MetaSmart 21.1 22.4 21.9 23.8 23.9 2.11 0.0539 0.9850 0.9875
Deficient Smartamine M 20.0 24.8 28.0 32.4 34.3 2.11 <0.0001 0.2768 0.7657
Phe
Adequate MetaSmart 47.7 46.0 45.0 45.2 45.3 1.49 0.1160 0.2399 0.8082
Adequate Smartamine M 43.1 45.3 44.7 45.5 44.0 1.49 0.5703 0.1619 0.8920
Deficient MetaSmart 46.3 48.8 46.1 47.3 46.6 1.49 0.7903 0.5317 0.3431
Deficient Smartamine M 45.2 46.6 46.4 44.8 43.8 1.49 0.1780 0.1241 0.5026
Thr
Adequate MetaSmart 112.7 115.1 114.1 115.8 116.3 5.47 0.3835 0.9198 0.8224
Adequate Smartamine M 111.0 115.8 119.5 112.3 108.3 5.47 0.3576 0.0136 0.6523
Deficient MetaSmart 133.0 129.7 123.9 128.1 122.5 5.47 0.0144 0.6233 0.4203
Deficient Smartamine M 119.9 123.0 126.1 121.3 118.2 5.47 0.5850 0.0644 0.8409
Trp
Adequate MetaSmart 37.1 37.5 37.6 36.6 36.3 1.34 0.2850 0.3819 0.7410
Adequate Smartamine M 36.9 37.8 36.8 36.4 35.9 1.34 0.1607 0.4582 0.4460
Deficient MetaSmart 40.1 39.1 39.1 39.7 38.4 1.34 0.2354 0.9927 0.2120
Deficient Smartamine M 38.4 37.7 38.8 38.1 37.5 1.34 0.5142 0.5984 0.4626
Val
Adequate MetaSmart 296.6 277.6 277.5 280.2 282.1 15.10 0.3243 0.1637 0.4653
Adequate Smartamine M 247.9 265.4 262.1 253.2 241.2 15.10 0.3684 0.0564 0.5345
Deficient MetaSmart 286.2 304.3 277.1 296.9 279.5 15.10 0.4419 0.4498 0.7642
Deficient Smartamine M 282.3 298.6 290.2 284.4 272.4 15.10 0.2082 0.0916 0.4901
Smartamine M was included in the Met adequate diet in an amount sufficient to generate a 3.0:1 Lys/Met ratio in MP.











Table 3.12 cont’d. Plasma essential AA (EAA) concentrations (pM) of Holstein cows fed Met-adequate or Met-deficient diets 
supplemented with incremental amounts of Smartamine M or MetaSmart1.___________________________________________________
Methionine equivalents (g/d per 24 kg DMI)
SE2
P =
Item 0 3 6 9 12 L Q C
EAA
Adequate MetaSmart 1063.5 1024.8 1025.6 1034.7 1035.1 41.15 0.5492 0.3532 0.5397
Adequate Smartamine M 956.6 1006.4 1002.2 986.8 957.7 41.15 0.8341 0.0862 0.6272
Deficient MetaSmart 1057.9 1101.8 1027.2 1080.6 1026.6 41.15 0.2865 0.4648 0.8863
Deficient Smartamine M 1023.8 1073.7 1074.2 1046.6 1010.3 41.15 0.4903 0.0322 0.6064
BCAA3
Adequate MetaSmart 589.0 552.4 549.0 554.7 557.1 29.39 0.2592 0.1781 0.5019
Adequate Smartamine M 489.9 520.6 509.9 497.3 474.7 29.39 0.3499 0.1124 0.5853
Deficient MetaSmart 565.3 606.9 550.6 592.0 554.9 29.39 0.5127 0.3549 0.7213
Deficient Smartamine M 556.9 588.6 579.5 564.8 533.4 29.39 0.1958 0.0424 0.6573
Met+Cys
Adequate MetaSmart 82.6 84.8 86.5 85.4 86.5 3.29 0.1073 0.4266 0.6207
Adequate Smartamine M 82.7 89.8 95.0 97.1 102.3 3.29 <0.0001 0.2886 0.3525
Deficient MetaSmart 62.3 62.4 62.4 65.0 65.0 3.29 0.1275 0.6893 0.6257
Deficient Smartamine M 
i v, , ■" • ... r .  • , , ,
59.0 66.2 71.5 76.7 79.2 3.29 <0.0001 0.1195 0.8739
Smartamine M was included in the Met adequate diet in an amount sufficient to generate a 3.0:1 Lys/Met ratio in MP.
2 Largest standard error o f treatment means is shown.












Table 3.13. Plasma nonessential A A (NEAA) concentrations (pM) of Holstein cows fed Met-adequate or Met-deficient diets 
supplemented with incremental amounts o f Smartamine M or MetaSmart1.___________________________________________________
Item
Methionine equivalents (g/d per 24 kg DMI)
SE2
P =
0 3 6 9 12 L Q C
Ala
Adequate MetaSmart 299.3 293.4 300.6 311.7 291.1 13.32 0.9358 0.3370 0.0462
Adequate Smartamine M 292.2 291.3 301.2 288.4 284.5 13.32 0.4372 0.3040 0.9361
Deficient MetaSmart 310.8 288.1 293.5 292.7 290.6 13.32 0.1077 0.1845 0.1890
Deficient Smartamine M 287.5 297.8 286.2 290.5 279.9 13.32 0.3063 0.3281 0.7427
Asn
Adequate MetaSmart 54.0 55.5 56.5 58.9 56.6 2.36 0.0567 0.2456 0.3437
Adequate Smartamine M 52.2 54.1 54.8 52.1 49.6 2.36 0.1281 0.0288 0.7731
Deficient MetaSmart 62.0 60.0 59.9 60.6 57.5 2.36 0.0580 0.7720 0.2078
Deficient Smartamine M 57.3 58.8 59.6 58.3 56.6 2.36 0.5768 0.0795 0.9913
Asp
Adequate MetaSmart 2.8 2.9 2.7 3.0 3.2 0.26 0.0983 0.2393 0.6914
Adequate Smartamine M 2.6 2.4 2.9 2.6 2.7 0.26 0.5001 0.6710 0.6977
Deficient MetaSmart 3.3 2.9 3.2 3.1 3.0 0.26 0.5184 0.8246 0.2936
Deficient Smartamine M 2.9 2.8 2.7 3.1 2.6 0.26 0.6092 0.5970 0.2033
Cit
Adequate MetaSmart 90.0 89.8 89.9 87.5 89.6 5.25 0.6655 0.7887 0.5620
Adequate Smartamine M 88.7 94.0 87.6 90.3 91.0 5.25 0.9095 0.9827 0.2043
Deficient MetaSmart 96.9 97.5 98.3 97.5 93.9 5.25 0.4046 0.2352 0.6738
Deficient Smartamine M 99.0 95.2 97.5 94.0 97.2 5.25 0.4979 0.3293 0.9307
Cys
Adequate MetaSmart 43.7 46.0 46.0 45.9 46.4 1.96 0.0484 0.2358 0.3118
Adequate Smartamine M 44.7 45.1 46.3 45.2 44.9 1.96 0.8306 0.2769 0.9757
Deficient MetaSmart 41.2 40.0 40.5 41.2 41.1 1.96 0.6790 0.4464 0.3258
Deficient Smartamine M 39.0 41.5 43.5 44.3 44.9 1.96 <0.0001 0.1061 0.9315
Smartamine M was included in the Met adequate diet in an amount sufficient to generate a 3.0:1 Lys/Met ratio in MP.











Table 3.13 cont’d. Plasma nonessential AA (NEAA) concentrations (pM) o f Holstein cows fed Met-adequate or Met-deficient diets 
supplemented with incremental amounts of Smartamine M or MetaSmart1.___________________________________________________
Methionine equivalents (g/d per 24 kg DMI) P =
Item 0 3 6 9 12 SE2 L Q C
Gin
Adequate MetaSmart 230.3 237.4 236.8 239.6 237.8 9.15 0.3609 0.5151 0.8658
Adequate Smartamine M 237.2 245.3 248.0 239.0 237.8 9.15 0.7956 0.1971 0.5051
Deficient MetaSmart 248.4 237.1 249.0 237.7 231.2 9.15 0.0717 0.5391 0.3219
Deficient Smartamine M 258.2 252.5 251.8 246.2 249.1 9.15 0.1913 0.5750 0.8502
Glu
Adequate MetaSmart 52.7 53.1 53.2 53.7 53.0 2.78 0.7787 0.7272 0.8236
Adequate Smartamine M 60.2 58.4 58.1 58.5 58.7 2.78 0.5055 0.3634 0.7073
Deficient MetaSmart 53.2 52.6 51.7 52.6 52.0 2.78 0.5519 0.7204 0.7869
Deficient Smartamine M 55.6 54.1 56.6 55.2 54.3 2.78 0.7365 0.6146 0.4258
Gly
Adequate MetaSmart 313.9 327.2 332.3 337.8 347.5 16.46 0.0042 0.8227 0.6470
Adequate Smartamine M 329.8 321.1 331.2 322.5 309.9 16.46 0.1753 0.4219 0.4213
Deficient MetaSmart 388.6 356.7 368.8 359.2 345.0 16.46 0.0018 0.6647 0.0703
Deficient Smartamine M 362.9 372.2 348.4 344.8 345.2 16.46 0.0200 0.9388 0.1654
Hcys
Adequate MetaSmart 4.0 4.2 4.3 4.1 4.2 0.72 0.5671 0.4766 0.6567
Adequate Smartamine M 4.7 5.3 5.0 4.8 4.8 0.72 0.6456 0.2675 0.1495
Deficient MetaSmart 5.3 5.7 5.6 5.0 5.4 0.72 0.4070 0.6109 0.0660
Deficient Smartamine M 6.5 6.1 6.2 6.3 6.1 0.72 0.3723 0.6540 0.2412
~T~.........       —-------------    — -        — ...... ........  ...................  .........................  .............. ....... .
Smartamine M was included in the Met adequate diet in an amount sufficient to generate a 3.0:1 Lys/Met ratio in MP. 












Table 3.13 cont’d. Plasma nonessential AA (NEAA) concentrations (fiM) o f Holstein cows fed Met-adequate or Met-deficient diets 
supplemented with incremental amounts o f Smartamine M or MetaSmart1.___________________________________________________
Item
Methionine equivalents (g/d per 24 kg DMI)
SE2
P =
0 3 6 9 12 L Q C
Om
Adequate MetaSmart 47.3 46.2 45.9 48.6 47.5 3.15 0.5570 0.6019 0.3313
Adequate Smartamine M 48.0 49.0 47.0 49.4 45.6 3.15 0.3670 0.3808 0.5224
Deficient MetaSmart 46.6 45.6 45.2 48.2 45.6 3.15 0.8714 0.9733 0.1871
Deficient Smartamine M 45.9 47.4 47.6 45.0 45.8 3.15 0.5716 0.4464 0.3067
Pro
Adequate MetaSmart 86.5 85.0 87.3 92.1 89.1 3.55 0.0561 0.9506 0.0706
Adequate Smartamine M 84.9 85.7 85.1 83.1 79.8 3.55 0.0596 0.2300 0.9776
Deficient MetaSmart 94.7 90.3 90.1 90.5 88.7 3.55 0.0663 0.4633 0.3180
Deficient Smartamine M 90.4 93.1 92.3 89.1 89.1 3.55 0.3117 0.3067 0.2980
Ser
Adequate MetaSmart 80.6 82.4 84.3 88.7 86.2 3.52 0.0046 0.4029 0.2608
Adequate Smartamine M 88.0 86.7 88.5 85.9 80.9 3.52 0.0215 0.1236 0.3909
Deficient MetaSmart 98.8 93.7 91.8 93.2 90.8 3.52 0.0074 0.2290 0.2540
Deficient Smartamine M 95.1 95.2 93.1 87.3 86.5 3.52 <0.0001 0.4559 0.2355
Tau
Adequate MetaSmart 48.4 50.3 52.6 49.4 52.3 2.54 0.1770 0.5365 0.2607
Adequate Smartamine M 54.4 53.4 56.3 53.7 59.4 2.54 0.0556 0.2073 0.4087
Deficient MetaSmart 42.6 44.2 44.8 43.4 44.0 2.54 0.6706 0.4989 0.5470
Deficient Smartamine M 43.7 45.2 46.7 47.3 52.2 2.54 0.0002 0.3117 0.3871
Tyr
Adequate MetaSmart 45.6 45.7 44.7 46.1 43.4 2.38 0.3715 0.5462 0.4800
Adequate Smartamine M 42.0 46.7 45.6 43.4 41.7 2.38 0.4117 0.0133 0.1801
Deficient MetaSmart 49.0 50.9 48.2 50.5 48.1 2.38 0.6108 0.5115 0.9755
Deficient Smartamine M 45.3 44.7 46.6 43.2 41.0 2.38 0.0254 0.1171 0.7566
1 Smartamine M was included in the Met adequate diet in an amount sufficient to generate a 3.0:1 Lys/Met ratio in MP.











Table 3.13 cont’d. Plasma nonessential AA (NEAA) concentrations (pM) of Holstein cows fed Met-adequate or Met-deficient diets 
supplemented with incremental amounts o f Smartamine M or MetaSmart1.___________________________________________________
Methionine equivalents (g/d per 24 kg DMI) P =
Item 0 3 6 9 12 SE2 L Q C
Total NEAA 
Adequate MetaSmart 1399.2 1419.1 1436.9 1467.2 1447.6 37.52 0.0604 0.4644 0.5338
Adequate Smartamine M 1429.6 1438.5 1457.6 1418.8 1391.2 37.52 0.2354 0.1734 0.9890
Deficient MetaSmart 1541.4 1465.2 1490.7 1475.3 1436.7 37.52 0.0103 0.7049 0.1051
Deficient Smartamine M 1489.3 1506.6 1478.6 1454.3 1450.2 37.52 0.0907 0.6662 0.3930
Total SAA3
Adequate MetaSmart 135.0 139.3 143.4 139.0 142.9 4.48 0.0655 0.3583 0.3108
Adequate Smartamine M 141.8 148.5 156.3 155.6 166.5 4.48 <0.0001 0.9978 0.2348
Deficient MetaSmart 110.2 112.2 112.8 113.4 114.4 4.48 0.2605 0.8418 0.8295
Deficient Smartamine M 109.2 117.5 124.4 130.3 137.5 4.48 <0.0001 0.7465 0.7502
Total AA
Adequate MetaSmart 2462.7 2443.9 2462.5 2501.8 2482.7 60.72 0.4524 0.8962 0.4618
Adequate Smartamine M 2386.1 2445.0 2459.8 2405.6 2348.9 60.72 0.4088 0.0668 0.7634
Deficient MetaSmart 2599.2 2567.1 2517.8 2555.9 2463.3 60.72 0.0311 0.8274 0.3834
Deficient Smartamine M 2513.1 2580.2 2552.9 2500.9 2460.5 60.72 0.1577 0.1212 0.4159
Smartamine M was included in the Met adequate diet in an amount sufficient to generate a 3.0:1 Lys/Met ratio in MP.
2 Largest standard error o f treatment means is shown.












Table 3.14. Plasma essential AA (EAA) (% total AA) o f Holstein cows fed Met-adequate or Met-deficient diets supplemented with
incremental amounts o f Smartamine M or MetaSmart1.
Methionine equivalents (g/d per 24 kg DMI) P =
Item 0 3 6 9 12 SE2 L Q C
Arg
Adequate MetaSmart 3.4 3.4 3.4 3.4 3.4 0.16 0.4441 0.5543 0.8018
Adequate Smartamine M 3.6 3.6 3.5 3.7 3.7 0.16 0.0834 0.1370 0.2633
Deficient MetaSmart 3.6 3.7 3.6 3.6 3.6 0.16 0.5702 0.4156 0.1534
Deficient Smartamine M 3.5 3.5 3.7 3.5 3.6 0.16 0.1836 0.1251 0.4639
His
Adequate MetaSmart 2.4 2.4 2.5 2.5 2.5 0.11 0.2280 0.2358 0.6800
Adequate Smartamine M 2.4 2.4 2.4 2.5 2.5 0.11 0.4319 0.9071 0.8464
Deficient MetaSmart 2.5 2.5 2.5 2.5 2.5 0.11 0.8162 0.5363 0.9537
Deficient Smartamine M 
He
Adequate MetaSmart
2.6 2.6 2.5 2.5 2.5 0.11 0.2782 0.1409 0.4539
5.4 5.1 5.1 5.0 5.0 0.21 0.0438 0.3646 0.6627
Adequate Smartamine M 4.5 4.7 4.5 4.5 4.4 0.21 0.3743 0.5758 0.7576
Deficient MetaSmart 4.8 5.3 4.9 5.1 5.0 0.21 0.5819 0.3428 0.2705
Deficient Smartamine M 4.9 5.1 5.1 5.0 4.8 0.21 0.7215 0.0361 0.9127
Leu
Adequate MetaSmart 6.5 6.2 6.0 6.0 6.1 0.27 0.0137 0.0397 0.8347
Adequate Smartamine M 5.6 5.8 5.5 5.6 5.5 0.27 0.4854 0.7057 0.5997
Deficient MetaSmart 5.9 6.5 6.0 6.3 6.1 0.27 0.5131 0.2404 0.2464
Deficient Smartamine M 6.0 6.1 6.2 6.1 5.8 0.27 0.2907 0.0547 0.6749
Lys
Adequate MetaSmart 3.9 3.8 3.9 3.9 3.9 0.13 0.8999 0.9521 0.7059
Adequate Smartamine M 3.9 3.9 3.9 4.0 3.9 0.13 0.9069 0.8197 0.4714
Deficient MetaSmart 3.6 3.8 3.7 3.7 3.7 0.13 0.6657 0.2359 0.5048
Deficient Smartamine M 3.6 3.7 3.9 3.8 3.8 0.13 0.0631 0.0305 0.5696
Smartamine M was included in the Met adequate diet in an amount sufficient to generate a 3.0:1 Lys/Met ratio in MP.











Table 3.14 cont’d. Plasma essential AA (EAA) (% total AA) o f Holstein cows fed Met-adequate or Met-deficient diets supplemented
with incremental amounts o f Smartamine M or MetaSmart1.
Methionine equivalents (g/d per 24 kg DMI)
SE2Item 0 3 6 9 12 L Q C
Met
Adequate MetaSmart 1.6 1.6 1.6 1.6 1.6 0.06 0.6715 0.6094 0.6454
Adequate Smartamine M 1.6 1.8 2.0 2.2 2.4 0.06 <0.0001 0.5466 0.1249
Deficient MetaSmart 0.8 0.9 0.9 0.9 1.0 0.06 0.0010 0.8727 0.6325
Deficient Smartamine M 0.8 1.0 1.1 1.3 1.4 0.06 <0.0001 0.5988 0.4069
Phe
Adequate MetaSmart 2.0 1.9 1.8 1.8 1.8 0.07 0.0106 0.1945 0.8635
Adequate Smartamine M 1.8 1.9 1.8 1.9 1.9 0.07 0.1467 0.9297 0.9341
Deficient MetaSmart 1.8 1.9 1.8 1.9 1.9 0.07 0.1986 0.6486 0.0873
Deficient Smartamine M 1.8 1.8 1.8 1.8 1.8 0.07 0.7134 0.5480 0.8512
Thr
Adequate MetaSmart 4.6 4.7 4.6 4.6 4.7 0.18 0.5169 0.9024 0.2317
Adequate Smartamine M 4.6 4.7 4.8 4.7 4.6 0.18 0.4475 0.0365 0.6954
Deficient MetaSmart 5.1 5.0 4.9 5.0 5.0 0.18 0.2384 0.2787 0.7457
Deficient Smartamine M 4.8 4.8 5.0 4.8 4.8 0.18 0.5734 0.1835 0.6117
Trp
Adequate MetaSmart 1.5 1.5 1.5 1.5 1.5 0.05 0.0400 0.2627 0.2060
Adequate Smartamine M 1.5 1.6 1.5 1.5 1.5 0.05 0.5144 0.3862 0.5230
Deficient MetaSmart 1.5 1.5 1.6 1.6 1.6 0.05 0.4164 0.7926 0.4658
Deficient Smartamine M 1.5 1.5 1.5 1.5 1.5 0.05 0.5822 0.3962 0.1816
Val
Adequate MetaSmart 12.0 11.4 11.3 11.2 11.3 0.46 0.0390 0.0731 0.6772
Adequate Smartamine M 10.4 10.9 10.6 10.5 10.3 0.46 0.5258 0.1733 0.4496
Deficient MetaSmart 11.0 11.8 10.9 11.6 11.3 0.46 0.6159 0.5000 0.2997
Deficient Smartamine M 11.2 11.5 11.3 11.3 11.0 0.46 0.5321 0.2604 0.8009
Smartamine M was included in the Met adequate diet in an amount sufficient to generate a 3.0:1 Lys/Met ratio in MP.












Table 3.14 cont’d. Plasma essential AA (EAA) (% total AA) o f Holstein cows fed Met-adequate or Met-deficient diets supplemented
with incremental amounts of Smartamine M or MetaSmart1.
Methionine equivalents (g/d per 24 kg DMI) P =
Item 0 3 6 9 12 SE2 L Q C
EAA
Adequate MetaSmart 43.2 42.0 41.7 41.3 41.6 1.04 0.0309 0.1416 0.8603
Adequate Smartamine M 40.0 41.2 40.5 41.0 40.7 1.04 0.5223 0.3825 0.5680
Deficient MetaSmart 40.7 42.8 40.7 42.1 41.6 1.04 0.5034 0.4103 0.2021
Deficient Smartamine M 40.6 41.4 41.9 41.7 40.9 1.04 0.5986 0.0555 0.9123
BCAA3
Adequate MetaSmart 23.9 22.6 22.3 22.2 22.4 0.90 0.0245 0.0879 0.7037
Adequate Smartamine M 20.5 21.4 20.6 20.7 20.2 0.90 0.4580 0.3564 0.5449
Deficient MetaSmart 21.7 23.5 21.8 23.0 22.5 0.90 0.5700 0.3609 0.2606
Deficient Smartamine M 22.0 22.6 22.6 22.4 21.6 0.90 0.4788 0.0981 0.9821
Met+Cys
Adequate MetaSmart 3.4 3.5 3.5 3.4 3.5 0.10 0.1943 0.2016 0.1527
Adequate Smartamine M 3.5 3.7 3.9 4.0 4.3 0.10 <0.0001 0.4400 0.3926
Deficient MetaSmart 2.4 2.4 2.5 2.5 2.6 0.10 0.0001 0.4845 0.8727
Deficient Smartamine M
l o ____• »- ■ . . .
2.4 2.6 2.8 3.1 3.2 0.10 <0.0001 0.6077 0.3507
Smartamine M was included in the Met adequate diet in an amount sufficient to generate a 3.0:1 Lys/Met ratio in MP.
2 Largest standard error o f treatment means is shown.











Table 3.15. Plasma nonessential AA (NEAA) (% total AA) of Holstein cows fed Met-adequate or Met-deficient diets supplemented
with incremental amounts of Smartamine M or MetaSmart1.
Item
Methionine equivalents (g/d per 24 kg DMI)
SE2
P =
0 3 6 9 12 L Q C
Ala
Adequate MetaSmart 12.2 12.0 12.2 12.5 11.7 0.48 0.6373 0.2330 0.0880
Adequate Smartamine M 12.3 11.9 12.2 12.0 12.1 0.48 0.8181 0.5362 0.6805
Deficient MetaSmart 12.0 11.3 11.7 11.5 11.9 0.48 0.9677 0.0979 0.4672
Deficient Smartamine M 11.5 11.6 11.3 11.7 11.4 0.48 0.9875 0.9894 0.7979
Asn
Adequate MetaSmart 2.2 2.3 2.3 2.4 2.3 0.06 0.0134 0.0346 0.3366
Adequate Smartamine M 2.2 2.2 2.2 2.2 2.1 0.06 0.0662 0.0469 0.9364
Deficient MetaSmart 2.4 2.3 2.4 2.4 2.3 0.06 0.4767 0.7947 0.2821
Deficient Smartamine M 2.3 2.3 2.3 2.3 2.3 0.06 0.4418 0.2492 0.3131
Asp
Adequate MetaSmart 0.1 0.1 0.1 0.1 0.1 0.01 0.1682 0.3920 0.4896
Adequate Smartamine M 0.1 0.1 0.1 0.1 0.1 0.01 0.3908 0.8538 0.7196
Deficient MetaSmart 0.1 0.1 0.1 0.1 0.1 0.01 0.9265 0.8152 0.4612
Deficient Smartamine M 0.1 0.1 0.1 0.1 0.1 0.01 1.0000 0.7553 0.1682
Cit
Adequate MetaSmart 3.7 3.7 3.6 3.5 3.6 0.20 0.4073 0.8531 0.2846
Adequate Smartamine M 3.7 3.8 3.6 3.8 3.9 0.20 0.4188 0.1625 0.2071
Deficient MetaSmart 3.7 3.8 3.9 3.8 3.8 0.20 0.5444 0.2337 0.7101
Deficient Smartamine M 4.0 3.7 3.9 3.8 4.0 0.20 0.7483 0.0305 0.8326
Cys
Adequate MetaSmart 1.8 1.9 1.9 1.8 1.9 0.07 0.1146 0.1542 0.0720
Adequate Smartamine M 1.9 1.8 1.9 1.9 1.9 0.07 0.1922 0.5897 0.6294
Deficient MetaSmart 1.6 1.6 1.6 1.6 1.7 0.07 0.0176 0.3202 0.8054
Deficient Smartamine M 1.6 1.6 1.7 1.8 1.8 0.07 <0.0001 0.8139 0.5704
Smartamine M was included in the Met adequate diet in an amount sufficient to generate a 3.0:1 Lys/Met ratio in MP.












Table 3.15 cont’d. Plasma nonessential AA (NEAA) (% total AA) o f Holstein cows fed Met-adequate or Met-deficient diets 
supplemented with incremental amounts o f Smartamine M or MetaSmart1.___________________________________________________
Methionine equivalents (g/d per 24 kg DMI)
SE2
P =
Item 0 3 6 9 12 L Q C
Gin
Adequate MetaSmart 9.4 9.7 9.6 9.6 9.6 0.38 0.6262 0.4904 0.4883
Adequate Smartamine M 10.0 10.0 10.3 10.0 10.2 0.38 0.6281 0.8653 0.6725
Deficient MetaSmart 9.6 9.3 10.0 9.3 9.4 0.38 0.6994 0.4911 0.7692
Deficient Smartamine M 10.3 9.8 9.9 9.9 10.2 0.38 0.7492 0.0887 0.7210
Glu
Adequate MetaSmart 2.2 2.2 2.2 2.2 2.1 0.12 0.6776 0.6622 0.7445
Adequate Smartamine M 2.6 2.4 2.4 2.5 2.5 0.12 0.9322 0.0193 0.4732
Deficient MetaSmart 2.1 2.1 2.1 2.1 2.1 0.12 0.4933 0.6970 0.9061
Deficient Smartamine M 2.2 2.1 2.2 2.2 2.2 0.12 0.6410 0.6316 0.2156
Gly
Adequate MetaSmart 12.7 13.4 13.5 13.5 14.0 0.61 0.0022 0.7174 0.2505
Adequate Smartamine M 13.8 13.1 13.6 13.4 13.2 0.61 0.2446 0.6782 0.2335
Deficient MetaSmart 15.0 13.9 14.7 14.2 14.0 0.61 0.0621 0.5614 0.1236
Deficient Smartamine M 14.5 14.5 13.7 13.8 14.0 0.61 0.0758 0.1787 0.3311
Hcys
Adequate MetaSmart 0.2 0.2 0.2 0.2 0.2 0.03 0.7246 0.3724 0.5645
Adequate Smartamine M 0.2 0.2 0.2 0.2 0.2 0.03 0.9645 0.4546 0.1660
Deficient MetaSmart 0.2 0.2 0.2 0.2 0.2 0.03 0.8981 0.6262 0.0309
Deficient Smartamine M
..1 ........... ......V..T
0.3 0.2 0.3 0.3 0.3 0.03 0.6772 0.4020 0.2129
Smartamine M was included in the Met adequate diet in an amount sufficient to generate a 3.0:1 Lys/Met ratio in MP. 











Table 3.15 cont’d. Plasma nonessential AA (NEAA) (% total AA) o f Holstein cows fed Met-adequate or Met-deficient diets 
supplemented with incremental amounts o f Smartamine M or MetaSmart1._____________________________________________________
Item
Methionine equivalents (g/d per 24 kg DMI)
SE2
P =
0 3 6 9 12 L Q C
Om
Adequate MetaSmart 1.9 1.9 1.9 1.9 1.9 0.11 0.7196 0.5276 0.4964
Adequate Smartamine M 2.0 2.0 1.9 2.1 1.9 0.11 0.4114 0.9232 0.2446
Deficient MetaSmart 1.8 1.8 1.8 1.9 1.8 0.11 0.1344 0.8348 0.2129
Deficient Smartamine M 1.8 1.8 1.9 1.8 1.9 0.11 0.8575 0.8102 0.4917
Pro
Adequate MetaSmart 3.5 3.5 3.5 3.7 3.6 0.10 0.0140 0.7888 0.0210
Adequate Smartamine M 3.5 3.5 3.4 3.4 3.4 0.10 0.0148 0.8448 0.7120
Deficient MetaSmart 3.6 3.5 3.6 3.5 3.6 0.10 0.5781 0.1277 0.5173
Deficient Smartamine M 3.6 3.6 3.6 3.6 3.6 0.10 0.8991 0.7299 0.4225
Ser
Adequate MetaSmart 3.3 3.4 3.4 3.5 3.5 0.12 0.1391 0.3068 0.4338
Adequate Smartamine M 3.7 3.6 3.6 3.6 3.5 0.12 0.0067 0.7647 0.0799
Deficient MetaSmart 3.8 3.7 3.7 3.7 3.7 0.12 0.1529 0.0528 0.4263
Deficient Smartamine M 3.8 3.7 3.7 3.5 3.5 0.12 <0.0001 0.5428 0.3701
Tau
Adequate MetaSmart 2.0 2.1 2.2 2.0 2.1 0.10 0.3108 0.5393 0.0841
Adequate Smartamine M 2.3 2.2 2.3 2.2 2.5 0.10 0.0039 0.0136 0.4047
Deficient MetaSmart 1.6 1.7 1.8 1.7 1.8 0.10 0.1404 0.5013 0.3902
Deficient Smartamine M 1.7 1.8 1.8 1.9 2.1 0.10 <0.0001 0.0442 0.5749
Tyr
Adequate MetaSmart 1.9 1.9 1.8 1.9 1.8 0.09 0.0613 0.3507 0.6974
Adequate Smartamine M 1.8 1.9 1.8 . 1.8 1.8 0.09 0.5598 0.0428 0.1099
Deficient MetaSmart 1.9 2.0 1.9 2.0 2.0 0.09 0.3852 0.5195 0.5320
Deficient Smartamine M 1.8 1.7 1.8 1.7 1.7 0.09 0.0396 0.2686 0.3186
Smartamine M was included in the Met adequate diet in an amount sufficient to generate a 3.0:1 Lys/Met ratio in MP.











Table 3.15 cont’d. Plasma nonessential AA (NEAA) (% total AA) o f Holstein cows fed Met-adequate or Met-deficient diets 
supplemented with incremental amounts of Smartamine M or MetaSmart1.__________________________________________________
Methionine equivalents (g/d per 24 kg DMI) P =
Item 0 3 6 9 12 SE2 L Q C
Total NEAA
Adequate MetaSmart 56.8 58.0 58.4 58.7 58.4 1.04 0.0309 0.1416 0.8603
Adequate Smartamine M 60.0 58.8 59.5 59.0 59.3 1.04 0.5223 0.3825 0.5680
Deficient MetaSmart 59.3 57.2 59.4 57.9 58.4 1.04 0.5034 0.4103 0.2021
Deficient Smartamine M 59.4 58.6 58.1 58.3 59.1 1.04 0.5986 0.0555 0.9123
Total SAA3
Adequate MetaSmart 5.5 5.7 5.8 5.6 5.8 0.13 0.1141 0.1901 0.0253
Adequate Smartamine M 5.9 6.1 6.4 6.5 7.1 0.13 <0.0001 0.0254 0.1974
Deficient MetaSmart 4.2 4.4 4.5 4.4 4.6 0.13 0.0006 0.8914 0.3058
Deficient Smartamine M. .. 4.3 4.6 4.9 5.2 5.6 0.13 <0.0001 0.1890 0.7650
Smartamine M was included in the Met adequate diet in an amount sufficient to generate a 3.0:1 Lys/Met ratio in MP.
2 Largest standard error o f treatment means is shown.












Table 3.16. Met “bioavailability” o f Met-adequate and Met-deficient MetaSmart relative to that of Met-adequate and Met-deficient 
Smartamine M, respectively, using changes in milk protein concentration (Figure 3.1), plasma Met concentration (pM) (Figure 3.2), 
plasma Met (% total AA) (Figure 3.3), plasma Met+Cys concentration (pM) (Figure 3.4), plasma Met+Cys (% total AA) (Figure 3.5), 




























Plasma Met, pM 
Slope
95% confidence interval 
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Plasma Met, % total AA 
Slope




0.0587 -  0.0744 
0.011
0.00164 
-0.0081 -0 .0113 
0.006
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0.0477 -  0.0550 
0.003
0.01243 
0.0041 -0 .0207  
0.003 
24.1 ± 16.2
Plasma Met+Cys, pM 
Slope




1.5541 -  1.5734 
0.469
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Plasma Met+Cys, % total AA 
Slope
















Plasma total sulfur AA, pM 
Slope















Plasma total sulfur AA, % total AA
Slope 0.09033 0.01314 0.10513 0.02893
95% confidence interval 0 .0810-0.0995 0 .0034-0.0228 0.0987-0.1115 0.0196-0.0383
SE 0.022 0.016 0.013 0.015
(MetaSmart/Smartamine M)5 - - - 27.5 + 8.91 " ■ ■    1 " "  ,, ■— —  . ....  —— -------------------- —
Results based on n = 45 observations (9 observations per Met supplementation level).
2 Results based on n = 50 observations (10 observations per Met supplementation level).
3 Linear contrast of treatment means significant at P  < 0.05 for incremental amounts Adequate Smartamine M, Adequate MetaSmart, 
Deficient Smartamine M or Deficient MetaSmart.
4 Linear contrast o f treatment means non-significant at P < 0.05 for incremental amounts Adequate Smartamine M, Adequate 
MetaSmart, Deficient Smartamine M or Deficient MetaSmart.
5 Calculated as slope o f Adequate or Deficient MetaSmart divided by the slope o f Adequate or Deficient Smartamine M, respectively, 
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Y = 2.8846 + 0.0083x; R2 = 0.0030; SE = 0.2332; n = 50. Y = 2.919 + 0.0063x; R2 = 0.0036; SE = 0.1751; n = 50.
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Figure 3.1. Effects of feeding incremental amounts of MetaSmart or Smartamine M to cows receiving Met-adequate or Met-deficient diets on milk
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Y = 39.076 + 1.531 lx ;R 2 = 0.2980; SE = 9.8229; n = 45.
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Y = 20.637 + 1.21x; R2 = 0.7563; SE = 2.9339; n = 50.
12
Figure 3.2. Effect of feeding incremental amounts of MetaSmart or Smartamine M to cows receiving Met-adequate or Met-deficient diets
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Y = 1.5929 + 0.0666x; R2 = 0.4590; SE = 0.306; n = 45.













Y = 0.8164 + 0.0124x; R2 = 0.2594; SE = 0.0871; n = 50.
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Y = 0.8006 + 0.0514x; R2 = 0.8565; SE = 0.09; n = 50.
Figure 3.3. Effect of feeding incremental amounts of MetaSmart or Smartamine M to cows receiving Met-adequate or Met-deficient diets on
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Y = 61.822 + 0.2636x; R = -0.0022; SE = 8.3764; n = 50.
Y = 84.456 + 1.5637x; R2 = 0.1870; SE = 13.346; n = 45.
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Figure 3.4. Effect of feeding incremental amounts of MetaSmart or Smartamine M to cows receiving Met-adequate or Met-deficient diets on
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Y = 2.3778 + 0.0199x; R2 = 0.0726; SE = 0.2719; n = 50.
Y = 3.458 + 0.071x; R = 0.3818; SE = 0.3809; n  =  45. 
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Met equivalents, g/d 
Y = 2.3536 + 0.0745x; R2 = 0.6464; SE = 0.2348; n = 50.
Figure 3.5. Effect of feeding incremental amounts of MetaSmart or Smartamine M to cows receiving Met-adequate or Met-deficient diets on
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Y = 109.93 + 2.3112x; R2 = 0.3126; SE = 14.369; n = 50.
12
Figure 3.6. Effect of feeding incremental amounts of MetaSmart or Smartamine M to cows receiving Met-adequate or Met-deficient diets on










































Y = 5.8862 + 0.0903x; R2 = 0.2593; SE = 0.6343; n = 45.
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Figure 3.7. Effect of feeding incremental amounts of MetaSmart or Smartamine M to cows receiving Met-adequate or Met-deficient diets on
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CHAPTER IV
A COMPARISON OF THE RELATIONSHIPS BETWEEN PREDICTED 
SUPPLIES OF METABOLIZABLE PROTEIN (MP), MP-METHIONINE, AND 
MP-LYSINE AS PREDICTED BY NRC (2001) AND ACTUAL YIELD OF MILK
AND MILK PROTEIN
ABSTRACT
In the year 2002, dairy producers and nutritionists observed a severe decline in the 
price of milk. As a result, interest in reducing the cost of rations peaked and the addition 
of expensive protein supplements in dairy rations such as, blood meal and supplemental 
Met sources was questioned. In response to this situation, Schwab et al. (2003) attempted 
to generate prediction equations for determining expected responses in milk and milk 
protein yield with different levels o f metabolizable protein (MP), MP-Met, and MP-Lys. 
The goals o f this study were to extend the preliminary work o f Schwab et al. (2003; 
2004) of predicting milk and milk protein yield from metabolizable protein, Lys and Met 
and to determine whether using the first limiting amino acid for milk protein production 
is more accurate than using metabolizable protein to predict milk and milk protein yield. 
Predicted supplies o f MP-Met and MP-Lys than MP, results from 464 diets published in 
the Journal o f  Dairy Science were entered into the NRC (2001) model and results from 
the Summary and Duodenal Amino Acid Supply Reports were used to generate plots of
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measured milk and milk protein yield vs. predicted supplies of MP, MP-Met, and MP- 
Lys (g/d). Several restrictions on the dataset for generating plots of measured milk and 
milk protein yield vs. predicted supplies o f MP, MP-Met, and MP-Lys (g/d) were 
imposed based on NRC (2001) dietary predictions. They were: 1) MP-balance ranged 
from -300 to 100 g/d, 2) RDP balance had to be greater than -200 g/d, 3) Lys as a percent 
of MP had to be less than 7.2% and Met as a percent o f MP had to be less than 2.4%, 4) 
for plots based on MP-Met flows, diets had to have a Lys to Met ratio o f greater than or 
equal to 3.0:1, and 5) for plots based on MP-Lys flows, diets had to have a Lys to Met 
ratio of less than or equal to 3.0:1. The following regression equations describe the 
relationship between measured milk yield and MP, MP-Met and MP-Lys supplies, 
respectively: MP (n = 153): y = -1.9003 + 0.0164x, R2 = 0.81, SE = 3.04; MP-Met (n = 
141): y = 2.3205 + 0.7551x, R2 = 0.69, SE = 3.82; MP-Lys (n -  16): y = 3.3641 + 
0.2146x, R2 = 0.95, SE = 1.86 and between milk protein yield and MP, MP-Met and MP- 
Lys, respectively: MP (n =153): y = -137.61 + 0.5183x, R2 = 0.89, SE = 69.09; MP-Met 
(n = 141): y = -12.299 + 24.027x, R2 = 0.77, SE = 98.87; MP-Lys (n = 16): y = 91.461 + 
6.564x, R2 = 0.94, SE = 62.78, respectively. This study demonstrated that prediction 
equations based on NRC (2001) predicted flows o f MP-Lys may be more accurate at 
predicting milk and milk protein yield than MP or MP-Met flows when Lys is either the 
first limiting AA or co-limiting with Met. In addition, predicting milk protein yield from 
flows of MP, MP-Met and MP-Lys is more accurate than predicting milk yield.
(Key words: methionine, lysine, metabolizable protein)
Abbreviation key: EAA = essential amino acid, MP = metabolizable protein.
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INTRODUCTION
In the year 2002, dairy producers and nutritionists observed a severe decline in the 
price o f milk. As a result, interest in reducing the cost o f rations peaked and the addition 
of expensive protein supplements in dairy rations such as, blood meal, protected soy 
products, and protected Met products was questioned. In response to this situation, 
Schwab et al. (2003) attempted to generate prediction equations for determining expected 
responses in milk and milk protein yield with different levels o f MP, MP-Met, and MP- 
Lys. The goals were to determine whether prediction equations could be developed to 
predict milk and milk protein yield from NRC (2001) predicted flows of MP, MP-Met, 
and MP-Lys and to determine which parameter (i.e., MP, MP-Met, or MP-Lys) was the 
best predictor o f milk and milk protein yield. If equations could be developed, 
nutritionists could utilize them to determine a rough estimation o f the expected economic 
return from increased milk and milk protein yield in response to adding additional 
amounts of MP, MP-Met or MP-Lys to their rations. This would help them to determine 
whether it was more beneficial to continue to keep expensive protein supplements such 
as, blood meal, protected soy products, and protected Met products in their rations, 
reduce their inclusion rates, or remove them completely and replace them with lower 
cost, lower quality feeds.
The NRC (2001) predicts passage o f MP to the small intestine and the content of 
essential AA (EAA) in MP. From these values, flows o f MP-AA are calculated. The 
model predicts milk yield from predicted flows of MP; however, it does not predict milk 
protein yield. Schwab et al. (2003) entered the diet composition and production data of
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published studies into NRC (2001) and then used the results to generate prediction 
equations. In a subsequent effort, Schwab et al. (2004) utilized the same dataset but 
made further refinements. The prediction equations developed by Schwab et al. (2004) 
were derived by regressing milk or milk protein yield on NRC (2001) predicted flows of 
MP, MP-Lys and MP-Met, Their results indicated that flows of MP-Lys were the most 
accurate at predicting milk and milk protein yield followed by MP-Met and MP; 
however, the dataset was restricted to include only 28 of the original 321 diets when 
using flows of MP-Lys as a predictor. Regardless, the study was a first step in 
determining prediction equations for milk and milk protein yield in response to changes 
in supplies of MP, MP-Lys and MP-Met.
Doepel et al. (2004) conducted a similar but more technical approach using a 
more refined dataset than that used by Schwab et al. (2004). The first goal of the study 
was to generate prediction equations for milk protein yield and changes in milk protein 
yield in response to changes in intestinal AA supply. The second goal was to test the 
hypothesis that the efficiency o f conversion o f digestible AA into milk protein is not 
constant as is assumed by current models such as NRC (2001) and CNCPS (2000). The 
authors were unable to detect a significant relationship between the extent and direction 
of the change in milk protein yield and changes in total AA supply. As a result, 
regression equations predicting changes in milk protein yield in response to 
supplementary AA were not developed. The authors demonstrated that the efficiency of 
conversion of digestible AA into milk protein is variable and not constant as is assumed 
by NRC (2001) and CNCPS (2000).
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The goals of this study were to extend the preliminary work of Schwab et al. 
(2003) and Schwab et al. (2004) o f predicting milk and milk protein yield from MP, MP- 
Met, and MP-Lys and to determine whether using the first limiting/co-limiting amino 
acid for milk protein production is more accurate than using metabolizable protein to 
predict milk and milk protein yield. It must be noted that the prediction equations 
developed in this study were not intended to be incorporated into models such as the 
NRC (2001) and only represent a more refined approach of the work conducted by 
Schwab et al. (2003) and Schwab et al. (2004). This study represents only a preliminary 
attempt at utilizing published research studies to determine the association between 
predicted MP, MP-Met, and MP-Lys flows and milk and milk protein yields.
MATERIALS AND METHODS 
Source of Data and Criteria Used in Analyses
Data used in the analyses o f this study were derived from studies published only 
in the Journal o f  Dairy Science. A total of 464 experimental diets from 105 experiments 
in 83 published studies comprised the dataset. Several studies consisted of multiple 
experiments, however, each diet from each respective experiment was considered to be a 
separate data point.
The development o f the prediction equations was based on entering the results of 
published studies into the NRC (2001) model and using the predicted dietary flows of 
MP, Met and Lys. As a result, several restrictions were imposed on the dataset prior to 
entry into the NRC (2001) model in an effort to reduce grossly inaccurate predictions by
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the NRC (2001) model in relation to requirements. Restrictions included differences 
related to breed o f cow, forage types and studies in which the physiological behavior of 
supplementary AA products being tested were not thoroughly understood or documented. 
The restrictions imposed were: 1) only studies in which Holstein cows were used were 
included, 2) only studies in which chemical compositions o f all forages used in the study 
were provided; however, if  the nutrient compositions for feeds other than forages were 
provided, then these values were used, otherwise NRC (2001) default values were used 
and 3) studies in which protected AA products were fed were included only if the RPAA 
products were Smartamine M or Smartamine ML (as the efficacy of the protective 
coating technology and the bioavailability values o f these products have been well 
documented (Rulquin and Kowalczyk, 2003; Schwab, 2003). For studies using 
Smartamine M and Smartamine ML, it was assumed that Smartamine M contained 75% 
Met and that Smartamine ML contained 40% Lys (accounts for 20% HCL content) and 
15% Met. It was also assumed that 80% of the Lys and Met in each respective product 
was bioavailable. Studies in which AA were infused were included in the dataset if  the 
aforementioned criteria were met. It was assumed that 100% of the infused AA were 
bioavailable.
All animal information reported in the published studies, such as BW, BCS, DIM, 
and lactation number was used when entering the diets into the NRC (2001) model. 
However, 25 diets from 5 experiments in 4 studies did not report BW; therefore, the 
default value o f 650 kg from NRC (2001) was used. O f the 105 experiments used, 68 
used multiparous cows, 2 used primiparous cows, 27 used both multiparous and 
primiparous, and 8 experiments did not provide parity information. As a result, default
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parity values in NRC (2001) of fourth lactation cows 65 months old were used. Sixty 
experiments began in early lactation (<70 DIM), 40 began in midlactation (70 to 203 
DIM) and 5 began in late lactation (>203 DIM).
Statistical Analysis
The Proc Reg procedure of SAS [Version 8.2 (2001); (SAS Institute, Inc., Cary, 
NC)] was used to examine the relationship between measured milk and milk protein yield 
and NRC (2001) predicted flows of MP, MP-Met and MP-Lys. Initially, the results of 
464 NRC (2001) diet evaluations were included in the regression analysis. However, 
restrictions were imposed in an effort to eliminate studies from the dataset which the 
model predicted values of MP balance (g/d), RDP balance (g/d), and Lys and Met as a 
percent of MP which deviated widely from predicted requirements. The imposed 
restrictions were: 1) an MP-balance of the diets had to range from -300 to 100 g/d, 2) an 
RDP balance of the diets had to be greater than -200 g/d, 3) Lys as a percent of MP had 
to be less than 7.2% and Met as a percent of MP had to be less than 2.4%, 4) for plots 
based on MP-Met flows, diets had to have a Lys to Met ratio o f greater than or equal to 
3.0:1, and 5) for plots based on MP-Lys flows, diets had to have a Lys to Met ratio of less 
than or equal to 3.0:1. Four diets which contained Lys to Met ratios o f exactly 3.0:1 were 
included in plots based on flows of MP-Met and MP-Lys because a ratio o f 3.0:1 was 
considered to be co-limiting in both Lys and Met.
Restricting the dataset to include diets with a predicted MP balance o f no greater 
than 100 g/d was done to exclude diets in which AA supply, including Lys or Met, may 
have exceeded requirements. The restriction to include diets with a predicted MP balance
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of no less than -300 g/d was done to exclude diets, which were excessively limited in 
protein and could have led to excessive protein mobilization. Restricting the dataset to 
include diets with a predicted RDP balance of no less than -200 g/d was done to ensure 
that the nitrogen requirements of the microorganisms in the rumen were met. Restricting 
the dataset to include only diets which contained predicted Lys and Met concentrations in 
MP of less than 7.2 and 2.4%, respectively, was done to keep within the boundaries of the 
optimal maximum requirements for Lys and Met as predicted by NRC (2001).
RESULTS AND DISCUSSION
This study was designed to extend the preliminary work of Schwab et al. (2003; 
2004) of predicting milk and milk protein yields from predicted flows of MP, MP-Met, 
and MP-Lys and to determine whether using the first limiting amino acid for milk protein 
production is more accurate than using MP to predict milk and milk protein yield.
The restrictions placed on the dataset were designed to remove diets which 
deviated widely from NRC (2001) predicted requirements. The restrictions were 
developed to allow for some inaccuracy in the NRC (2001) model’s ability to predict 
flows o f MP, yield of RDP, and content of AA in MP. However, there was a significant 
amount o f confidence placed on the NRC (2001) model to accurately predict the results 
of the experimental diets. This is why the boundaries used for flows o f MP, yield of 
RDP, and content o f AA in MP are limited to what were believed to be normal ranges 
beyond which point the experimental diets used were considered to produce abnormal 
results.
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To examine the impact each restriction had on the overall dataset, each restriction 
was removed one at a time while leaving the other restrictions in place and the overall 
number of diets added back into the resulting regression plots was observed. With all of 
the restrictions imposed, the resulting regression plots based on NRC (2001) predicted 
flows of MP contained 153 data points (Figure 4.1). When the restriction that the balance 
of MP had to be greater than -300 g/d as predicted by NRC (2001) was removed, only 20 
diets were added back into the resulting plots and the R2 and standard error were 
decreased from 0.81 and 3.04 to 0.76 and 3.28, respectively, for milk yield and from 0.89 
and 69.09 to 0.84 and 83.27, respectively, for milk protein yield. This indicated that only 
20 diets had an MP balance o f less than -300 g/d. When the MP balance restriction of 
100 g/d was removed from the model, 201 diets were added back into the regression plots 
and the R2 and standard error were decreased from 0.81 and 3.04 to 0.38 and 5.25, 
respectively, for milk yield and from 0.89 and 69.09 to 0.48 and 142.08, respectively, for 
milk protein yield. When the RDP balance restriction o f -200 g/d was removed only 27 
diets were added back into the regression plots and the R and standard error remained 
similar at 0.81 and 3.04 vs. 0.81 and 3.18, respectively, for milk yield and 0.89 and 69.09 
vs. 0.90 and 69.90, respectively, for milk protein yield. When the restriction that Lys and 
Met concentrations in MP could not be greater than 7.2 and 2.4%, respectively, was 
removed from the dataset, only 12 studies were added back into the resulting regression 
plots and the R2 and standard error remained similar at 0.81 and 3.04 vs. 0.83 and 3.01, 
respectively, for milk yield and 0.89 and 69.09 vs. 0.90 and 67.18, respectively, for milk 
protein yield. For plots based on MP-Lys and MP-Met, the additional restrictions that the 
Lys to Met ratio in MP had to be less than or equal to 3.0:1 for MP-Lys and had to be
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greater than or equal to 3.0:1 for MP-Met were added. When these restrictions were 
loosened to include a Lys to Met ratio of less than or equal to 3.1:1 for MP-Lys and 
greater than or equal to 3.1:1 for MP-Met, 5 diets were added back into the MP-Lys plots 
and 11 diets were removed from the MP-Met plots. Interestingly, the Revalues for the 
regression plots o f  milk protein yield vs. predicted MP-Lys flows decreased slightly 
when the Lys to Met ratio was increased from being less than or equal to 3.0:1 to less 
than or equal to 3.1:1 (0.94, SE = 62.78 vs. 0.93, SE 64.16). It appears that the NRC 
(2001) suggestion o f the optimum Lys to Met ratio of 3.0:1 for maximizing milk protein 
synthesis is sensitive to increases in the ratio as small as moving from 3.0:1 to 3.1:1.
Schwab et al. (2004) entered the diet composition and production data of 
published studies into NRC (2001) and then used the results to develop prediction 
equations. The prediction equations were derived by regressing milk or milk protein 
yield on NRC (2001) predicted flows of MP, MP-Lys and MP-Met. The dataset based on 
supplies of MP was restricted so that predicted NEL-allowable milk was greater than MP- 
allowable milk to ensure that energy was not limiting the responses in milk or milk 
protein yield. Another restriction imposed was that actual milk minus MP-allowable 
milk had to be within ± 6 kg/d of MP-allowable milk to help eliminate studies in which 
factors other than MP or energy limited lactation performance or where excessive protein 
mobilization may have been occurring. The dataset based on supplies of MP-Lys and 
MP-Met was restricted so that MP balance was between -250  and +100 g/d. A further 
restriction was imposed so that the Lys to Met ratio in MP was less than 3.25:1 for the 
dataset based on supplies o f MP-Lys and greater than 3.0:1 for the dataset based on 
supplies of MP-Met. Their results indicated that flows o f MP-Lys were the most accurate
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at predicting milk and milk protein yield followed by MP-Met and MP. However, these 
diets may not have been limiting in MP-Lys. The restriction used for ensuring that the 
diets were limiting in MP-Lys was <3.25:1, which brings into question whether the diets 
were in fact Lys-deficient.
Doepel et al. (2004) conducted a more detailed and technical study using only 
published infusion studies with the goal of generating prediction equations for milk 
protein yield and changes in milk protein yield in response to changes in intestinal AA 
supply. Another goal o f their study was to test the hypothesis that the efficiency of 
conversion of digestible AA into milk protein is not constant as is assumed by current 
models such as NRC (2001) and CNCPS (2000). The authors were unable to detect a 
significant relationship between the extent and direction o f the change in milk protein 
yield and changes in total AA supply. As a result, regression equations predicting 
changes in milk protein yield in response to supplementary AA were not developed. 
However, they were able to demonstrate that the conversion o f digestible AA into milk 
protein is not constant as is assumed by NRC (2001) and CNCPS (2000), but instead is 
variable. They concluded that by using variable efficiency coefficients, the ability to 
predict milk protein yield in response to additional supplemental protein would be 
improved.
Prediction Equations for Milk Yields and Milk Protein Yields
The plots derived by regressing milk and milk protein yield on MP, MP-Met and 
MP-Lys are presented in Figures 4.1-4.3, respectively. This study demonstrated that MP, 
MP-Met, and MP-Lys flows as predicted by NRC (2001) can be used to predict milk and
164
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
milk protein yield. In addition, this study demonstrated that MP-Lys was the most 
accurate predictor of milk and milk protein yield and milk protein yield is more 
accurately predicted by MP, MP-Met and MP-Lys than milk yield.
One o f the most striking results o f this study is the lack of diets which are 
deficient in MP-Lys as predicted by NRC (2001). A similar finding was observed by 
Schwab et al. (2004) where only 28 diets were included in the regression plots for milk 
and milk protein yield vs. MP-Lys (Figure 4.4). In that study, the Lys to Met ratio for 
diets considered deficient in Lys was even extended to 3.25:1. However, the resulting 
R -values of 0.90 and 0.92 indicate a strong association between milk and milk protein 
yield and MP-Lys flows when cows are fed Lys-deficient diets. In the current study, 
there was an even stronger association observed as indicated by Revalues of 0.95 and
0.94 for milk and milk protein yield, respectively. The standard error was also lower for 
plots based on MP-Lys compared to MP or MP-Met for both milk and milk protein yield 
(1.86 vs. 3.036 and 3.82, respectively, and 62.78 vs. 69.09 and 98.87, respectively; 
Figures 4.1-4.3). This result would not be totally unexpected considering Lys is 
predominantly used for protein synthesis (Chung and Baker, 1992) as opposed to Met, 
which has a myriad of physiological functions. Because of the lack of diets which are 
deficient in Lys, it is difficult to determine the extent, if  any, o f adding more Lys- 
deficient diets to the dataset would improve the accuracy of predicting milk and milk 
protein yield based on MP-Lys flows. Regardless, as indicated by the results o f this 
study and the results o f Schwab et al. (2004), using MP-Lys flows is the best predictor o f 
milk and milk protein yield compared to MP and MP-Met flows when Lys is first 
limiting or co-limiting with Met.
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As previously mentioned, Doepel et al. (2004) observed that the efficiency of 
conversion of digestible AA into milk protein is variable and not constant as is assumed 
by models such as NRC (2001) and CNCPS (2000). It is important to note that the 
prediction equations developed in this study were not intended to be incorporated into the 
NRC (2001) model and only represent a more refined approach of the work conducted by 
Schwab et al. (2003) and Schwab et al. (2004). When examining the plots presented in 
Figures 4.1-4.3, it is evident that the data appears to follow a curvilinear pattern and not 
necessarily a linear pattern which confirms the results of Doepel et al. (2004). This study 
did not test for non-linearity and the authors recognize this deficiency. However, the goal 
of this study was to refine the results of Schwab et al. (2003) and Schwab et al. (2004) 
and now that this goal has been accomplished, new opportunities for conducting more 
complex statistical analyses on this dataset have been realized. Although the study 
conducted by Doepel et al. (2004) represents a more statistically complex analysis, the 
dataset used in that study was extremely limited. The dataset used in this study 
represents the results o f a larger number and more varied research studies, which could 
be used to help further refine the results obtained by Doepel et al. (2004). Additional 
parameters to those used in the current study, such as stage o f lactation, BW, parity, and 
breed could be included in future analyses to determine the effects these parameters have 
on the conversion of AA into milk protein.
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CONCLUSIONS
This study demonstrated that MP, MP-Met, and MP-Lys flows as predicted by 
NRC (2001) can be used to predict milk and milk protein yield. In addition, this study 
demonstrated that MP-Lys was the most accurate predictor o f milk and milk protein yield 
and milk protein yield is more accurately predicted by MP, MP-Met and MP-Lys than 
milk yield. However, this study was designed to further refine the results of previous 
attempts in our laboratory to predict milk and milk protein yield using NRC (2001) 
predicted flows of MP, MP-Met, and MP-Lys. It was not designed to develop prediction 
equations which could be incorporated into existing models, such as NRC (2001). The 
original idea for this effort was designed to help dairy nutritionists predict milk and milk 
protein yields when protein supplements such as, blood meal, protected soy products, and 
protected Met products were included in rations. Future research should focus on 
determining the variable conversion of MP-AA into milk protein to better predict milk 
and milk protein yield responses. In addition, stage of lactation, BW, parity, and breed 
effects could be included in future analyses to determine their impact on the conversion 
of AA into milk protein.
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Figure 4.1. Plots of measured milk yields and milk protein yields vs. NRC (2001) predicted flows 
of metabolizable protein (MP) (g/d). Data used were selected from a database of 464 diets and 
were restricted to include only diets with an MP balance of -300 to 100 g/d, an RDP balance of 
greater than -200 g/d, Lys, % MP less than 7.2 and Met, % MP less than 2.4. The prediction 
equations for milk yields and milk protein yields, respectively, were (n = 153): y = -1.9003 + 
0.0164x, R2 = 0.8121, SE = 3.036 and y = -137.61 + 0.5183x, R2 = 0.8934, SE = 69.087.
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Figure 4.2. Plots of measured milk yields and milk protein yields vs. NRC (2001) predicted flows 
of metabolizable Met (g/d). Data used were selected from a database of 464 diets and were 
restricted to include only diets with an MP balance of -300 to 100 g/d, an RDP balance of greater 
than -200 g/d, Lys, % MP less than 7.2, Met, % MP less than 2.4, and Lys to Met ratio greater 
than or equal to 3.0:1. The prediction equations for milk yields and milk protein yields, 
respectively, were (n = 141): y = 2.3205 + 0.7551x, R2 = 0.6914, SE = 3.815 and y = -12.299 + 
24.027x, R2 = 0.7717, SE = 98.873.
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Figure 4.3. Plots of measured milk yields and milk protein yields vs. NRC (2001) predicted flows 
of metabolizable Lys (g/d). Data used were selected from a database of 464 diets and were 
restricted to include only diets with an MP balance of -300 to 100 g/d, an RDP balance of greater 
than -200 g/d, Lys, % MP less than 7.2, Met, % MP less than 2.4, and Lys to Met ratio less than 
or equal to 3.0:1. The prediction equations for milk yields and milk protein yields, respectively, 
were (n = 16): y = 3.3641 + 0.2146x, R2 = 0.9506, SE = 1.8611 and y = 91.461 + 6.564x, R2 = 
0.9406, SE = 62.775.
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Figure 4.4. Plots o f measured milk and milk protein yields vs. NRC (2001) predicted 
flows of metabolizable protein (MP) and MP-Lys and M P-M et. Data were selected from 
a database involving 321 diets fed to Holstein cows without AA supplementation 
(restrictions used for selecting data are indicated above each o f the plots) (Adapted from 
Schwab et al., 2004).
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Approval is granted for a period of three years from the approval date above. Continued approval 
throughout the  three year period is contingent upon completion of annual reports on the use of 
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request for extension to continue this study. Requests for extension m ust be filed prior to the 
expiration of the original approval.
Please Note:
1. All cage, pen, or other animal identification records must include your IACUC #  listed above.
2. Use of animals in research and instruction is approved contingent upon participation in the 
UNH Occupational Health Program for persons handling animals. Participation is mandatory 
for all principal investigators and their affiliated personnel, employees of the University and 
students alike. A Medical History Questionnaire accompanies this approval; please copy and 
distribute to all listed project staff who have not completed this form already. Completed 
questionnaires should be sent to Dr. Gladi Porsche, UNH Health Services.
If you have any questions, please contact either Van Gould a t 862-4629 or Julie Simpson at 862- 
2003.
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The Institutional Animal Care and Use Committee (IACUC) has reviewed and approved the protocol 
submitted for this study under Category A on Page 4 of the "Application for Review of Animal Use or 
Instruction Protocol" - the study involves only observation or normal maintenance of animals, or animals 
being held/bred but not yet used for research or teaching purposes.
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